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Abstract 
The Influence of Fluorine Substitution on some Enzyme Mediated Reactions 
Colin Francis Bridge 
Ph.D. 1997 
The replacement of a hydrogen or hydroxy group with a fluorine atom is a popular 
strategy to alter the activity of biologically important molecules, as their similar sizes 
mean that such a replacement has little steric impact. The effect of fluorine substitution 
in a number of enzyme mediated processes has been investigated. 
3-Fluorocyclohex-l-enylcarbonyl-CoA has been synthesised and the reaction 
with cyclohexenylcarbonyl-CoA reductase investigated. The fluorinated substrate has a 
comparable Km value to that of the natural substrate but a V^ax that is five times greater. 
A change in the rate-determining step of the reduction was also observed upon fluorine 
incorporation. The enzyme showed a small but significant stereochemical preference 
for the production of the axial isomer, consistent with an Anh-Eisenstein model for the 
transformation. 
The 6a and 6(3 isomers of benzyl fluoropenicillanate were synthesised and their 
methoxide-mediated hydrolyses were investigated. Competitive hydrolysis, using '^ F 
NMR spectroscopy, demonstrated that the p isomer was hydrolysed preferentially. A 
frill kinetic analysis was undertaken, which furnished the rate and equilibrium constants. 
Monofluorinated enamines were treated in situ with a range a Michael acceptors 
to afford a variety of novel substituted a-fluoro ketones. 
2-Fluorohexanal was synthesised from methyl hexanoate and was demonstrated 
to be a substrate for the enzyme transketolase with hydroxypyruvate. The enzyme 
reaction was monitored by '^ F NMR spectroscopy. The enzyme showed a 
diastereoselectivity of 9:1 in the condensation of the aldehyde and hydroxypyruvate, and 
a self-condensation product was also produced. 
The enzymatic oxidation of the mono- and di-fluoromethylenephosphonate 
analogues of glycerol-3-phosphate was investigated at neutral pH using a co-factor 
recycling protocol. The reactions allowed for the first time the identification of the 
products of oxidation and demonstrated the lability of fluoride via non-enzymatic 
elimination and stoichiometric defluorination. 
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Chapter One 
An Introduction to the Effects of Fluorine 
Substitution in Bio-organic Chemistry 
An Introduction to the Effects of Fluorine 
Substitution in Bio-organic Chemistry 
1.1 Introduction 
As the thirteenth most abundant element in the Earth's crust,' surprisingly, natural 
products that contain fluorine are rare and in the cases where they are found very little is 
known about their origin or the enzymatic processes for generating the C-F bond. Only 
ten naturally occurring organofluorine metabolites have been identified,^ five of which 
are homologous fatty acids from the bacterium Dichapetalum toxicarium. - Potassium 
monofluoroacetate, the most common fluorinated natural product, is present in the 
South African plant Dichapetalam cymosum and in more than thirty other tropical plants 
in South America, Africa and Australia.^ Most organofluorine compounds are therefore 
'unnatural' or anthropogenic in origin. 
Fluorinated compounds can more generally be divided into two categories; 
firstly, perfluorinated or highly fluorinated derivatives, i.e. where all or most of the 
hydrogens are replaced by fluorine, and secondly, lightly fluorinated compounds which 
typically contain only one fluorine. The molecules within these two broad groups 
generally find quite different applications. 
Perfluorocarbon (PFC) chemistry is a highly specialised area in industry with 
strong biomedical and technological connections. PFCs are characterised by 
exceptional chemical stability, high oxygen solubility and low surface tension, and are 
of medical interest because they are not metabolised in the human body. Perfluoro-
octane (CgFig), used in vitreo-retinal surgery, and perfluorodecalin (FDC), or notional 
derivatives thereof, e.g. perfluorotripropylamine (FTPA) and perfluoro-octyl bromide 
(PFOB), are examples of PFC compounds with important biomedical applications. 
Fluoropolymers, e.g. poly(tetrafluoroethylene) (PTFE) and poly(vinylidene fluoride) 
(PVDF), provide fiirther examples of the increase in the use of PFCs in technology and 
medicinal applications. 
(i) Blood substitutes 
(C3F7)3N 
Perfluorodecalin Perfluorotripropylamine 
(ii) Oxygen transport/X-ray contrast agent 
CF3(CF2)7Br 
Perfluorooctyl bromide 
(iii) Inhalation anaesthetics 
CF3CHCIOCHF2 CF3CHClBr 
Isoflurane Halothane 
Selective fluorination has become an extremely effective tool for modifying 
reactivity. It has been known for some time that the introduction of fluorine can alter 
the chemical and physical properties of organic compounds. Analogues of biologically 
important compounds, prepared by the replacement of a hydrogen or hydroxy group by a 
fluorine, can have usefiil modifications to their biological selectivity and activity."^ The 
importance of organofluorine-containing compounds is highlighted by the growing 
number of new drugs containing fluorine and the ever increasing number of 
publications. A number of usefiil reviews have been written on the subject of 
organofluorine compounds.^ 
Two of the current top twenty most successful drugs are fluoro-pharmaceuticals. 
One of these, the broad spectrum antibiofic ciprofloxacin 1 (Bayer's Cipro), with sales 
in the region of $1 billion, is the leading member of a chemical class of antibiotics, the 
6-fluoroquinolones. The second drug is the antidepressant fluoxetine 2 (Lilly's Prozac). 
COzH 
Ph 
CH2CH2NHCH3 
1 (Antibacterial) 2 (Antidepressant) 
The range of other therapeutic classes where fluorinated compounds have found 
utility demonstrates the effectiveness that fluorine substitution can have. 
• anti-psychotics (e.g. butyrophenones and phenothiazines typified by 
haloperidol and trifluoroperazine). 
• other CNS agents, including the sedatives flurazepam and flunitrazepam. 
• anti-cancer agents (5-fluorouracil). 
• corticosteroids (e.g. the recently introduced asthma inhaled steroid 
fluticasone). 
• non-sedating antihistamines such as astemizole. 
1.2 Historical perspective 
Although hydrogen fluoride was discovered in 1771 by Scheele,^  molecular fluorine was 
7 8 
not prepared until 1886 by Moissan. The work of the Belgian chemist Swarts in the 
early 1890s on the preparation of fluorinated materials by metal fluoride-promoted HF 
exchange heralded the beginning of modem organofluorine chemistry. Swarts 
subsequently prepared trifluoroacetic acid in 1922. During the 1930s Midgley and 
Henne prepared a range of fluorocarbons,^ and pioneered their use as thermally and 
chemically stable refrigerants and lubricants. Fluorinated chlorocarbons (CFCs) were 
developed in the 1930s by the General Motors Research Laboratories in a search for a 
non-toxic, non-flammable refrigerant to replace the then in use SO2 and NH3. The CFC 
CF2CI2 is a typical example and is identified by the notation CFC-12.^ In addition to 
their use as refrigerants their chemical inertness has made CFCs valuable as aerosol 
propellants, blowing agents for plastic foam production, and as solvents. The two most 
t CFC is followed by a coded two or three digit number. The hundreds unit is the number of carbon 
atoms minus one, the tens is the number of hydrogen atoms plus one, the units is the number of fluorine 
atoms, and the residue is assumed to be chlorine, if the first digit is zero it is dropped. Thus CFC-1! is 
C F C I 3 , CFC-12 is CF2CI2 and CFC-115 is CFjCFjCI . 
common CFCs are CFC-11 and CFC-12, with an estimated 3.1 x 10^  and 4,5 x 10^  kg 
respectively manufactured in 1981. These CFCs, notably the chlorofluoromethanes 
(CFMs) used as aerosol propellants, have been released into the atmosphere where, due 
to their high chemical stability, they accumulate in the stratosphere (CF2CI2 atmospheric 
lifetime 107.8 years). Once there they dissociate under the influence of solar radiation 
to provide chlorine atoms which catalyse the destruction of ozone. 
CF2CI2 • •CF2C1+Cr 
Cr + 03 • C10* + 02 
C10* + 0 >• c r + 02 
Net reaction O3 + O • 2O2 
With the environmental implications of the destruction of the ozone layer, the 
production and use of CFCs have been reduced under the Montreal Protocol, to be 
replaced by HFCs which are 'ozone friendly'. A key replacement, HI34a (CF3CH2F), 
manufactured by Dupont and ICI is however required by the Protocol to be phased out 
by ca. 2005. 
The biological effects of introducing fluorine into organic molecules were fu-st 
studied during World War II by Saunders at Cambridge and Schrader in Germany.'" 
The revelation by Marais in 1943" that the toxicity of the South African plant 
Dichapetalum cymosum was due to monofluoroacetate provided the impetus for studies 
on the toxicology and pharmacology of organofluorine compounds more generally. The 
first significant report of the use of selective fluorination to modify biological activity 
came from Fried in 1954, when 9a-hydrocortisone acetate was monofluorinated to 9a-
fluorohydrocortisone acetate 3.'^ The fluorine in this case is judged to increase the 
acidity of the geminal hydroxy group, strengthen hydrogen bonding and electronically 
retard in vivo oxidation, thus adding to the in vivo half-life of this corticosteroid. 
In 1957 Heidelberger'*^ described the results of initial clinical trials of 5-
fluorouracil (5FU) 4 in patients with advanced cancer. This chemotherapeutic agent is a 
frequently cited example of a fluorinated antimetabolite, which is an effective cytotoxic 
agent that inhibits the enzyme thymidylate synthetase'^  and is much used in cancer 
chemotherapy. Since the 1950s selective fluorination for the purpose of modifying 
biological activity has been carried out routinely by medicinal and bio-organic chemists. 
OAc 
HN 
1.3 Fluorine in biological chemistry 
Hydrogen atom or hydroxy group substitution by fluorine in enzyme substrate analogues 
has been widely practised in various areas of medicinal and bio-organic chemistry. The 
attractiveness and utility of fluorine as a substituent in a biologically active molecule 
results fi-om the profound electronic effects that may result on fluorination as well as the 
fact that fluorine is not a sterically demanding substituent. The van der Waals radius of 
fluorine (1.47 A) lies between that of oxygen (1.57 A) and hydrogen (1.20 A).'"* 
Fluorine therefore has a close isosteric relationship to oxygen and is significantly larger 
than hydrogen. This is not often appreciated as the old Pauling value of 1.35 A is often 
cited as the accepted radius of fluorine.'^ Comparison of the van der Waals volume of a 
methyl group (19.6 A^), using a half sphere approximation, with a trifluoromethyl group 
(42.6 A^) shows that the CF3 group is sterically more akin to an isopropyl group. 
Table 1.1 summarises some of the physical properties of hydrogen, fluorine and 
oxygen. 
Table 1.1 Comparison of size and electronegativity for hydrogen, fluorine and oxygen 
Element van der Waals C-X Bond Electronegativity Bond energy to 
radius/A length Ik carbon/kcal mol"' 
H 1.20 1.09 2.1 100 
F 1.47 1.39 4.0 107 
0 1.57 1.43 3.5 66.5 
Despite this increase in size, the steric impact of a single fluorine is never too 
great and the binding of monofluorinated analogues to target proteins is not normally 
impaired. For example, the steric impact of fluorine substitution has been studied using 
aryl fluorines with lipases.'^ A series of partially fluorinated benzhydrol acetates 5 were 
presented to the lipase from C. cylindracea. The reactions were terminated after 40% 
conversion and the %ee of the resultant alcohols determined (Table 1.2). 
OAc 
C. cylindracea 
*• 
Table 1.2 Enantiomeric excess (% ee) of recovered alcohol 
Fluorine substitution of benzhydrol acetate Ee of alcohol at 40% conversion (%) 
2-fluoro 10 
4-fluoro 0 
2,5-difluoro 57 , 
2,6-difluoro 52 
3,5-difluoro 24 
Mono-substitution at the para position (4-fluoro) resulted in a racemic alcohol, 
and clearly no distinction was made by the enzyme between the two ar}'l groups. 
Substitution, however, at the ortho position (2-fluoro), closest to the reaction centre, 
resulted in some resolution, although the effect was small. The enantioselectivity was 
however increased significantly by the introduction of a second fluorine atom. The 
experiments showed that certain enzyme-substrate combinations will distinguish 
between hydrogen and fluorine on steric grounds. 
Table 1.1 also shows some other significant differences between a hydrogen and 
fluorine atom. The high electronegativity of fluorine compared to hydrogen {c.f. 4.0 to 
2.1) can dramatically alter the electronic profile of a substrate. Fluorine also forms the 
strongest bond to carbon and thus it renders the substituent relatively resistant to 
metabolic transformations. The formation of a C-F bond may also increase the 
lipophilicity of the molecule, particularly as the CF3 group is one of the most lipophilic 
groups known. CF3 substitution renders organofluorine compounds more fat-soluble 
than their non-substituted counterparts, a feature that makes systematic fluorine 
substitution a useful tool in optimising the absorption properties of a drug. For 
7 
example, almost all of the clinically useful quinolone antibacterial agents (e.g. 1 
ciprofloxacin) contain a fluorine at the C-6 position due in part to a 1-70-fold increase 
in cell penetration compared to derivatives with no substitution at the C-6 position.'^ 
Finally, fluoride is a moderately good leaving group, and may be eliminated at or near to 
the enzyme active site leading to covalent attachment of the substrate to the enzyme. 
I f the substitution of a single hydrogen has little steric impact the replacement of 
a methylene for a difluoromethylene group (CHi for CF2) can however induce much 
more dramatic steric and geometric effects. In a recent study, the physical properties of 
the tristearins 6 and 7, containing one and two fluorine atoms at C-12, were examined.'^ 
The substitution of one fluorine atom at C-12 was seen to have little effect on the 
observed melting point and other physical properties. The introduction, however, of a 
second fluorine lead to a significant lowering of the melting point (72 vs. 58 °C) and 
changes in the other observed physical properties. The stability of the Langmuir films 
of the corresponding fluorinated stearic acids 8-10 was also investigated. 12-
Fluorostearic acid 9, like stearic acid 8, formed a stable monolayer on, the surface of the 
aqueous subphase. 12,12-Difluorostearic acid 10, however, formed a monolayer that 
was unstable and susceptible to collapse and reorganisation at comparable surface 
pressures. The observations were indicative of significant conformational disorder as a 
result of the difluoromethylene group. 
R R" 
R = R ' = H mp72°C 
6 R = H , R' = F mp73 °C 
7 R = R' = F mp58°C 
R R" 
8R=R' = H 
9 R = H , R = F 
10 R= R = F 
A similar lowering in the melting point upon the introduction of a CF2 group has 
been observed in diacylphosphatidylcholines^° and the phenomenon, whereby a CF2 
group increases the conformational flexibility of a hydrocarbon chain, appears to be 
general. 
Important differences in the chemical reactivity commonly arise on fluorine 
substitution due to the difference in electronegativity and the increased C-F bond 
8 
strength. The effects may be briefly summarised as follows.^' Fluorine stabilises a-
cations by the interaction of the vacant p-orbital of the carbocation with the filled 
orbitals of the fluorine. Fluorine bonded directly to a carbanionic centre is generally 
destabilising, but when not bonded directly, as in trifluoromethyl-substituted carbanions, 
it can be stabilising. 
v A \ + \ - \ -
^ C - ^ F -< • ^ C = F ^ C — C F 3 ^C—F 
Stabilizing Destabilizing 
1.4 Fluorinated substrate analogues 
1.4.1 ^Fluorinated a-amino acids 
The ability of fluorine to act as a leaving group in addition-elimination processes has 
been exploited in the development of 'suicide' substrates for enzymes. Selectively 
fluorinated P-fluorinated a-amino acids have been widely explored as mechanistic 
based inhibitors'*''''^'^^ for decarboxylases, racemases and transaminases. These 
enzymes are all pyridoxal phosphate (PL?) linked enzymes which generate an a-
carbanion equivalent during catalysis. An example of such an application is the use of 
fluoroalanine^^ as an inhibitor of the enzyme alanine racemase. Fluoroalanine differs 
little sterically from alanine which enables the enzyme to accept the fluorinated 
analogue as a substrate. 
The PLP binds to the enzyme through a lysine residue via an imine which then 
transaminates with the amino acid. The enzymatic inactivation is thought to be 
dependent upon loss of fluoride from the intermediate Schiff base 11 formed between 
pyridoxal phosphate and the fluoromethyl amino acid. Loss of fluoride generates a 
reacfive Michael type acceptor 12 which can add an enzyme-bound nucleophilic 
funcfional group {e.g. -NH2, -OH, -CO2", -SH). The covalently bound enzyme is then 
no longer free to bind any additional substrate. (Fig 1.1). 
The E. coli enzyme processes either enantiomer of p-fluoroalanine with a 
partition ratio of about 800 eliminative turnovers to pyruvate for every Michael attack 
and alkylative inactivation.'^^ Other fluorinated amino acids have been assimilated 
biochemically into proteins '^* and used to study structural changes that result from ligand 
binding or interaction with other macromolecules. 
O3PO 
Me 
EnzB 
€ 0 0 -
O3PO 
+ -O3PO 
O3PO 
N Me Me 
HoO '-'3 
N Me N Me 
Fig. 1.1 Mechanism of inhibition of alanine racemase by fluoroalanine 
1.4.2 Fluoroacetate 
Fluoroacetate 13 is the most common of the ten occurring natural products that contain 
fluorine and has now been identified in over 30 plant species on four continents.^ 
Fluoroacetate is toxic to all cells when activated to fluoroacetyl-CoA 14 and is an 
excellent acetyl-CoA 15 mimic for citrate and malate synthases. The toxicity arises 
because fluoroacetyl-CoA leads to the inhibition of the citric acid (Krebs') cycle, a 
central pathway responsible for generating metabolic energy. Peters showed that 
fluoroacetyl-CoA competes with acetyl-CoA for the enzyme citrate synthase, where it 
reacts with oxaloacetate and is involved in the 'lethal synthesis' of (2./?,3i?)-fluorocitrate 
16 instead of citrate (Fig. 1.2). It is an interesting quirk that citrate synthase mediates the 
formation of the only toxic stereoisomer of the four possible forms. This fluorocitrate 
isomer is a powerful competitive inhibitor of the next enzyme on the pathway, 
aconitase, and this in turn induces inhibition of respiration. There is also evidence that 
fluorocitrate can bind irreversibly to a protein responsible for transporting citrate into 
mitochondria, the site of a cell's energy production, and thus disrupt citrate transport. 
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Fig, 1.2 The 'lethal synthesis' pathway for the inhibifion of the Krebs' cycle 
1.4.3 Aromatic amines 
Fluorine has a useful short-lived isotope, '^ F (half life 110 min), which decays by 
positron emission. Positron emission tomography (PET) using '^ F has become 
increasingly important in identifying the binding sites of selective drug molecules, 
particularly those acting on the brain. One application of '^ F PET is the brain imaging 
of Parkinson's disease patients using the fluorinated amine 6a-['^F]fluoro-L-dopa 17. 
C O o H 
The use of fluorine to modify and probe the reactivity of organic compounds has 
also been extended to carbohydrates,^ '^^ ^ prostaglandins,^^ steroids,'^ acids and esters.^ ' 
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1.5 Fluorine as a hydrogen bond acceptor 
Despite the good size correlation between fluorine and oxygen the ability of fluorine to 
act as a hydroxy mimic is less clear. For fluorine to be a successful hydroxy mimic in 
bio-organic chemistry it must replace the hydrogen bond acceptor ability of the hydroxy 
oxygen. Clearly fluorine cannot replace the hydrogen bonding donor role as it is devoid 
of the hydroxy group's acidic hydrogen (Fig. 1.3). 
Hydrogen bonding, particularly when considering enzyme-substrate binding 
interactions, is important in bio-organic chemistry. The higher electronegativity and 
lower polarisability of fluorine however, weaken its electrostatic influence in 
comparison to oxygen. This compromises its hydrogen bonding ability, and in turn 
effects the ability of fluorine to act as a hydroxy group mimic. 
X ' " O ' F " X 
R R 
donor acceptor acceptor 
Fig. 1.3 OH can act as a hydrogen bond donor or acceptor, 
fluorine can only act as an acceptor 
Theoretical calculations have estimated the strength of an F«««H hydrogen bond 
to be between 2 and 3.0 kcal mol"' with an upper value of 3.2 kcal moF* in the cw-enol 
tautomer of fluoroacetaldehyde.^^ This can be compared to an 0»"H hydrogen bond 
which is typically between 5-10 kcal mol"'.'^^ In strength, therefore, F"«H hydrogen 
bonds are more comparable to 0-H*««rt interactions.''*^ Consistent with this the 
electrostatic influence of fluorine is approximately half that of oxygen.'" Thus the 
greater electronegativity and lower polarisability of fluorine over oxygen suppresses its 
electrostatic influence and renders it a poorer hydrogen bond acceptor. 
Studies of organofluorine compounds in the Cambridge Crystal lographic Data 
Centre database have revealed only a few situations where fluorine is involved in short 
contacts to acidic hydrogens.^ ^ Acidic hydrogens show an overwhelming preference for 
an oxygen or nitrogen acceptor in preference to fluorine. Theoretical and 
crystallographic evidence force the conclusion that fluorine is a poor hydrogen bond 
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acceptor with only moderate capacity to replace oxygen (or nitrogen) in this role. None-
the-less, in the desolvated and preorganised binding site of a receptor or enzyme, a 
fluorine atom substituted for a hydroxy group should be inclined towards the acidic 
hydrogen bond donor, particularly if there are other peripheral stabilising interactions 
present. In such a case an F»»»H hydrogen bond may contribute up to half the energy of 
the original 0«»»H hydrogen bond to the overall binding energy. 
^ O H 
HO 
O 0 
O - - ^ ^ ^ ^ ? I I 
18 R1 = H, R2 = F UDP FGal 
19 R1 = F, R2 = H UDP FC5al 
In this context the fluorodeoxysugars 18 and 19 emerge as good substrate 
analogues for the appropriate enzymes.^ ^ Support for an F"«H hydrogen bond 
confroUing the enzymatic fransformation was provided by Chapeau.^ "* UDP-4-Deoxy-4-
fluoroglucose 18 and UDP-4-deoxy-4-fluorogalactose 19 were tested as substrates for 
the enzyme UDP-D-glucose dehydrogenase. It was foimd that 18 was an excellent 
substrate for the enzyme whereas the diastereoisomeric C-4 epimer 19 was not a 
substrate but a competitive inhibitor. The configuration of the fluorine at C-4 therefore 
appears crucial in securing the correct reactive conformation of the subsfrate on the 
enzyme surface for reaction at the remote C-6 centre. The example suggests that 
fluorine is replacing OH, possibly as a hydrogen bond acceptor, however other examples 
are rare and more often than not the substitution proves detrimental.^ '^^ ^ Such examples 
could be due to the hydrogen bond donor finding an alternative acceptor to fluorine with 
corresponding adverse effects on the binding interaction of the substrate and enzyme. 
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1.6 Stereoelectronic effects 
The active site of an enzyme provides an attractive environment in which geometric and 
stereoelectronic effects that emerge as a consequence of fluorine substitution can be 
probed. Stereoelectronic effects are significantly effected by indiscriminate solvent 
interactions in solution and are generally considered to be low energy phenomenon. The 
dielectric constant of water, at 78.5,''can be compared to estimates of 15-20 for that of 
an enzymatic environment. The enzyme active site is therefore significantly less polar 
than aqueous solvent. Once bound, the substrate is largely desolvated, and exposed to 
either the co-factor, enzyme or second substrate without the presence of any intervening 
solvent. Additionally, the ability of enzymes to restrict the conformational freedom of 
bound substrates may maximise a stereoelectronic effect i f a particular conformation is 
adopted. 
1.6.1 The gmche^^'^'^ and ds*° effects 
For butane, and most other molecules of the form YCH2-CH2Y and YCH2-CH2X, the 
most stable conformation is that of the anti conformer. However, molecules that 
contain small, electronegative atoms like fluorine, e.g. 1,2-difluoroethane,'" are known 
to exist predominantly in the gauche form (Fig. 1.4). 
> 
F 
gauche fevoured cis fevoured 
Fig. 1.4 The gauche and cis effects favour a syn relationship between vicinal fluorines 
The gauche effect is ascribed to nuclear electron attractive forces between the 
groups or unshared pairs of electrons.'*^ This attractive interaction will be maximal for 
the syn eclipsed conformation, however the syn conformafion will suffer from repulsive 
H - H eclipsing interactions and so the gauche conformation is adopted as a compromise. 
For molecules such as 1,2-difluoroethene, the cis geometric isomer is 1-2 kcal moF' 
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more stable than the trans isomer. This is known as the cis effect and is probably 
related in origin to the gauche effect. 
1.6.2 The cis effect in chemistry; citrate synthase 
The action of fluoroacetate with cifrate synthase has been discussed previously in 
section 1.4.2. The high stereospecificity of the formation of only one of the four 
possible stereoisomers of 4-fluorocitrate is of interest, particularly as a related reaction 
mediated by malate synthase does not show the same level of stereochemical 
discrimination. 
During the condensation of fluoroacetyl-CoA with oxaloacetate (Fig. 1.5), citrate 
synthase abstracts with a high level of selectivity (AG > ca. 3 kcal mol"') only the pro-
2S hydrogen atom. The condensation proceeds with inversion of configuration at this 
centre and attack is to the 5/-face of the a-carbonyl of oxaloacetate. 
HOjC 
5/-fece attack 
SCoA 
citrate 
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synthase 
HOjC. 
COjH HOjC 
H 
(2i?,3i?)-fluorocitrate 
Fig. 1.5 Condensation of oxaloacetate and fluoroacetyl-CoA 
Malate synthase can also employ fluoroacetyl-CoA as a subsfrate and mediates 
the condensation with glyoxal to generate two diastereoisomers (2R,3R) and (2R,3S) of 
3-fluoromalate 20 in an approximate 3:4 ratio (Fig. 1.6).'*^ '''^  Malate synthase therefore, 
unlike citrate synthase, does not control the stereochemistry of the new chiral cenfre 
generated as a consequence of fluorine substitution. 
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Fig. 1.6 3-Fluoromalate formation with malate synthase 
The rate determining step for both enzymes is the abstraction of the proton fi-om 
acetyl-CoA (citrate synthase''^  kn/ko = 1.94, malate synthase"*^  kn/ko = 3.9). When 
fluoroacetyl-CoA is the substrate the enzyme bound enol or enolate can have E ox Z 
geometries. 
The relative energies of the enols and enolates were calculated by computational 
modelling.'*^ High level ab initio calculations of a model system, FCH2C(0)SH, 
showed a significant difference (ca. 4 kcal mol"') in the relative energies of the neutral E 
and Z enols. This difference was significantly reduced (ca. 1.8 kcal mol"') when the 
charged enolate intermediates were modelled (Fig. 1.7). 
P OH . SH 
H SH H OH 
£-enol Z-enol 
more stable less stable 
Fig. 1.7 Enols formed from FCH2C(0)SH 
It would therefore appear that in the case of citrate synthase, the enolate as it is 
formed is protonated to an enol in the more stable E geometry to give the resultant 
(2i?,37?)-fluorocitrate product (Fig. 1.8). The preference for the E isomer is consistent 
with the cis effect where the harder fluorine and oxygen atom pair. This is preferred 
over the hard/soft interaction between fluorine and sulfiir. By analogy malate s>Tithase 
is predicted to have a more enolic intermediate giving less control over the 
stereochemistry of the product. 
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Fig. 1.8 Proposed intermediate for formation of enol and aldol condensation 
1.6.3 The fluorine anomeric effect 
The anomeric effect'^^ is a common phenomenon in carbohydrate chemistry where a 
polar group, usually OH, prefers the axial conformation over the s.terically preferred 
equatorial position (Fig. 1.9). This observation extends more generally to X-C-Y 
systems where X has non-bonding electrons and Y is an electronegative group/atom, 
e.g. 0-C-F and N-C-F systems."*^  
X 
x = o 
X = F Ip-n-o* 
Fig. 1.9 Molecular orbital representation of the anomeric effect 
The most accepted molecular orbital explanation for the anomeric effect 
suggests that the lone pair on oxygen lying antiperiplanar to the C-X bond donates 
electron density into the adjacent a*c-x orbital in a stabilising hyperconjugative 
interaction, as shown in Fig. 1.9. This interaction is proportional to the overlap {i.e. 
relative orientation) of the participating orbitals and is inversely proportional to the 
energy gap between them.^" Theoretical studies for understanding the role and nature of 
stereoelectronic effects in 0-C-F and N-C-F systems do not go beyond the smallest 
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molecules, namely fluoromethanol (H0CH2F),'*^ fluoromethyl methyl ether 
(Me0CH2F)^''" and fluoromethylamine (H2NCH2F)." These studies show a preference 
for the gauche conformer over the anti with an energy stabilisation of 6.0 kcal moF'. 
The structural trends associated with the anomeric effect, a shortening of the C-0 bond, 
lengthening of the C-F bond and opening of the 0-C-F bond angle, are observed in X-
ray structure data of the appropriate compounds and is consistent with the 
hyperconjugation hypothesis. 
1.6.4 The Anh-Eisenstein effect 
The search for an understanding of the underlying reasons for Ji-facial selectivity in the 
addition of nucleophiles to double bonds, especially carbonyls, has generated more 
models and hypotheses than any other subject in the field of stereoselective synthesis. 
The most widely accepted model for explaining Jt-facial stereoselectivity in nucleophilic 
addition reaction to cyclic and chiral acyclic carbonyl compounds is'that based on the 
Felkin-type transition structure (Fig. 1.10).^ '' In Felkin's model, the favoured transition 
state structures have a conformation where the bulkiest of the a ligands (L) takes up a 
perpendicular relationship to the plane of the carbonyl group and is anti to the incoming 
nucleophile. Steric and torsional repulsions are then at a minimum. The major 
stereoisomer results from the conformation in which the medium sized group (M) 
occupies the sterically less congested inside position gauche to the carbonyl. 
Nuc- Nuc" 
Major Minor 
Fig. 1.10 Felkin model for nucleophilic addition to carbonyl (L>M>S) 
A particular problem with this model lies with the correct identification of the 
Targe' group (L), because the attribute 'large' incorporates not only obvious steric 
factors, but also electronic factors. Anh and Eisenstein have undertaken a theoretical 
study of the various models, using the reaction of hydride attack on 2-chloropropanal.^^ 
Ab initio calculations found that the conformations assumed by the Felkin model were 
energetically the most favoured, with hydride approaching antiperiplanar to the most 
electronegative atom, chlorine, on C-2. 
The principal of stereoelectronic control states that, 'all other things being equal 
reactions will proceed along paths corresponding to the most favourable molecular 
orbital attack'. Validation of the Anh-Eisentein model comes from consideration of the 
molecular orbitals involved. The low relative energy of the Felkin transition state arises 
from the antiperiplanarity of the C l - H " and C2-L bond. The principal molecular orbital 
(MO) interaction occurring is that between the HOMO of the nucleophile and the 
LUMO (jt*co) orbital of the substrate. Although overlap would be maximised by a 
perpendicular approach of the nucleophile, there are destabilising interactions arising 
from the out-of-phase overlap with the oxygen atom and the four electron interaction 
with the HOMO of the substrate. These are reduced by increasing the angle of attack of 
the nucleophile corresponding to the Biirgi-Dunitz trajectory (Fig. 1.11).^ ^ 
Q Nuc- > — - Q Nuc" 
^*co ^co 
Fig. 1.11 Non-perpendicular attack as a result of stereoelectronic control 
As the principle interaction is the J I ; * C O with the nucleophile's HOMO any effect 
which lowers the energy of jt*co will increase this interaction and stabilise the ttansition 
state. When C l - H " and C2-L bonds are antiperiplanar there is a good overlap between 
JT;*CO and a*c2-L which leads to a stabilisation of the former. However, this good 
overlap also occurs for a synperiplanar attack but this stereochemistry is disfavoured for 
two reasons: (i) anti attack with respect to L leads to an in phase overiap between H ' 
and a*c2-L (n-a*) at C2, syn attack leads to an out-of-phase overiap (Fig. 1.12); and (ii) 
syn attack implies an eclipsing of C l - H " and C2-L bonds. 
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Fig. 1.12 Secondary interactions for anti- and syn-periplanar attacks 
In summary, the electronic factors attributed to L, in tiie context of frontier 
orbital theory, arise from stabilising two-electron interactions in the transition structure. 
These are thought to be dominated either by mixing the filled OHOMO of the forming 
nucleophile-carbon bond with the vacant a*LUMO of the C - L bond (Anh-Eisenstein 
model),^ ^ or by mixing the vacant o* MO of the forming bond with the filled a MO of 
the C - L bond (Cieplak model)." 
Steric factors aside therefore, the Anh-Eisenstein model assigns the best 
acceptor ligand to ' L ' , whereas the Cieplak model assigns the best donor ligand to ' L ' . 
In a further theoretical study, Wong and Paddon-Row sought to tackle which 
electronic model was the more realistic using an ab initio MO study of nucleophilic 
attack on a chiral carbonyl system with fluorine as one of the substituents on the a-
carbon.^ ^ The study specifically concentrated on the addition of a cyanide nucleophile 
to 2-fluoropropanal. 
The results of the study showed that the lowest energy transition state was 
achieved when the best acceptor, fluorine, was antiperiplanar to the attacking cyanide 
nucleophile, and the methyl group occupied the inside position to give the product 21 
which agrees with the Anh-Eisenstein model. 
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The transition state structure for 21 is 12.4 kJ mol"' more stable than the Cieplak 
transition structure 22, in which the C - H bond is antiperiplanar; this gives rise to the 
corresponding diastereoisomer of 21. 
ctr-
The greatest amount of charge transfer to the aldehyde was observed when the 
C - F bond was antiperiplanar. This is in accord with the stabilisation of electron rich 
transition states by an electron-withdrawing antiperiplanar C - F bond. The results of the 
study concluded that the electronic component to the determinant of jc-facial 
stereoselectivity in the nucleophilic addition to a-halogenated carbonyl groups is better 
represented by the Anh-Eisenstein model. However it should be noted that the 
preference for the C - F to adopt the antiperiplanar conformation could be contributed in 
part to adverse dipole or electrostatic effects which are reduced by anti attack. 
The origins of both the fluorine anomeric effect and the Anh-Eisenstein effect 
therefore lie in the ability of the a* LUMO orbital of the C - F bond to accept electron 
density, from either the heteroatom in the former or attacking nucleophile in the latter 
case. 
1.6.5 The Anh-Eisenstein effect in enzyme reactions 
There is now considerable interest in the use of enzymes to produce optically active 
compounds either by means of a kinetic resolution or stereospecific chemical 
transformation {e.g. reductions, oxidations, epoxidations). This interest extends to the 
preparation of homochiral fluorinated compounds. A recent publication by Haufe '^ 
reported the first example of enzymatic esterifications of monofluorinated alcohols in 
organic media. Racemic a)-fluoro-(cc)-l)-hydroxyalkaiioates were resolved by the lipase 
of Pseudomonas cepacia (LAPS) in toluene at room temperature (Fig. 1.13). 
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Hydrolases in general have been used to effect kinetic resolutions of racemic 
esters, primarily in the enantioselective hydrolysis of mono- and di-esters with chiral 
centres on the carboxylate part of the molecule.^" Lipases have been used to effect 
kinetic resolutions of chiral alcohols via enantioselective hydrolysis of their esters, but it 
is their application to the hydrolysis of racemic esters with chirality on the carboxylate 
moiety that has been more widely exploited.^' The availability and low cost of lipases 
make them a very attractive class of catalyst for effecting kinetic resolutions in 
industrial applications. 
Pig Liver Esterase (PLE) is one of the most useful enzymes for the preparation 
of valuable chiral synthons. However, its applications in asymmetric synthesis has been 
hampered by its seemingly unpredictable specificity. This disadvantage has been 
overcome by the development of active-site models which can account for the structural 
and stereoselectivity of PLE-hydrolases reported and is of predictive value for new 
substrate structures.^^ The model depicted in Fig. 1.14 is comprised of four binding 
regions. The two hydrophobic pockets, which interact with the aliphatic or aromatic 
hydrocarbon portions of the substrate, are designated H L and Hs- Two more polar 
cavities at the front PF and PB can accommodate electron-rich functions and act as 
hydrogen bond acceptors. The ester group to be hydrolysed must locate in the serine 
nucleophile region (dotted circle). 
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Fig. 1.14 Active site model of pig liver esterase' 62 
The active site of a lipase is therefore generally considered to accommodate a 
particular substrate on the basis of fit and electronic compatibility to the surface of the 
protein. This gives rise to the preferential binding and subsequent hydrolysis of one 
enantiomer over the other. 
Despite this recent rapid development in the use of enzymes in organic synthesis 
only a few successful examples of enzymatic hydrolysis of monofluorinated compounds 
have been found. In this context the lipase resolution in high enantiomeric excess of a-
fluoro esters 23 and 25 (Fig. 1.15) are remarkable."'^ 
In the first example racemic ethyl 2-fluorohexanoate 23 was resolved into its 
component enantiomers using a lipase from Pseudomonas fluorescens (P30)." The 
reaction was allowed to proceed to 60% conversion, at which point the isolated residual 
ester was judged to be solely the R enantiomer 24 in 99% ee. In the second example the 
Amano MY lipase from Candida cylindracea exclusively hydrolysed the pro-S ester 
group of the prochiral compound 2-fluoromalonate 25, to give 26 with a 99% ee.^ 
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Fig. 1.15 Lipase hydrolysis of a-fluorinated esters 
These levels of stereoselectivity are difficult to rationalise on the basis of a 
spatial active site model. In each case the lipase makes a complete distinction between 
the fluorine and hydrogen atoms. As already discussed, the steric influence of fluorine 
over hydrogen is predicted to be too small to lead to such high levels of selectivity. It 
has therefore been proposed^^ that the high selectivity displayed in these lipase 
resolutions arises due to an Anh-Eisenstein type stabilisation in the transition state. 
In a lipase-mediated hydrolysis a serine alkoxide nucleophile at the enzyme 
active site attacks at a predesignated face of the ester carbony! group. The two 
enantiomers of the a-fluoro ester substrate will then give rise to two different 
diastereoisomeric transition states (Fig. 1.16). 
E n z Enz 
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Fig. 1.16 Diastereoisomeric transition states formed by alkoxide attack 
on a-fluoro esters 
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Following the Felkin model the nucleophile can approach either anti to the C-F 
bond (TS 1) or gauche (TS 2) to the C-F bond. Clearly, from previous analysis of 
nucleophilic attack at carbonyl groups with a fluorine at the a-carbon, the preferred 
transition state geometry will be as shown in TS 1 where the incoming nucleophile is 
antiperiplanar to the C-F bond. The situation was modelled at an ab initio level, using 
MeO" as the nucleophile (serine hydroxide surrogate) and methyl 2-fluoropropionate as 
the substrate ester. The results of the study revealed a significant discrimination in the 
energies of the two transition states with TS 1 lower in energy than TS 2 by 2.8 kcal 
mol'V The calculated entropy difference between the two transition states of 0.4 cal K ' ' 
mol"' gave a free energy difference at 300 K of 2.5 kcal mol"'. An energy difference of 
this magnitude would correspond to a ratio between TS 1 and TS 2 of ca. 100:1, which 
can frilly account for the observed high enantioselectivities (99% ee). 
Implicit in these resolutions is the ability of the enzyme to hold the substrate in a 
conformation which can accommodate the stereoelectronic effect as the reaction moves 
towards a transition state. Depending on the bound conformation of the ester substrates, 
differing lipases will show varying abilities to resolve the a-fluoro esters. 
1.7 NMR Spectroscopy 
Since the first attempts to detect fluorine NMR signals over fifty years ago, '^ F NMR 
spectroscopy has evolved into a powerful analytical tool routinely used for the 
elucidation of chemical structures.^ ^ With a 100% natural abundance and a large 
magnetic moment, the '^ F isotope presents no problems in sensitivity. Like a proton, 
'^ F has a spin quantum number of / = Vi making coupling patterns easy to deduce. The 
range of chemical shifts is very wide, around 800 ppm, however most resonances of a 
carbon-fluorine environment occur within a 300 ppm range. Strong coupling (Table 
1.3) to other nuclei results in long range effects that influence both the '^ F NMR 
spectrum and that of the other nuclei. At 2.35 T, fluorine resonances are at 94 MHz: the 
range of 5 values in common environments is around 300 ppm, so the spread of 
frequencies is approximately 30 000 Hz. This range is far greater than for any other 
commonly studied NMR nucleus. '^ F NMR spectra are routinely referenced to C F C I 3 as 
0 ppm, with the usual convention that positive 8 means higher frequency than C F C I 3 . 
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Table 1.3 Representative '^F NMR coupling constants' ..67 
System Type Typical J 
value/Hz 
System Type Typical J 
value/Hz 
x ; Vpp 150-270 1 160-370 
>< 45-65 " C - C - F 30-45 
70-90 ^ ^ C — C — C — F ^•^CF 5-25 
1.8 Aims and objectives 
The objectives of the project were to further probe the effects of fluorine substitution in 
a range of enzymatic transformations. This would involve the synthesis of a number of 
regio- and stereo-specifically fluorinated compounds which would, by a series of 
techniques, be studied through the course of given enzyme reactions. Suitable 
fluorinated substrate analogues for various enzymatic transformations are outlined 
below. 
(i) Cyclohex-l-enecarbonyl-CoA reductase (enoyl reductase) 
^SCoA 
F O 
S C o A 
(ii) P-Lactamase 
-N 
CO2H 
-N 
C O j H 
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(iii) Glycerol-3-phosphate dehydrogenase 
OH F H OH F F 
H O . X " ° ^ 0 < P C °O-
(iv) Transketolase 
For each transformation the fluorinated analogue of the natural substrate is 
employed to explore any kinetic differentiation or stereoelectronic control exhibited by 
the enzyme. 
1.9 Fluorinating reagents 
With the need to prepare a number of fluorinated compounds it is useful to briefly 
review some of the methods employed for fluorination of organic compounds, with a 
particular emphasis on those methods employed in this thesis. The preparation of 
organofluorine compounds remains a difficult area, especially when incorporation of 
fluorine is required in a regio- or stereo-selective manner. Since fluorine itself is so 
reactive and difficult to control, alternative methods of incorporating fluorine into 
organic molecules are required. The great importance of selectively fluorinated 
molecules has unsurprisingly given rise to numerous methods for fluorine insertion and 
a number of reviews have been published covering fluorination techniques.^ '^^ ^ 
Fluorinating reagents are classified into groups according to their mode of action, i.e. 
nucleophilic, electrophilic or free radical fluorine transfer. The methods discussed here 
and used throughout the project are all of the nucleophilic type. 
7.9.7 Sulfur tetrafluoride (SF4) 
Sulfur tetrafluoride (SF4) was first introduced by Dupont in 1960 and many reviews 
have described its app l ica t ions .The main uses of SF4 are outlined in Fig. 1.17. 
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Fig. 1.17 Major functional group interconversions using SF4 
Sulfur tetrafluoride is usually used in conjunction with a Lewis acid or with liquid HP, 
which act catalytically and reduce reaction temperatures and times. However, the major 
drawbacks of SF4 are its volatility (bp -38 °C) and its toxicity, which is comparable to 
phosgene. Reactions also require the use of sealed, stainless steel vessels which make 
the reagent relatively difficult to handle. 
1.9.2. Diethylaminosulfur trifluoride (DAST) 
Diethylaminosulfur trifluoride (DAST), which was first prepared by Middleton, has 
become the most widely used fluorinating reagent.^ '^  Its success is due to the fact that it 
can mimic the chemistry of SF4 while avoiding the problems of high pressure and 
toxicity. It is a commercially available liquid that is relatively easy to handle (bp 46-47 
°C at 10 mmHg), and can be stored for long periods without significant decomposition. 
Among the major uses of DAST are the fluorination of alcohols to monofluorinated 
species and the conversion of aldehydes and ketones to gew-difluorides.^^ 
Mechanistically, the reaction of DAST with hydroxy groups proceeds via 
nucleophilic attack by the hydroxy group on to sulfur generating the intermediate 27. 
Nucleophilic attack of fluoride to the intermediate gives the product, generally with 
overall inversion of stereochemistry (Fig. 1.18). 
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Fig. 1.18 Mechanism of fluorination of alcohols with DAST 
Although reactions usually occur with stereochemical inversion, reactions where 
stereochemistry is retained are known, as well as SNI type mechanisrns. Two problems 
that can occur when replacing O H groups with DAST are carbonium ion type rearrange-
ments and dehydration to give alkenes. The carbonium ion rearrangements are however 
less likely to occur with DAST than with other known fluorinafing reagents. For 
example, fluorination of isobutyl alcohol with DAST gave more than a 2:1 ratio of 
isobutyl fluoride to tert-h\x\y\ fluoride, whereas fluorination with SeF4»pyridine is 
reported to give only the rearranged ^er^butyl fluoride.^'* 
D A S T 
OH * • 
49% 21% 
Dehydration (eliminafion) is also less of a problem with DAST. For example, 
cyclooctanol reacts with DAST to give a 70:30 rafio of cyclooctyl fluoride to 
cyclooctene, whereas as Et2NCF2CHClF gives only cyclooctene.^" 
-OH D A S T 
70% 30% 
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1.9.3 Hydrogen fluoride 
Anhydrous hydrogen fluoride is one of the classical fluorinating reagents, but though 
cheap and readily available its volatility (bp 19.6 °C) and corrosiveness provide 
obstacles to its utility. The introduction of pyridinium poly(hydrogen fluoride), 
(HF)xpy, a stable liquid of approximate composition 30% pyridine-70% HF, by Olah in 
1973 has allowed numerous new applications for the use of HF.^ ^ The reagent is 
commercially available, does not lose HF below 50 °C, and is relatively easy to handle. 
It has proved to be an extremely versatile reagent which can be used to fluorinate a 
range of reagents including fluorination of alkenes and alkynes, isocyanates, alcohols, 
diazoalkenes and diazoketones and acid chlorides (Fig. 1.19).^ ^ 
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Fig. 1.19 Functional group interconversions with HF-pyridine 
1.9.4. Metal fluorides 
Nucleophilic displacement of a halide by fluoride is amongst the cheapest and most 
widely employed methods for the introduction of fluorine. Among the most common 
reagents are KF, CsF, KF-HF and AgF, which are generally used in the displacement of 
tosylates, mesylates and triflates.'*'^  Anhydrous polar solvents {e.g. MeCN, DMF) are 
usually required to obtain a high concentration of dissolved fluoride, as water reduces 
the nucleophilicity of fluoride. 
Silver fluoride is a commercially available solid which was used by Swarts in his 
synthesis of methyl fluoroacetate.^* It is a popular reagent because of its high selectivity 
and low basicity (compared to alkali metal fluorides) which minimises elimination 
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reactions. Its main use is in selective halogen exchange reactions, e.g. RI RF. 
However, its disadvantages are its high cost (5 g = £35) and that two equivalents of 
reagent are required to generate one equivalent of fluorinated product. 
RX 2 A g F R F + A g F ' A g X 
1.9.5 Tetraalkylammoniumfluorides 
Tetraalkylammonium fluorides overcome the problems of alkali metal fluorides by 
providing (i) a soluble source of F' and (ii) replacing the M"^  ion with a bulky organic 
cation, thereby reducing ion-pairing and enhancing the nucleophilicity of F". The most 
common reagent of this class is 'anhydrous' tetrabutylammonium fluoride (TBAF). 
TBAF is commercially available, however it suffers from being extremely hygroscopic 
and its major disadvantage is that the presence of varying amounts of water often 
produce erratic results. However, wet TBAF has been successfiiUy used to prepare 
fluorinated compounds. Tetrabutylammonium hydrogen bifluoride (Bu4N'^ HF2") 
(TBABF) has been used as an improved source of 'naked' fluoride ion.^^ TBABF has 
been used in the halofluorination of alkenes by treatment of the alkene with NBS and 
TBABF in dichloromethane.^^ However, unlike reaction with TBAF-NBS mixture 
which gives high yields of the bromo-fluoro product, a major side product with 
TBABF-NBS was the formation of vicinal dibromides (Fig. 1.20). 
NBS 
T B A B F 
'Br 
65% 25% 
Fig. 1.20 Halofluorination of alkene using NBS-TBABF 
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An Investigation into the Anh-Eisenstein Effect 
in an Enzymatic Transformation 
2.1 Introduction 
In 1961 the Intemafional Union of Biochemistry adopted a systematic scheme for the 
classification of the known enzymes. The six main classes of enzyme were established 
as the oxidoreductases, transferases, hydrolases, lyases, isomerases and ligases.^ ^ The 
action of the oxidoreductases (group I) is the catalysis of oxidation-reduction reactions, 
of which the most common is the interconversion of alcohols to aldehydes or ketones 
(E.C. 1.1.1.1 alcohol dehydrogenase) (Fig. 2.1). 
alcohol 
dehydrogenase O 
"OH 
H 
NAD+ NADH 
Fig . 2.1 
In order for enzymes to be catalytically active many require additional co-
factors. These co-factors may be as simple as metallic cations or as elaborate as 
complex organic molecules known as co-enzymes. When co-factors are required, the 
enzyme must include additional binding sites. An enzyme that lacks an essential co-
enzyme is knovm as an apoenzyme, while the complex between enzyme and co-enzyme 
is termed the holoenzyme. 
Nicotinamide adenine dinucleotide and its reduced form (NAD^ and NADH) 
serve as co-enzymes in a large number of enzymatic redox reactions, and form one of 
two co-enzyme forms of nicotinamide. The other is nicotinamide adenine dinucleotide 
phosphate (NADP^ and NADPH), which differs by the presence of a phosphate group at 
C-2' of the adenosyl moiety (Fig. 2.2). The NAD(P)H dependent enzymes include 
dehydrogenases, transhydrogenases, oxidases and enoyl reductases. 
HoN 
HO OH 
H (PO32-) 
Fig. 2.2 Structure of NADH (and NADPH) co-enzyme 
The fimction of the NAD(P)H co-enzyme is to either accept a hydride (H") from 
a substrate (oxidation) or to donate hydride to a substrate (reduction). This hydride 
fransfer takes place between the substrate and the pyridinium cation or, conversely, the 
1,4-dihydropyridine in the nicotinamide moiety and the carbonyl substrate, and is a 
readily reversible process (Fig. 2.3). 
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Fig. 2.3 Interconversion of NAD^ (NADP"") and NADH (NADPH) 
The essential characteristics of NAD(P)H-dependent enzymes can be 
summarised as follows: (i) the reactions take place with the ternary (apoenzyme-co-
enzyme-subsfrate) complexes; (ii) the fransfer of the hydride is direct and apparently 
involves no exchange with solvent proton; (iii) the reactions are stereospecific with 
respect to both the co-enzyme and the substrate.^° Once formed, the NADH diffuses or 
is fransported to the terminal electron-transfer sites of the cell and is re-oxidised by 
terminal electron acceptors (O2 in aerobic organisms) with the concomitant formation of 
ATP. 
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2.1.1 NAD(P)H-dependent alcohol dehydrogenases 
Among the enzymes that ufilise NAD(P)H as a co-enzyme are a number of 
dehydrogenase activities which include alcohol dehydrogenase, glutamate 
dehydrogenase and glyceraldehyde-3P-dehydrogenase. Many alcohol dehydrogenases 
such as horse liver alcohol dehydrogenase (HLADH) have been identified which 
catalyse the redox conversion of carbonyls and alcohols. Such enzymes have been the 
subject of extensive kinetic and mechanistic studies and have been widely exploited in 
biotransformations.^' These enzymes are readily available, and accept a broad range of 
substrates. The chemical mechanism by which NAD'^ is reduced to NADH is shown in 
Fig. 2.4. 
B — E ^ R - N H - B - E 
Fig. 2.4 
NAD(P)'^ fiinctions as a co-enzyme in redox reactions by reversibly accepting 
hydrogen at the 4-position of the nicotinamide ring (Fig. 2.3). The C-4 position in the 
dihydronicotinamide ring is prochiral and thus the faces of the nicotinamide ring 28 and 
the C-4 protons of the dihydronicotinamide ring 29 may be assigned by the re and si 
convention. 
re I R 
28 
NH, 
29 
In a series of historically important experiments, Westheimer, Vennesland and 
co-workers demonstrated that the hydrogen transfer between substrate and NAD"^ was 
direct and stereospecific.^ '^^ ^ The experiments with alcohol deydrogenase were the 
earliest to show the high stereospecificity of enzymatic action at prochiral centres 
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involving chemically equivalent hydrogen atoms and were achieved by tracing 
deuterium through the course of the transformations. Yeast alcohol dehydrogenase 
transfers 1 mol of deuterium from C H 3 C D 2 O H to NAD^. When the formed NADD was 
incubated v^th unlabelled acetaldehyde, all the deuterium was lost from the NADD and 
incorporated back into the alcohol formed. The deuterium or hydrogen was transferred 
stereospecifically to one face of the NAD"^  and then transferred back from the same face. 
A non-specific fransfer to both faces would have lead to the transfer of 50% of the 
deuterium back to the acetaldehyde (Fig. 2.5). 
C H , - O H 
H 
NH, 
H 
D H 
Fig. 2.5 
Through the use of deuteriated substrates it has been determined that some 
dehydrogenases will transfer hydrogen to one face of the ring preferentially, while others 
will transfer to the opposite face. The enzymes have therefore been classified as 'A' or 
'B' on this basis (Table 2.1). 
D R H S 9 H R _DS O 
Class 'A' Class 'B' 
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The enzymes in class 'A ' transfer the proAR hydrogen from NAD(P)H to a 
substrate, whereas those in class 'B ' transfer the proAS hydrogen. Crystal structures of 
the dehydrogenases show that for the class 'A ' enzymes the NAD"^ binds with the 
nicotinamide ring in the anti conformation about the glycoside bond, where the class 'B ' 
enzymes bind in the syn conformation 84 
Table 2.1 The co-enzyme specificity of some dehydrogenases' 85 
Dehydrogenase Co-enzyme Stereospecificity class 
Glutamate NAD* orNADP* B 
Glucose-6-phosphate NADP* B 
3-Glycerol phosphate NAD* B 
Glyceraldehyde-3 P NAD* B 
Alcohol NAD* A 
Lactate NAD* A 
Isocitrate NADP* ' A 
The specificity shown by the enzyme is thought to arise as a natural consequence 
of the fact that enzymes are asymmetric molecules that form highly stereoselective 
complexes with their substrates. The enantiomeric specificity of HLADH has been 
widely exploited for the resolution of racemic alcohols and ketones.^ ^ 
H/? H S 9 
O H 
L 
OH NH, 
Fig. 2.6 Stereochemical course of most ADH-catalysed reactions 
The stereochemical course for most ADH catalysed reductions is known to 
involve attack at the re face of the carbonyl by the pro-AR hydrogen giving an alcohol 
with the S configuration (Fig. 2.6). This observation has been formulated as Prelog's 
rule 87 
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The major practical problem with the use of enzymes in organic synthesis is the 
expense of co-enzymes like NAD(P)H. The co-enzymes are much more expensive than 
the most expensive competitive selective chemical reducing agent. This economic 
problem can be overcome by using catalytic quantities of the co-enzyme and recycling it 
in situ to the active form. Recycling can be achieved in three ways; non-enzymatically, 
88 
e.g. with sodium dithionite (Na2S204), enzymatically by a coupled enzyme system or 
enzymatically by a coupled substrate system. The first extensively-used method 
employed coupled substrates using only one enzyme which catalyses the desired redox 
reaction as well as the recycling reaction.^^ This is achieved by the addition of a second 
compound which is a good substrate for the enzyme but in the opposite direction (Fig. 
2.7). 
HLADH 
NADH 
HLADH 
Fig. 2.7 Coupled-substrate NADH regeneration' 90 
In coupled enzyme recycling methods an auxiliary enzyme system is used to 
regenerate the active co-enzyme. This auxiliary enzyme may be one single enzyme or a 
multi-enzyme system. It was the work of Whitesides who first demonstrated that 
NAD(P)H could be recycled in up to mole quantities using a coupled enzyme system^ 
and this will be discussed further in Chapter 5. 
91.92 
2.7.7 Enoyl reductases 
In contrast to the alcohol dehydrogenases, NAD(P)H-dependent enoyl thioester 
reductases have received limited study, even though such enzymes play a key role in 
processes such as fatty acid and polyketide biosynthesis.^ '^  In the biosynthesis of fatty 
acids the enoyl reductase is the enzyme responsible for catalysing the final reaction in 
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the cycle of condensation-reduction-dehydration-reduction sequence that results in the 
lengthening of the fatty alkyl chain by one C H 2 C H 2 unit.^'' 
Interestingly, up until the final stage of the cycle it appears that the individual 
enzymes of the fatty acid synthatase (FAS) operate with a universal stereo-integrity. 
However, the stereochemical course of the final reduction by the enoyl reductase 
appears to vary in different organisms. Within the final reduction by the enoyl reductase 
there are three stereochemical issues to be addressed. Firstly, which of the hydrogens, 
pro-AR or pro-AS, in NADPH is delivered to the alkene. Secondly, to which face of the 
alkene at C-3 is the hydrogen transferred. Finally, to which face does protonation from 
the medium occur at C-2. trans-2-Enoy\ reductases from different sources are known to 
utilise different prochiral hydrogens of NAD(P)H and present to them to varying faces 
of the double bond (Fig 2.8). 
3-si 2-re 
3-re 
enoyl reductase 
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NAD(P)H 
pro-3R 
pro-3S H,„ 
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H pro-2R 
pro-2S 
Fig. 2.8 Stereochemistry of enoyl reductases 
The reductase from E. coli, for example, is known to present the pro-AS 
hydrogen of NADPH, and adds hydrogens suprafacially to the 2re,3si face of the double 
bond. Yeast also transfers the pro-AS hydrogen of NADPH but instead adds hydrogens 
antarafacially in a 2si,3si mode. Some of the available stereochemical data on this 
transformation is summarised in Table 2.2.^ ^ 
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Table 2.2 Stereochemistry of various trans-2-enoyl reductases 
Source NAD(P)H C-2 C-3 Classification 
E. coli pro-AS re si bacteria 
A. nidulands — re — blue-green algae 
B. ammoniagenes pro-AS si si bacteria 
S. cerevisiae pro-AS si si yeast 
Rat Liver pro-4R si re mammal 
A. cinerariae — si — fungi 
The stereochemical outcome at C-2 of a number of fungal strains {A. cinerariae 
and C. cladosporiodes) which produce polyketide secondary metabolites has also been 
investigated.^^ The enoyl reductase of fungal polyketide synthase presents hydride to 
the re face at C-2, whereas in the same organism the corresponding enzyme from the 
FAS presents hydride to the si face at C-2. This observation suggests that the polyketide 
synthase and FAS have different evolutionary origins. 
2.2 Cyclohex-l-enylcarbonyl-CoA reductase (CHCR) 
Ansatrienin A (mycotrienin I) 30 is an antibiotic metabolite that has been isolated from 
Streptomyces collinus^^ and Streptomyces rishiriensis^^ and shows pronounced activity 
against fungi and yeasts. 
O C H , 
6H3C H 
30 
40 
The structure of the antibiotic is unusual in that it contains a cyclohexane-
carboxylic acid moiety which is attached via an alanine residue to the ansa ring system. 
Biosynthetic studies have revealed that the cyclohexanecarboxylic acid moiety is 
98 99 
derived intact from the seven carbon atoms of Shikimic acid 31. ' The cyclohexane-
carboxylic acid of 30 was also found to have exclusively an S configuration at C-1 of the 
cyclohexane ring upon incorporation of [2-'''C]Shikimic acid. Furthermore, evidence 
that the pathway to cyclohexanecarboxylic acid passes through a cyclohex-1-
enecarboxylic acid intermediate 34 was obtained with the detection of an ansatrienin 
analogue (ansatrienin A4) which contains a cyclohex-l-ene rather than a cyclohexane 
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moiety. Conversion to the cyclohex-l-enecarboxylic acid moiety is accompanied by 
migration of the original double bond in the ring. The final process apparently involves 
the reduction of the double bond by addition of hydrogen to the re-face of C-1 (Fig. 2.9). 
COOH 
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Fig. 2.9 Incorporation of [2-'-'C]Shikimic acid into ansatrienin 30 
COSCoA 
30 
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The unique pathway from Shikimic acid to the cyclohexanecarboxylic acid 35 
would appear to progress through a series of alternating dehydrations and reductions. 
The last three steps of the pathway involve a reduction of the a,P-double bond of 
cyclohexa-l(6),2-dienylcarbonyl-CoA 32 to produce cyclohex-2-enylcarbonyl-CoA 33. 
This then undergoes an isomerisation of the double bond into conjugation with the 
carbonyl group to give cyclohex-l-enylcarbonyl-CoA 34. Finally, the alkene is reduced 
by an enoyl reductase activity to give the cyclohexanecarboxylic acid moiety which is 
incorporated into 30. 
Reynolds and co-workers have isolated the NADPH enoyl reductase activit>' 
from Streptomyces collinus. 100,101 This was the first isolation of an enoyl-reductase 
activity involved in a secondary metabolic process. The purified enzyme catalyses the 
conversion of cyclohex-l-enylcarbonyl-CoA 34, to the corresponding thioester of 
cyclohexanecarboxylic acid 35. The enzyme has recently been cloned, over-expressed 
41 
in E. coli, purified to homogeneity and has been named cyclohex-l-enylcarbonyi-CoA 
reductase (CHCR).'"^ 
This reductase is a dimer with subunits of identical Mr (36 000). It exhibits a Km 
of 1.5 ± 0.3 |J,M for NADPH and 25 ± 3 [xM for cyclohex-l-enylcarbonyl-CoA and it is 
most active at 30 °C at a pH optimum of 7.5, with a rapid fall-off in activity at pH 
values above 7.5. Like other previously studied enoyl reductases it is inhibited by thiol 
reagents, and divalent cations (only i f preincubated without co-factor). The enzyme is 
also highly specific for NADPH as the co-factor, with no measurable activity being 
observed with NADH. Unlike some other enoyl reductases, which have been shown to 
be active with the A^-acetycysteamine derivatives of the carboxylic acids,^ '* the enzyme 
showed no activity with either the free acid or A^-acetylcysteamiue derivatives and was 
only active when the cyclohex-l-enecarboxylic acid was activated as the CoA thioester. 
The stereochemical course of the reduction step has been evaluated by 
Reynolds. "^ '^  The reduced cyclohexanecarbonyl-CoA produced after an incubation of 34 
in ^HaO was hydrolysed, and converted into its corresponding methyl ester. The methyl 
cyclohexanecarboxylate obtained was found to be 77% monodeuteriated at C-1 by GC-
MS analysis. In order to determine the stereochemical course of hydrogen incorporation 
at C-2, [(47?)-^H]NADPH and [(4S)-^H]NADPH were synthesised and used in the 
reduction. Deuterium incorporation was only seen with [(4S)-^H]-labelled NADPH. 
Thus the stereochemical course of the reduction of 34 to 35 catalysed by 
cyclohex-l-enylcarbonyl-CoA reductase proceeds by transfer of the pro AS hydrogen of 
NADPH to the si face of the (5 carbon (C-2) and hydrogen incorporation at the a carbon 
(C-1) from the medium ( H 2 O ) in an anti mode (Fig. 2.10). 
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Fig. 2.10 Stereochemical course for the conversion of 34 to 35 catalysed by 
cyclohex-1 -enylcarbonyl-CoA reductase 
This enzymatic system attracted our attention as the product of the reduction 35 
contains a cyclohexane ring. The cyclohexane ring has long occupied a central place in 
the study and development of stereoelectronic theory, and therefore this enoyl reductase 
offered a unique and highly attractive system with which to probe the stereoelectronic 
effect of a fluorine atom in an enzymatic transformation. 
2.3 Exploring Anh-Eisenstein stabilisation 
Reynolds has shown that CHCR will accept some novel substrates. The enzyme was 
shown to display similar levels of activity for cyclohexa-l(6),2-dienylcarbonyl-CoA 32 
and cyclohex-1-enylcarbonyl-CoA. Analysis of the incubation of 32 with CHCR 
revealed that the product was exclusively cyclohex-2-enylcarbonyl-CoA 33. The 
enzyme also reduced trans-hexenoyl-CoA but it showed no activity with crotonyl-CoA 
36, benzoyl-CoA 37 or cyclohex-2-enylcarbonyl-CoA. However, low levels of 
reducfion were observed for cyclohexa-l,3-dienylcarbonyl-CoA (13%) and cyclohexa-
1,4-dienylcarbonyl-CoA (28%). 
SCoA 
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The introduction of fluorine onto the cyclohexene ring system would allow 
further probing of the substrate specificity of the enzyme, but more importantly, the 
stereoelectronic effect of a fluorine atom in an enzymatic transformation could be tested 
with the reductase. In the previously cited examples of lipase resolutions with 
fluorinated substrates, the fluorine atom was placed on the a carbon of the sp^  carbon 
centre under nucleophilic attack. It was then possible to explain the high levels of 
stereoselectivity by an Anh-Eisenstein stabilising interaction. 
Similarly, substitution of a single fluorine atom at either the allylic C-3 or C-6 
positions in the cyclohex-1 -eneylcarbonyl-CoA substrate might induce the same effect. 
This substitution, as discussed in Chapter 1, would be expected to impart only a small 
steric perturbation on the ring because of the similar sizes of fluorine and hydrogen, but 
it may induce significant changes in the electronic character of the substrate. 
Clearly, in the fluorinated substrate analogue the fluorine atom may occupy 
either an axial or equatorial position in the substrate. I f the approach of the incoming 
hydride nucleophile is considered with respect to the fluorine on the a-carbon then two 
diastereoisomeric transition states emerge (Fig. 2.11). 
2.3.1 3-Fluorocyclohex-l-enylcarbonyl-CoA 41 
It can be envisaged that for the 3-fluorocyclohex-l-enylcarbonyl-CoA substrate the (37?) 
pseudo-axial fluorine would give the lower energy transition state. In this case approach 
to the double bond at C-2 is antiperiplanar to the fluorine, allowing an Anh-Eisenstein 
n-a* stabilising interaction to occur (Fig. 2.11). This stabilisation is not, however, 
possible i f the fluorine occupies a pseudo-equatorial position (35). It would therefore be 
anticipated that the enzyme will show a kinetic discrimination in favour of the (37?) 
isomer over the (35) i f such a stereoelectronic effect operates. 
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Fig 2.11 Schematic representation of the transition states for hydride delivery to 41 
2.3.2 6-Fluorocyclohex-l-enylcarbonyl-CoA 
I f the reaction is interpreted such that in the course of the reduction an anion develops at 
C-1, a fluorine at C-6 may also stabilise this anion by an Anh-Eisenstein interaction. In 
this case the anion may be stabilised at the transition state by an axially orientated 
fluorine, and much less significantly by an equatorial fluorine at C-6 (Fig. 2.12). At the 
outset a comparison of rates for the C-3 and C-6 fluorinated substrates appeared valid 
and attractive to determine i f discrimination between an early or late transition state 
could be evaluated. 
SCoA 
SCoA 
Fig. 2.12 Schematic representation of stereoelectronic stabilisation of an 
anion at C-1 by an axial fluorine at C-6 
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2.3.3 '^F NMR spectroscopy of fluorocyclohexanes 
It is well established that axial and equatorial fluorines on a cyclohexane ring can easily 
be distinguished by '^F NMR spectroscopy. Roberts' work, using '^F NMR 
spectroscopy as an aid to conformational analysis with gew-substituted 
difluorocycloalkanes, illustrated how at low temperatures the axial and equatorial 
fluorines are easily distinguishable. 
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Fig. 2.13 Chemical shift and spin-spin splitting in '^F NMR spectrum of 
1,1-difluorocyclohexane at -100 °C 
The observed '^F NMR spectrum at -100 °C (Fig. 2.13) showed a chemical shift 
difference between the two fluorines of 884 Hz at 56.4 MHz, a fluorine-fluorine 
splitting of 237 Hz and finally fluorine-hydrogen splittings which were assumed to only 
involve the four vicinal hydrogens. With the axial fluorines coupling more strongly 
with the adjacent hydrogens it was possible to assign the axial and equatorial fluorines 
in the spectra. 
Cantacuzene also used '^F NMR with a number of substituted cyclohexane rings 
to show how the axial and equatorial fluorines were readily identifiable. One specific 
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example used the cyclohexane derivative 38 in which the two fluorine resonances were 
observed to be 4 ppm apart and, as for 1,1-difluorocyclohexane, were easily assignable 
by their ' ^ F - ' H coupling patterns.'*^ 
CN 
38 
8 -181.5 8 -185.5 
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Fig. 2.14 Observed'^F NMR specfra of 38 at -100 °C 
With the ease of assignment of the axial and equatorial fluorines in a 
cyclohexane ring it was envisaged that any kinetic preference exercised by the enoyl 
reductase (CHCR) should therefore be assayable directly by '^F NMR spectroscopy. 
This could be achieved by analysis of the reaction and determining the relative rates of 
accumulation of both axial and equatorial products. This assay meant it was 
unnecessary to produce the fluorinated substrates in a homochiral form; they could be 
used as a racemate in a competitive reaction using '^F NMR specfroscopy to monitor the 
products of the reduction. 
Implicit in this analysis using '^F NMR spectroscopy, however, is the anticipated 
conformational preference for the product v^ ith the thioester group occupying the 
equatorial position at C-1. This preference should ensure little interconversion of the 
products upon their formation in the enzymatic reduction. It is therefore anticipated that 
the (3i?)-3-fluorocyclohex-l-enylcabonyl-CoA will give predominantly the axially 
orientated product upon reduction and likewise the (35) isomer will give the equatorial 
product. 
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Fig. 2.15 Interconversion of axial and equatorial products 
Conformational free energy differences, or 'A values', give the energy difference 
between axial and equatorial conformers for monosubstituted cyclohexanes.'^ ^ Some 
values are listed in Table 2.3. 
Table 2.3 Conformational free energy differences for monosubstituted cyclohexanes 
Substituent -^(f^kca\ mol-' 
F 0.25-0.42 
CH3 1.74 
CO2CH3 1.2-1.3 
COF 1.4-1.7 
C(CH3)3 4.7 
The values demonstrate that for a thioester a value of approximately 1.4 kcal 
mol"' may be anticipated. This, together with the small value for fluorine, should 
prevent any interconversion of the isomers; particularly unfavourable would be the 
diaxial species formed by the 'ring flip' of the equatorial product. However, any small 
interconversions should cancel out and would not be anticipated to effect the observed 
outcome of the reduction. 
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2.4 Target compounds 
For this study it was necessary to synthesise 3-fluorocyclohex-l-enylcarbonyl-CoA 41 
and 6-fluorocyclohex-l-enylcarbonyl-CoA 42. The synthetic targets were the 
corresponding free carboxylic acids 39 and 40 which would be activated in due course 
to their CoA esters. 
^OH 
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The mono-fluorinated cyclohexenes had not previously been synthesised and 
thus a synthetic route to the compounds had to be developed. Hudlicky has reported a 
synthesis of 3-fluorocylcohex-l-ene 43 but found it was unstable and rapidly 
decomposed at room temperature with the elimination of HF.'"^ The eliminated HF 
reacted strongly with glass and blue-green decomposition products containing 
cyclohexa-l,3-diene were detected. In view of this observation we were concemed that 
we may also experience difficulties with HF elimination during the course of the 
preparation of 41 and 42. The expected products of HF elimination from compounds 
like 39-42 would be the corresponding cyclohexa-l,3-dienes. The data provided by 
Delany in the synthesis of methyl cyclohexa-l,3-diene 44 could be used to assess i f any 
HF elimination was occurring to afford the cyclohexa-l,3-dienes."^^ 
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2.5 Synthesis of fluorocyclohexenes 
Initial preparative routes to the target compounds were based around a halogen 
exchange reaction replacing bromine with fluorine. The requisite 3- and 6-brominated 
isomers 45 and 46 were produced by the allylic bromination of commercially available 
methyl cyclohex-1-enecarboxylate with iV-bromosuccinimide (NBS) and AIBN.'"^''"^ 
The reaction gave a mixture of the two regioisomers (ca. 1:1 ratio), but in low overall 
yields, producing only small amounts of product (50 mg) for fiirther reaction. The two 
regioisomers were separable by column chromatography and were assigned by COSY 
' H NMR spectroscopy. 
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The halogen exchange was initially attempted using silver fluoride in wet 
acetonitrile.'°^ Product analysis by '^ F NMR spectroscopy did not indicate any 
incorporation of organic fluorine. Further analysis of the product was consistent with 
the formation of the 6-hydroxy compound 49, presumably via a silver ion-assisted 
displacement of the bromine either directly or by an Sn2' process (Fig. 2.16). Further 
attempts using antimony trifluoride in refluxing benzene and THF also proved to be 
ineffective methods for the replacement of the bromine with a fluorine atom.^ 
50 
CO, Me CO, Me COjMe 
Fig. 2.16 
2.5.1 Synthesis of 3-fluorocyclohex-l-enecarboxylic acid 39 
It became attractive to generate the appropriate methyl 3-hydroxycyclohex-l-
enecarboxylate 51 such that an attempt could be made to fluorinate it using DAST.^^ 
The proposed route outlined in Fig. 2.17 again began with the readily available methyl 
cyclohex-1-enecarboxylate. This was initially oxidised to give the a,(3-unsaturated 
ketone compound 50 which could be subsequently reduced to afford ,the desired allylic 
alcohol 51. 
.COjMe .COjMe 
50 
.COjMe 
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Fig. 2.17 Reagents: i , CrOs, AcOH, A C 2 O , benzene, 56%; i i , NaBFL, CeCl3«7H20, 
MeOH, 80%; i i i , DAST, C H 2 C I 2 , 69%; iv, 5% KOH in MeOH, 77% 
The allylic oxidation was achieved using 3 equiv. of chromium trioxide in an 
oxidising solution of acetic acid and acetic anhydride in benzene. This generated 
the desired 3-oxo product 50 in 56% yield. 
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The regioselective 1,2 reduction of the a-enone 50 was achieved following the 
conditions of Luche, using NaBH4 in conjunction with CeCl3»7H20 in methanol."^ 
After significant experimentation Luche determined that the optimal conditions for yield 
and regioselectivity were a 1 equiv. of NaBH4 for each mole of substrate in a 0.4 M 
methanolic solution of CeCl3»7H20. Under these conditions the reduction of 50 proved 
successful and the desired allylic alcohol 51 was recovered in 80% yield after 
purification. When the reduction was attempted in the absence of the CeCls'THiO 
concomitant 1,2 and 1,4 reduction was observed with none of the desired product being 
isolated. Luche considered the major role of the Ce^ ^ in the regioselective reduction to 
be the catalysis of BH4' decomposition by the solvent to afford alkoxyborohydrides. 
The substitution of hydrides in BH4" increases the hardness of the reagent and enhances 
the attack at the hard C-2 carbon of the conjugate enone (Fig. 2.17). 
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Fig. 2.18 Luche's mechanistic interpretation of 1,2 reduction with Ce'^ "^  
With the allylic alcohol in hand the fluorination was attempted. Despite the 
potential for elimination, fluorination with DAST proved straightforward, affording the 
desired allylic fluorine compound 48 in 69% yield, an overall yield of 31%) from methyl 
cyclohex-l-enecarboxylate. This route proved relatively straightforward and enabled 
several grams of 48 to be prepared in a satisfactory state of purity. 
The final stage of the synthesis required the conversion of the methyl ester 48 to 
the free carboxylic acid 39. With the anticipated potential problem of base-induced 
elimination of HF, the initial methods of hydrolysis which were considered all avoided 
the use of base. Initially enzymatic hydrolysis under neutral conditions was explored. 
Pig liver esterase, wheatgerm lipase and the Candida cylindracea lipase were all 
employed to try to effect hydrolysis. The course of the enzyme reactions were followed 
over time by '^ F NMR spectroscopy directly on the reaction solutions. Although the 
NMR analysis showed progressive changes, no free carboxylic acid could be isolated. It 
was also clear by '^ F NMR spectroscopy that fluorine was lost as fluoride on work up. 
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The second reagent explored for the hydrolysis of the ester was trimethylsilyl 
iodide (TMSI), which can also hydrolyse esters under neutral conditions."-^'"" After 
work up, '^F NMR analysis of the product did not show the presence of any 
organofluorine compounds. This may be due to silicon's high affinity for fluorine 
resulting in the formation of trimethylsilyl fluoride. 
Base hydrolysis of the ester was attempted using a 5% solution of KOH in 
methanol. The reaction could easily be monitored by TLC and after 1 h the starting 
material had been consumed. The reaction was acidified and the products extracted into 
diethyl ether. Upon removal of the solvent a white solid formed which proved to be the 
desired 3-fluorocyclohex-l-enecarboxylic acid 39. The compound was unstable at room 
temperature, thus in order to prevent decomposition- it was necessary to store the 
material at -20 °C. Nonetheless the compound could be readily prepared and was used 
on several occasions throughout the programme. 
2.5.2 Synthesis of 6-fluorocyclohex-l-enecarboxylic acid 40 
In an attempt to synthesise the 6-fluoro analogue of cyclohex-l-enylcarbonyl-CoA, an 
analogous strategy to that used for the 3-fluoro isomer was implemented. Thus the 
allylic alcohol 53 became the substrate required for fluorination. The commercially 
available ethyl 2-oxocyclohexanecarboxylate was readily converted into the p-
dicarbonyl derivative 52 by selenation using a 1:1 complex of phenylselenenyl chloride 
and pyridine. This was followed by an in situ oxidation using 30% hydrogen peroxide 
which afforded 52 in 95% yield (Fig 2.19)."^ This method for the formation of 
unsaturated P-dicarbonyls works particularly well in compounds where the (3-dicarbonyl 
compound exists substantially in its enolised form."^ 
C02Et CO2B. 
OH 
C02Et 
52 53 
Fig. 2.19 Reagents: i , PhSeCl-pyridine, CH2CI2, H2O2, 95%; i i , NaBH4, CeCl3.7H20 
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With the unsaturated p-dicarbonyl compound 52 in hand the selective reduction 
was attempted with NaBH4 and CeCl3'7H20 to obtain the allylic alcohol 53. However 
in this case, even with the CeCl3*7H20, the double bond was significantly reduced by a 
1,4 hydride addition. ' H N M R analysis of the crude product from the reduction showed 
that all the alkene had been reduced, and there was a concomitant increase in the 
complexity of the CH2 region. It appeared that in this case 1,4 addition was unhindered 
and occurred rapidly, whereas in the case of the 3-0x0 isomer 50, attack of the hydride 
in a 1,4 manner is controlled by the addition of the lanthanoid. 
An alternative method was attempted which formed 53 directly in a one pot 
reaction."^ The reaction is a bis-aldolisation using commercially available aqueous 
25%o glutaraldehyde and triethyl phosphonoacetate. The Wittig-Homer reaction under 
weak basic conditions gave rise to two products, the desired 6-hydroxy compound 53 
and the dienic diester 54, which are obtained from the concurrent bis-aldolisation and 
elimination processes on the first aldol intermediate (Fig. 2.20). 
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Fig 2.19 Reagents: i , (EtO)2P(0)CH2C02Et; i i , K2CO3 
The two products of the reaction were easily separated by distillation and the 
reaction was amenable to scale-up, allowing the production of several grams of material. 
Fluorination using DAST generated the desired 6-fluoro ethyl ester 55, which was 
purified, giving satisfactory analytical data. 
54 
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Fig. 2.21 Reagents: i , DAST, CH2CI2, 69% 
Activation to the CoA ester again initially required the hydrolysis of the ester to 
the free acid and it was at this stage that an insurmountable problem arose. In order to 
hydrolyse the ester the same methods as used previously were attempted. However, no 
method was found to hydrolyse the ester and all the methods employed resulted in the 
loss of organofluorine material as determined by '^ F NMR spectroscopy. Analysis of 
the product from the TMSI reaction appeared to show the formation of an iodo species, 
possibly by an SN2' reaction involving I ' as a nucleophile. Methanolic KOH hydrolysis 
resulted in some transesterification, as well as loss of fluorine with the formation of the 
methyl ether. To prevent the transesterification the methyl ester 47 was prepared using 
trimethyl phosphonoacetate in the Wittig-Homer reaction with glyceraldehyde. 
Subsequent hydrolysis with methanolic KOH was, however, unsuccessful with loss of 
organic fluorine. Acidic hydrolysis using THF-HCl mix gave the same unsuccessful 
result. At this stage it also became a concern that, even i f it were possible to synthesise 
the free acid 40, it may not prove possible to activate it as the CoA ester. Formation of 
the thioester would require the addition of a sulfur nucleophile to an activated mixed 
anhydride (Fig. 2.22); however, with all the previous examples of nucleophiles (H", T 
and MeO") which had apparently undergone SN2' type reactions eliminating fluorine, it 
was quite likely that this would occur in the formation of the CoA ester. 
2.5.3 Synthesis of thio and CoA esters 
In order to carry out the enzyme studies with the CHCR it was necessary to activate 39 
as its CoA ester. This could be achieved by two methods. 
The first involved reaction of the acid with triethylamine and ethyl 
chloroformate to produce a mixed anhydride 56. The mixed anhydride is then coupled 
to CoASH to give the desired thio ester 41 (Fig. 2.22)."^ An alternative method 
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involves reaction with carbonyldiimidazole to form a reactive A^-acylimidazole 
intermediate which is coupled to CoASH. 
F 
39 
OH 
O O 
X ^
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56 
SCoA 
41 
Fig. 2.22 Reagents: 1, EtaN, ClC02Et: i i , CoASH 
The coupling reaction was initially modelled using //-propionylcystamine 58, 
which is an analogue of co-enzyme A as it bears structural similarities to the terminus of 
the co-factor. Often the esters formed by A/-propionylcystamine can be used as enzyme 
substrates, however it is known that in this case the cyclohex-l-enylcarbonyl-CoA 
reductase does not accept TV -^acetylcysteamine derivatives as substrates. 
S—S 
57 58 
Fig. 2.23 
/»/-propionylcystamine was synthesised from cystamine dihydrochloride and 
propionyl chloride, which form the disulfide dimer 7V,7V-dipropionylcystamine 57. The 
disulfide is reduced using 3% sodium amalgam to give 58 as a colourless oil. This 
material was then efficiently coupled to 39 using triethylamine and ethyl chloroformate 
to afford the A'^ -acetylcysteamine derivative 59 as a colourless oil. '^ F NMR spectral 
analysis of this thioester derivative showed a chemical shift of 6 -172, compared with 
that of the free acid of 8 -173.3. Thus the compound provided a model for optimising 
the activation to the co-enzyme A ester and a usefial '^ F NMR reference. 
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In the event the co-enzyme A ester 41 was prepared by the ethyl chloroformate-
triethylamine method. The product of the reaction was a white powder generated after 
freeze-drying the reaction mixture. This material was used directly in the enzyme 
studies as attempts to purify 41 by HPLC proved unsuccessfiil due to apparent 
decomposition. '^F NMR analysis of 41 showed a single peak at 6 - 1 7 0 with fluoride 
evident, indicating some fluoride release. 
2.6 Kinetic studies with fluorinated substrate 
Initial experiments carried out demonstrated that the 3-fluorocyclohex-l-enecarbonyl-
CoA 41 was a substrate for the enzyme. A series of control experiments showed that 
the presence of both enzyme and co-factor were required for any reduction of the 
substrate to take place. '^F NMR analysis of the reaction products demonstrated that the 
two expected products were clearly visible and could be readily assigned to the axial and 
equatorial isomers by reference to the ' H - ' ^ F coupling constants and the examples 
previously cited. 
A kinetic analysis was undertaken to determine the and Fmax values of the 
enzymatic reduction, for comparison with those of the natural substrate 34. The 
reactions were carried out in 1 ml cuvettes in a potassium phosphate buffer solution (pH 
7.3), and were monitored by following the rate of depletion of NADPH 
spectrophotometrically at 340 nm. The data obtained were used to evaluate the 
effectiveness of the enzyme to reduce the fluorinated substrate. A kinetic analysis of the 
fluorinated substrate 41 was carried out independently both in Durham and at the 
University of Baltimore. 
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2.6.1 Determination o/K^ and Ymax 
Km and Fmax are two experimentally measurable kinetic parameters that may be defined 
as follows. 
Vmax is the maximum initial velocity of the enzyme catalysed reaction under the 
given conditions, and is the limiting value that VQ approaches as [S]->QO. The value of 
Vmax is measured in units of quantity of substrate per unit time for a given concentration 
of enzyme. 
Km is the Michaelis constant. It can be defined only in experimental terms and 
equals the value of [S] at which vo equals l/lVmax- The value of Km is measured in units 
of concentration. 
The Michaelis equation, which relates Vo (initial velocity) and [S] , is normally 
written as: 
max 
Vn = 
A plot of Vo versus [S] gives a hyperbolic graph from which the values of Km and 
Fmax can be read. However in practice it can often prove difficult to draw accurate 
hyperbola, and to supply sufficiently high concentrations of S to ensure the attainment 
of Vmax- These difficulties are overcome by the Lineweaver-Burk equation, which 
makes use of the fact that the reciprocal of the equation of a rectangular hyperbola is the 
equation of a sfraight line. 
1_ 1 ^ „ 1 
0^ 
Therefore, i f 1/vo is plotted against 1/[S], a straight line is obtained whose slope 
is Km/Vmax, whose intercept on the y-axis equals l/Pmax, and whose intercept on the 
negative side of the jc-axis equals -I/Km-
In the case of the enoyl reductase activity two substrates have to be considered, 
the cyclohex-l-enylcarbonyl-CoA and the co-factor NADPH. To perform initial 
velocity studies v^th a two substrate system, values of M) are measured using different 
concentrations of one substrate in the presence of a series of fixed concentrations of the 
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second. In this way, a family of plots is obtained of I/VQ against 1/[S] using different 
fixed concentrations of NADPH. The kinetic parameters, though, cannot be determined 
from primary reciprocal plots obtained at arbitrary concentrations of fixed substrate 
(even i f this is thought to be saturating). The values of Km and Vmax are obtained from 
secondary plots of (i) the intercepts, and (ii) the slopes of the primary reciprocal plots 
against the reciprocal of the concentration of the fixed substrate (Fig. 2.24). 
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Fig. 2.24 Determination of and Fmax via Lineweaver-Burk plots 
2.6.2 Kinetic analysis: results and discussion 
The Km and Fmax values were obtained for the enzymatic reduction of the natural 
substrate cyclohex-l-enylcarbonyl-CoA 34 with purified CHCR using NADPH and [AS-
"y lie 
HJNADPH (Table 2.4). The results showed a significant decrease in the observed 
value of Fmax for the reduction when using [45'-^H]NADPH as the co-factor. This 
observation is indicative of a primary isotope effect such that ky^lkx) = 3.0, demonstrating 
that hydride (or deuteride) delivery, is the rate limiting step of the reduction in the case 
of the natural substrate 34. Similar primary isotope effects {k^lkx) = 3-5) have 
previously been observed in NAD(P)"^-dependent alcohol dehydrogenases where hydride 
(deuteride) transfer between the substrate and nucleotide co-factor is the rate limiting 
step of the reaction."^ The observed values of K^ for 34 were unaffected by the choice 
of co-factor. The co-factor K^ values, however, showed a significant decrease when 
[45-^H]NADPH was employed. Such a decrease is unlikely to be due to an isotope 
effect on binding. The observation of an isotope effect on K^ under conditions where 
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there are substantial isotope effects on Fmax more likely indicates a Michaelis constant 
that is a steady state rather than a dissociation constant. 
The steady state assumption by Briggs and Haldane assumes that in an enzyme 
reaction of the form outlined in Fig. 2.25 the concentration of the enzyme-substrate 
complex [ES] remains constant, which in turn gives rise to eqn. (2.1). 
E + S ^ [ E S ] ^ E + P 
Fig. 2.25 
^ " = ~ V ^ (2.1) 
This is in contrast to the rapid equilibrium assumption in which it is assumed that the 
rate of dissociation of [ES] (^ 2) is much smaller than k_i such that its value is negligible 
which gives rise to eqn. (2.2). 
= 1 ^ (2.2) 
Table 2.4 Kinetic analysis of the reaction catalysed by CHCR using NADPH and 
NADP^H. Substrate concentrations ranged from 3-100 fxmol dm"^. Data were analysed 
by Lineweaver-Burk plots and non-linear regression (latter values in brackets). 
Substrate Substrate Km /\iM ' Cofactor Km /[iM ' Fmax/U mg"' protein 
Cyclohex-1- 22±3 (25±1) 9.0±1 (9.5±1) 6.3±0.6 (7.5±0.5) 
enylcarbonyl-CoA 23±3 (26±4) 3.8±0.5 (3.6+0.9) 1.9±0.3 (2.5±1.0) 
3 -Fluorocyclohex-1 - 28±2 (44±4) 13.5±3 (16±3) 29±4.6 (36±5) 
enylcarbonyl-CoA 22±5 (14±4) 17±4 (28±4) 28±4.6 (27±1) 
Table 2.4 shows the obtained values for the parameters of K^ and V^ax- The data 
was initially analysed by Lineweaver-Burk plots and then by non-linear regression 
(figures in parenthesis). The substrate K^ values are averages obtained from analyses 
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conducted at 50 and 100 mmol dm"-^  co-factor concentrations while co-factor K^ were 
conducted at 100 and 200 mmol dm"'' substrate concentrations. 
The observed Fmax for the reaction catalysed by CHCR with 3-fluorocyclohex-l-
enylcarbonyl-CoA 41 was almost five times greater than that observed with the natural 
substrate. A rate enhancement of this magnitude by addition of a fluorine substituent in 
an enzyme catalysed reaction is unprecedented.'^ *' It is presumed that the increase arises 
due to the electronegativity of the fluorine atom at C-3 lowering the energy barrier for 
hydride delivery to C-2. Previously studied NAD^-dependent yeast alcohol 
dehydrogenases have shown an increase in the rate of hydride transfer to aldehydes with 
electron-withdrawing groups."^ However, all the substituted benzaldehyde derivatives 
were converted at a much slower rate than the natural acetaldehyde substrate. 
The determined Km value for 41 was initially similar to that of 34 by 
Lineweaver-Burk analysis. However when the data was analysed by non-linear 
regression the value inexplicably rose to 44 i^ M"'. However 41 still emerges as an 
excellent substrate for the enzyme. The cofactor K^ values for NADPH were higher for 
the fluorinated substrate and those determined for [45'-^H]NADPH were almost seven 
times greater with 41. These increases, accompanied by an increased reaction rate 
suggest that the Michaelis constant for the nucleotide co-factor is a steady state rather 
that a dissociation constant. 
The observed Fmax values for the fluorinated substrate with NADPH and [45-
^HJNADPH were significantly closer {k^lku = 1 -3) than those for the natural substtate, 
indicating that hydride (deuteride) is no longer the rate determining step of the reduction 
and is at best only partially rate limiting. The fluorine substituent at C-3 has presumably 
lowered the energy barrier for hydride delivery sufficiently to allow another step in the 
catalytic cycle to contribute to the overall rate. The energy profile diagram in Fig. 2.26 
schematically represents the lowering in energy of the hydride delivery step. 
Experiments carried out in D2O rather than H2O gave no change in the observed 
value of Fmax- This demonstrated that protonation from the solvent is not the rate 
limiting step of the reduction of 41. Consequently, the rate limiting step for the 
reduction of 41 by CHCR is either substrate-cofactor binding or product-cofactor 
release. The rate limiting step for NAD^-dependent horse liver alcohol dehydrogenase, 
which has a kwlk^i = 1 for the hydride step, is the release of the NAD"^ co-factor.'^' As 
hydride transfer is rate limiting for the reduction of the natural substrate but not 41, the 
difference in the Vmax values for the reduction of these substrates with [45- H]NADPH, 
approximately 15-fold, is even more dramatic than with NADPH. 
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Fig. 2.26 
2.7 ^ ' F N M R study of the reduction catalysed by C H C R 
As previously described in section 2.3, '^F NMR spectroscopy was used to determine 
whether any kinetic differentiation was made between the two diastereoisomers of 41 
upon reduction by the CHCR enzjone. The chemical shifts of the axial and equatorial 
fluorines can be clearly distinguished by 'V NMR specfroscopy and by using proton 
decoupling '^F{*H} the signal/noise ratio can be increased while simplifying the 
observed spectra. 
Analysis by '^F NMR spectroscopy of the products from initial reactions of 41 
with CHCR revealed the disappearance of the substrate signal at 6 -171.0 accompanied 
by a concomitant increase in two signals at 8 -168.5 and -182.5 (Fig 2.27). These 
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peaks were assigned to the formation of (17?,3S)-3-fluorocyclohexylcarbonyl-CoA 
(equatorial fluorine) and (li?,3-^)-3-fluorocycIohexyIcarbonyl-CoA (axial fluorine) 
respectively. The assignments, based on literature precedent for fluorinated 
cyclohexanes, were reinforced by analysis of the ' H - ' ^ F coupling constants in the '^F 
NMR spectrum. The equatorial product (8 -168.5) gave a broad doublet (J = 47 Hz) 
while the axial isomer (6 -182.5) gave a more complex doublet of broad triplets {J =41 
and 30 Hz). 
-168 -170 -172 -174 -176 -178 -182 
Fig. 2.27 
When the enzyme reaction of 41 with C H C R was allowed to run to completion 
the intensity of the two new product signals was determined to be equal by integration 
of the signals in the '^F N M R spectrum. 
In order to determine whether the enzyme demonstrated any stereochemical 
preference, experiments were performed under conditions which controlled the extent of 
conversion of substrate to product. This was achieved by limiting the amount of 
N A D P H co-factor added. When the reactions were complete, as determined 
spectrophotomerically, the aqueous solutions were freeze-dried, analysed by high field 
' ^ F { ' H } N M R spectroscopy and the relative ratio of axial to equatorial product 
calculated by integration of the respective signals. The results are given in Table 2.5. 
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Table 2.5 Relative rates of formation of axial and equatorial product from the reduction 
of 3 -fluorocyclohex-1 -enylcarbonyl-Co A 
Axial (%) Equatorial (%>) Conversion (%>) Ratio 
axiahequatorial 
5.9 4.3 10.2 1.37 
10.6 8.6 19.2 1.23 
12.2 9.4 21.6 1.30 
18.5 15.6 34.1 1.19 
19.8 18.4 38.2 1.08 
26.3 24.2 50.5 1.09 
27.0 25.2 52.2 1.07 
29.1 30.0 59.1 0.97 
32.6 32.4 65.0 1.01 
38.4 37.3 75.7 1.03 
48.6 46.8 95.4 1.03 
1.45 T 
1.35 
1.25 
0.95 
0.85 
0.75 
0% 10% 20% 30% 40% 50% 60% 
% Conversion 
70% 80% 90% 100% 
The results from these experiments show that in the early stages of the reduction 
the axial product predominates. The enzyme appears to exhibit a small but significant 
discrimination between the two diastereoisomers of the fluorinated substrate 41, with an 
observed value of 1.37 for the ratio of axial-equatorial product at approximately 10% 
conversion. This ratio is seen to decrease, as is expected, as the conversion approaches 
50% and progresses towards completion, and ultimately the ratio becomes 1:1. The 
experiments were repeated on three occasions and each time a comparable result 
emerged. Thus we are forced to conclude that the enzyme reaction shows a small but 
significant kinetic preference for the production of the axial over the equatorial product 
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in the early stages of the reaction. This observed discrimination could have two origins, 
either a binding effect or a kinetic preference. 
I f the discrimination arose due to a differential binding of the substrates, the K^ 
values would be significantly different for the two isomers, with the experimentally 
observed Km value emerging as an average of the two. The closeness of the 
experimentally determined values for Km of the natural and fluorinated substrate is 
inconsistent with a differential binding effect. On the other hand, the experimental 
observation for the preference of the axial over the equatorial product was predicted and 
is consistent with the Anh-Eisenstein effect operating. 
2.8 Conclusions 
The fluorinated analogue 41 of cyclohex-l-enecarbonyl-CoA was shown to be a good 
substrate for the CHCR enzyme. The results from the kinetic and '^ F NMR 
spectroscopic studies can be summarised as follows. 
(i) Introduction of the fluorine at C-3 increased the Fmax of the reaction by ca. 5 
times. 
(ii) A kinetic isotope effect of 3 for the natural substrate was reduced to 1.3 on 
fluorine substitution, demonstrating a change in the rate determining step of the 
reduction. 
(iii) '^F NMR analysis showed that the enzyme exhibited a small preference for 
the axial over the equatorial fluorine in the early stages of the reduction, indicative of a 
kinetic preference with a stereoelectronic origin. 
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Chapter Three 
The Synthesis and Hydrolysis of 
C-6 Fluorinated Penicillins 
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The Synthesis and Hydrolysis of 
C-6 Fluorinated Penicillins 
3.1 Introduction 
Sir Alexander Fleming's historical observations of the antibacterial properties of a 
culture of the fiangus Penicillium notatum in 1929 marks the starting point of research 
into the penicillin antibiotics. By 1940 a research team at Oxford, led by Abraham, 
Chain and Florey, had isolated penicillin [later known as penicillin G (60)] for the frrst 
time in reasonably pure form. 
COjH 
Fig. 3.1 Benzylpenicillin 60 (Penicillin G) 
Abraham and Chain also in 1940 reported that bacteria contained an enzyme 
capable of destroying the biological activity of penicillin which they termed 
penicillinase. Indeed soon after benzylpenicillin 60 was introduced into the clinic at the 
end of World War I I , the emergence of resistant strains of pathogenic micro-organisms 
threatened its efficacy as an antibiotic. Many enzymes of this type have now been 
characterised, generally termed ^-lactamases they are the commonest cause of bacterial 
resistance to ^-lactam antibiotics. 
The first proposal that penicillin contained a ^-lactam moiety was made in 
1943,'^ ^ however this was not generally accepted until the X-ray structural 
determination by Hodgkinson had been completed,'^^ which established the fused 
bicyclic p-lactam-thiazolidine nucleus and the relative stereochemistry of the penicillin 
molecule. 
The penam 61 and penicillanic acid 62 nomenclature systems were first 
proposed in 1953 by Sheehan.'^ '' 
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Penicillin was the first naturally occurring antibiotic to be characterised and used 
in clinical medicine. There were however a number of serious shortcomings evident in 
the early penicillins, in that they exhibited only weak activity when administered orally, 
their spectrum of antibacterial activity was very limited (particularly against Gram-
negative bacteria) and their in vivo half-lives were short owing to rapid renal excretion. 
Until 1970, penicillins and the structurally related cephalosporins were the only 
examples of nattirally occurring ^-lactam antibiotics. The discovery of 7a-methoxy-
cephalosporins from Streptomyces in 1971 stimulated the search for novel ^-lactam 
antibiotics of microbial origin.''^^ Today a large family of antibiotics exist which 
possess a ^-lactam ring. These include the penicillins, the cephalosporins 63, the 
cephamycins 64, the carbpenams 65 and the monobactams 66.'^ ^ 
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3.2 Mode of action of p-lactam antibiotics 
P-Lactams exert their lethal action only on growing bacterial cells. Within a short time 
of adding penicillin to a bacterial culture, small bulges form, which with time cause the 
cell to rupture, resulting in the death of the cell. These effects are accompanied by the 
covalent binding of the antibiotic to cellular proteins, called penicillin binding proteins 
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(PBP).'" The PBPs are located on the inner membrane and, to reach these, the 
antibiotic has to cross a variety of chemical and physical barriers (Fig. 3.2).'^^ 
When a (3-lactam antibiotic attacks a Gram-negative bacterium, e.g. E. coli, it 
must initially cross the outer membrane by passive diffusion through chaimels formed 
by the 'porin' proteins. The antibiotic then crosses the cell wall, which is a cross-linked 
peptidoglycan network upon which the structural integrity of the cell depends. Finally 
the (3-lactam must cross the periplasm on its way to the PBPs on the inner membrane. 
The periplasm may contain many thousands of (3-lactamse enzymes. For example, an E. 
coli cell carrying the plasmid RP4 contains around 65 000 molecules of ^-lactamase in 
the periplasm, which may catalyse the hydrolysis of the penicillin 67 to the harmless 
monocyclic penicilloic acid product 68. 
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Fig. 3,2 Passage of a p-lactam antibiotic through cell of a Gram-negative bacteria 
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The p-lactam antibiotics that survive the crossing to the inner membrane exert 
their antibacterial activity by disrupting bacterial cell wall biosynthesis. This is 
accomplished by specifically inhibiting the transpeptidases which cross-link 
peptidoglycan chains in the final stages of the biosynthetic sequence. The enzyme 
formally cleaves a D-alanyl-D-alanyl bond at the terminus of one peptidoglycan chain 
with the formation of a new amide linkage between the remaining D-alanine and the 
terminal glycine of a pentaglycine sequence of a second peptidoglycan chain.'^^ Tipper 
and Strominger first proposed that the penicillins are substrate analogues of the D-
alanyl-D-alanyl moiety cleaved by the transpeptidase.'^ *^ 
Seven PBPs have been identified, numbered la, lb, I I , I I I , IV, V and VI in order 
of decreasing molecular weight, and are "a mixture of transpeptidases and 
carboxypeptidases, with the latter predominating. PBPs la, lb, I I and III are 
transpeptidases, some or all of which are essential for cell survival. It is assumed that 
the p-lactams inhibit both the transpeptidases and carboxypeptidases by similar 
mechanisms (Fig. 3.4). 
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Fig. 3,4 Interaction of penicillins with bacterial ^-lactamases and carboxypeptidases 
(Nu = water, amino acid, alcohol) 
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Following initial formation of the Michaelis complex, a second complex forms 
where, through acylation of a serine residue, the penicillin becomes covalently bound to 
the enzyme.'^' The enzyme is regenerated in the case of the lactamase, by transfer of 
the penicilloyl moiety to water with the formation of penicilloic acid (Nu = OH). With 
the penicillin sensitive enzymes hydrolytic regeneration usually occurs concomitant with 
cleavage of the 5,6-bond to afford an acylated glycine and A'-formylpenicillamine. The 
rate of formation and stability of the acylated complex determines lactamase resistance 
and anti-bacterial activity. The rate of breakdown of the penicilloyated enzyme can be 
very slow, for example, under physiological conditions the half-life of the 
benzylpenicillin-carboxypeptidase complex from Streptomycete R39 is 70 h.'^^ The 
newer lactamase resistant antibiotics are resistant because they are poor substrates for 
lactamses, yet retain their inhibition properties for the penicillin sensitive-enzymes. 
There are several ways by which a bacterial population may become resistant to 
the action of p-lactam antibiotics. Firstly the target enzymes become less susceptible to 
acylation and inactivation. Secondly, changes in the outer membrane permeability may 
limit the access of the antibiotic to the periplasm. Finally, and most commonly, a p-
lactamase may result in the hydrolytic destruction of the antibiotic in the periplasm 
before it can reach its target. 
3.3 Inhibition of P-Iactamases 
Any compound that prevents or slows dovm enzyme catalysis is an enzyme inhibitor. A 
compound that prevents enzyme activity for an extended period of time is an irreversible 
inhibitor. The destructive action of a ^-lactamase may be overcome in two ways. 
Firstly, by ahering the structure of the p-lactam, rendering it insensitive to hydrolysis by 
the P-lactamase while retaining its antibiotic potency. Secondly, by using a reagent that 
disables the ^-lactamase, in association with a ^-lactam antibiotic that would otherwise 
be rapidly hydrolysed by the enzyme. The first approach became possible when the 
deacylated penam, 6-aminopenicillanic acid (6-APA) 69 was produced both 
microbiologically '^ ^and by de novo synthesis.'^ "* 
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The availability of 69 allowed the semi-synthesis of an immense number of 
acylated penams and cephams varying in their N-acyl side chains. It was, however, 
often found that the molecules more resistant to the ^-lactamase were also less effective 
antibiotics. 
The second approach, inactivating the ^-lactamase, was pursued, with the &:st 
success coming in 1976 with the isolation of clavulanic acid 70 from Streptomyces 
clavuigerus by workers at Beecham Pharmaceuticals.' ''^  
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Clavulanic acid differed from the previously studied P-lactams in that it was a 
weak anti-bacterial agent but an irreversible inhibitor of p-lactamases. It was capable of 
protecting susceptible p-lactam antibiotics against the hydrolytic action of bacterial p-
lactamases. A combination of amoxycillin and clavulanate ('Augmentin') is currently in 
clinical use. Mechanistic investigation into the interaction of 70 with the p-lactamases 
demonstrated it was a 'suicide' or 'mechanism-based' inhibitor. The errzyme recognises 
it as a potential substrate yet leads, in a diversion from the normal course of the 
hydrolytic reaction, to inhibition and/or inactivation of the enzyme. Penicillin G is a 
typical example of a compound which is a good inhibitor of the transpeptidases, but is 
also a good subsfrate for the ^-lactamases. Ceftazidine and cefoxitin, on the other hand, 
are good inhibitors of the transpeptidases and poor substrates for the ^-lactamases. 
Fisher suggested that clavulanic acid's inhibitory action arises from initial 
acylation of the enzyme followed by a p-elimination resulting in the conjugated enamine 
71 136 
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The discovery of the inhibitory action of clauvulanic acid stimulated the search 
for other inhibitors, both from natural sources and through synthesis. As a result a 
number of such compounds have emerged that have powerfiil inhibitory properties 
towards ^-lactamases, including penicillanic acid sulfone 72, 6p-bromopenicillanic acid 
73 and 6a-chloropenicillanic acid sulfone 74. In general these compounds' tend to be 
poor inhibitors of the transpeptidases but irreversible 'suicide' inhibitors of p-
lactamases. 
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Al l of the mechanism-based inhibitors of the ^-lactamases fall into two classes: 
those that contain a heteroatom at the 1 -position, which may act as a leaving group from 
C-5, and those such as the carbpenams that do not (Fig. 3.5). 
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Fig. 3.5 
3.3.1 Penicillanic acid sulfone 72 
The nature of the interaction of penicillanic acid sulfone has been extensively studied 
and the detailed mechanism elucidated by Knowles using the RTEM P-lactamase.'^ ^ 
The pathways that account for the observed kinetics is illustrated in Fig. 3.6. 
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Fig. 3,6 Interaction of penicillanic acid sulfone with the p-lactamase 
Following the formation of an acyl-enzyme intermediate (A) three separate 
processes can occur. Firstly, the penicillanic acid sulfone may act as a substrate for the 
enzyme and the p-lactam ring is hydrolytically cleaved, resulting in malonyl 
semialdehyde and the sulfinate of penicillamine. Secondly, the enzyme is transiently 
inhibited (B). Finally, the enzyme is irreversibly inactivated. The acyl-enzyme 
intermediate (A) is converted into a p-imino ester by an elimination reaction, which is 
followed by a transamination by an enzyme lysine residue. Such a reaction leads to a p-
aminoacrylate crosslinked to two active site residues. Inhibition is slower than the rate 
of hydrolysis with ca. 7000 molecules of penicillanic acid sulfone being hydrolysed for 
each molecule of inactivated enzyme formed. 
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3.3.2 6/3-Bromopenicillanic acid 73 
6p-Bromopenicillanic acid (6-BPA) 73 has been shown to be a specific and potent 
irreversible inhibitor of a variety of P-lactamases.'^ ^ The mechanism of the inactivation 
of Bacillius cereus ^-lactamase by 6-BPA has been extensively studied and several 
reaction mechanisms have been postulated. 
(i) Pratt and co-workers suggested that the formation of the acyl-enzyme 
complex is followed immediately by ring opening of the thiazolidine, with formation of 
a thiolate-immonium zwitterion 75, followed by rearrangement and cyclisation of the 
inhibitor to a 2,3-dihydro-l,4-thiazine-3,6-dicarboxylic acid derivative 76.'^ * The final 
step involves the fast isomerisation of an imine to an enamine, which is facilitated by 
the acidity of the hydrogen atom on C-6 of the (6-BPA) (Fig. 3.7). 
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(ii) A modified mechanism arose from the observation of the rapid loss of 
tritium from [^H]-6-BPA, which occurs on interaction with the enzyme.'^ * Knowles 
suggested that a base is present that assists the removal of the 6a proton in a 
stereospecific manner prior to the thiazolidine ring opening and that this is the driving 
force for a trans elimination across the C-5 and C-6 carbons, resulting in the direct 
formation of an enamine and ring opening.'^^ 
(iii) More recently, Pratt and Cahn studied the kinetics and mechanism of the 
rearrangement of 6-BPA to 2,3-dihydro-l,4-thiazines.''"' They concluded that the most 
likely mechanism does not involve thiazolidine ring opening but direct intramolecular 
nucleophilic attack by the thiazolidine sulfur atom at C-6, displacing Br' to give a 
bicyclic episulfonium ion intermediate. This then collapses to the dihydrothiazine 76 
(Fig. 3.8). 
75 
For mechanisms (i) and (iii) the most important structural feature is the presence 
of a good leaving group at C-6, whereas for (ii) the presence of an acidic 6a hydrogen is 
also essential for the rearrangement reactions leading to the dihydrothiazine formation. 
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Fig. 3.8 
Since the discovery of the potency of 6-BPA as a ^-lactamase inhibitor there has 
been much interest in the synthesis of other 6-mono- and 6,6-di-halopenicillins, and in 
turn this lead to a synthesis of the 6-fluoropenicillins.''" 
3.3.3 6a-(Hydroxymethyl)penicillanic acid 77 
More recently the compound 6a-(hydroxymethyl)penicillanic acid 77 has been sho^^ 'n to 
be a potent inhibitor for the TEM-1 p-lactamase.'"*^ 
This molecule was designed based on the minimal structure of penicillanic acid, 
which acylates the active site serine, but which would resist deacylation by being 
incorporated with a functionality that could displace an active-site water molecule 
responsible for the deacylation step of the hydrolytic reaction. Molecular modelling 
demonstrated that the hydroxy group of a 6a-hydroxymethyl functionality would 
overlap with the space occupied by the structurally conserved water molecule (Wat-
301). 
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After showing its potency as an inhibitor of the TEM-1 P-lactamase, a crystal 
structure of the complex of the p-lactamase inhibited by 77 was solved. Fig. 3.9 shows 
the 6a-hydroxymethyl group acting as a hydrogen bond donor to the hydrolytic water 
molecule, preventing deacylation.''*^ 
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Fig. 3,9 Crystal structure of acyl-enzyme complex with 77 
3.4 Fluorinated penicillins and stereoelectronic effects 
The introduction of a fluorine atom with either the a or p configuration at the C-6 
position in the penam nucleus provided an attractive system with which to probe the 
stereoelectronic influence of fluorine. 
As previously discussed the introduction of a fluorine atom at the C-6 position 
would be expected to cause little steric perturbation in the molecular geometry of the 
penam nucleus. However induced changes in the electronic character of the P-lactam 
can be expected with a fluorine at the C-6 position which may alter the mechanistic and 
inhibitory activity of the P-lactams. 
A particular structural requirement for the ability of compounds such as 
penicillanic acid sulfone and 6-BPA to act as 'suicide' substrates for p-lactamases is the 
presence of a sufficiently acidic proton at C-6. The presence of a C-6 fluorine with its 
high electronegativity should alter the acidity of the C-6 proton allowing easier removal 
by a stereospecific base. 
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The infroduction of a fluorine on the a carbon to a carbonyl functionality could 
be expected to induce a number of other effects. With the cyclohex-l-enylcarbonyl-
CoA enoyl reductase discussed in Chapter 2 the introduction of a fluorine had a 
dramatic effect on the rate of the reaction. This was presumed to be due to the fluorine 
making the sp^ cenfre more susceptible to hydride attack through an mductive effect. By 
direct analogy the fluorine at C-6 would be predicted to increase the susceptibility of the 
P-lactam carbonyl to attack by a serine residue and increase the acylating ability of the 
penicillin. The presence of the C-6 fluorine may also stabilise the tetrahedral transition 
state formed by attack of the serine residue (Fig. 3.10) onto the carbonyl which may 
subsequently slow the rate of further breakdown of the penicillin. 
Fig. 3.10 
A further consideration is the configuration of the fluorine atom at the C-6 
position which may be a or p. The relative rates at which the p-lactam ring is 
hydrolysed by the enzyme may alter in each case. Studies into the aminolysis of 
penicillins by Page have demonsfrated that attack of the nucleophile onto the carbonyl 
takes place from the least hindered a face of the p-lactam."*^ This result seems wholly 
reasonable with the thiazolidine ring and particularly the large sulfiir atom hindering the 
approach of the nucleophile to the top P-face (Fig. 3.11). 
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With the attack of the nucleophile to one face and a fluorine on the a-carbon the 
system is suitable for analysis by the Anh-Eisenstein model, and may be used to predict 
whether a difference in the rate of hydrolysis between the two isomers may be expected 
to occur. The two distereoisomeric transition states for the hydrolysis of the p-lactam 
are illustrated in Fig. 3.12. 
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The models show that the serine residue would be stabilised by an n-a* 
interaction in the case of the P-isomer, and it could therefore be predicted that the p-
isomer may be hydrolysed at a faster rate relative to the a isomer. 
3.5 Biological activity of fluorinated penicillins 
The inhibitory activity of a number of C-6 fluorinated penicillins against P-lactamase I 
of Bacillus cereus has been studied by Mascaretti (Table 3.1).''*' The experiments 
showed that p-lactamase activity was instantaneously inhibited by the addition of 6p-
fluoropenicillanic acid sulfone, 6p-fluoropenicillanic acid or 6a-fluoropenicillanic acid 
sulfone. The initial effect was followed by a progressive increase in the inhibition, but 
did not follow simple first order kinetics. The addition of 6a-fluoropenicillanic acid 
and 6p-bromo-6a-fluoropenicillanic acid produced only a slight inhibition of enzyme 
activity. This lack of inhibition can be related to the lack of a 6a hydrogen which 
Knowles postulates as a requirement for inhibitory action.'^^ 
Incubation of the p-lactam compounds with more enzyme was accompanied, 
except for 6p-fluoropenicillanic acid, by hydrolysis of the P-lactam ring, indicating that 
the compounds were also substrates for the enzyme. 
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It was therefore concluded, based on the inhibitory action and their ability to 
behave as substrates, that these fluorinated penicillins not only bind to the enzyme but 
also acylate it. 
Table 3.1 Inhibitory activity of 6-fluoropenicillins against p-lactamase I of Bacillus 
141 
cereus. 
P-Lactam compound 
ICso/mM (without 
preincubation) 
ICso/mM (with 10 min 
preincubation) 
6p-Bromopenicillanic acid 1.0 0.5 
6p-Bromo-6a-fluoropenicillanic >5.0 >5.0 
acid 
6a-Fluoropenicillanic acid >5.0 >5.0 
6p-Fluoropenicillanic acid >2.5 0.4 
Penicillanic acid sulfone 0.025 0.025 
6p-Fluoropenicillanic acid 1.0 0.25 
sulfone 
6a-Fluoropenicillanic acid 4.0 • 2.25 
sulfone 
3.6 Synthesis of 6-fluoropenicillins 
There have been a number of reports of the introduction of a fluorine atom into 
penicillins and cephalosporins. The recent developments in the chemistry and bio-
chemistry of fluorinated P-lactams have been reviewed by Mascaretti, who has 
developed much of the synthetic chemistry towards the 6-fluoropenicillins 78 and 79.''" 
CO2H CO2H 
6a-fluoropenicillanic acid 78 6p-fluoropenicillanic acid 79 
The first report of the introduction of a fluorine atom into a cephalosporin, at the 
C-7 position, was in 1973 by Slusarchyk.''*^ The method involved the generation of a 
carbanion at C-7 from the benzaldehyde Schiff base, which was fluorinated by the 
80 
addition of electrophilic fluorine from perchloryl fluoride. A similar approach was used 
in 1974 to generate the C-6 carbanion of 6-imino chloride penicillin 80, which was 
fluorinated with perchloryl fluoride to afford 81.'''^  
PH2N-Li+ ^ CI 
FCIO4 
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80 81 
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The stereochemistry of the 6-fluoro substituent was presumed to be 6a based on 
analogy with previous alkylation and acylation on the carbanion of the Schiff base of 
penicillins. No data was presented on the biological activity of these fluorinated 
penicillins. 
In 1980 and 1983 two patents by the same authors were published claiming the 
synthesis of several 6p-halopenicillanic acids and ester derivatives including 79.'''^  The 
merit of these patents is, however, difficult to judge, as no data on yield, 
characterisation, stereochemistry or biological activity of the compounds is reported. 
The synthetic route described in the patent for the synthesis of 79 is shown in Fig. 3.13. 
Benzyl diazopenicillanate was treated with A^^-bromosuccinimide (NBS) and 
pyridinium poly(hydrogen fluoride) to give the geminal 6,6-bromofluoropenicillanate 
82. Removal of the C-6 bromine was achieved using tributyltin hydride, which was 
followed by ester hydrolysis with iodotrimethylsilane giving the fluoropenicillin 79. 
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Fig. 3.13 Reagents and conditions: i , HF-pyridine, A'^ -bromosuccinimide, Et20-THF; 
i i , BusSnH, PhH; i i i , MesSil, CCI4 
The same authors also reported a second synthetic approach for the introduction 
of fluorine at C-6 with the P configuration, using DAST to covert a hydroxy group to 
the corresponding fluorine (Fig. 3.14). 
C02Pom C02Pom 
Fig. 3.14 Reagents and conditions: i , DAST, CH2CI2, -78 °C; Pom = CH2OCOBU' 
3.6.1 Synthesis of Pom 6a-fluoropenicillanate 
The synthesis of the two 6-fluoropenicillins 78 and 79 required for this study exploited 
the extensive work of Mascaretti et al. Initial efforts were focused on the synthesis of 
the pivaloyloxymethyl (Pom) protected penicillins as they appeared to provide a suitable 
route to the desired compounds. The first stages in the synthesis of all of the penicillins 
was the esterification and subsequent diazotisation to afford the diazopenicillanate 
compound 84. 
Commercially available 6-APA 69 was protected as its pivaloyloxymethyl ester 
following the procedure of Daehne et a/.'"*^  This involved the formation of the 
triethylammonium salt, which was reacted with chloromethyl pivalate in dry DMF. The 
free amino compound proved to be relatively unstable and was therefore isolated as its 
crystalline hydrochloride or toluene-/>-sulfonate salt 83, which was generally 
accomplished in 75% yield. The diazopenicillanate 84 was conveniently prepared 
following the method of Wiering and Wynberg,''*^ which involved stirring 83 in a 
mixture of dichloromethane and water (1:1) with sodium nitrite. Although the 
diazopenicillanate could be isolated as an amber glass in high yield (90%), it was 
routinely used without purification as decomposition at room temperature was rapid. 
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Fig. 3.15 Reagents and conditions: i , Et3N, C1CH20C0C(CH3)3, DMF; i i , PTSA, 
EtOAc; i i i , NaNOs, CH2CI2, H2O 
Pom 6a-fluoropenicillanate 86 was prepared from the corresponding Pom 6a-
hydroxy compound using DAST as the fluorinating reagent. Thus treatment of the 
diazopenicillanate 84 with a 1 M solution of perchloric acid in acetone at 5 °C following 
the method of Sheehan et o/. '^° afforded 85 in 83% yield. Treatment with DAST then 
introduced fluorine and furnished exclusively the 6a-fluoro stereoisomer 86 in 70% 
yield. 
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Fig. 3.16 Reagents and conditions: i , 1 M HCIO4, acetone, 83%; i i , DAST, CH2CI2, 
70% 
An important feature of the fluorination is the retention of the a stereochemistry 
of the C-6 substituent, with none of the corresponding p-isomer being produced. The 
retention of stereochemistry in the DAST reaction can be rationalised by either an Swi 
(intramolecular) type mechanism or by the formation of an intimate ion pair. A key 
feature in the fluorination is clearly the shape of the penam nucleus, where the fluorine 
approaches the least hindered face, so retaining the stereochemistry at C-6. 
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3.6.2 Synthesis of 6a-fluoropenicillanic acid 
With 86 in hand, attempts were made to remove the Pom protecting group to release the 
desired penicillanic acid. It is well documented that the application of conventional 
methods of ester cleavage to deprotection of penicillin esters presents" problems with 
hydrolysis of the p-lactam ring.'^' However Mascaretti has developed a simple and 
effective method for the removal of Pom esters of penicillins using bis(tributyltin) oxide 
in non-hydroxylic solvents, where the ester cleavage is thought to proceed as outlined 
below (Fig. 3.17) 152 
)1 + - + 
BUjSn—O—SnBuj 
Q ^ n B u j 
H2O /H+ 
OH 
Fig. 3.17 Ester deprotection wdth bis(tributyhin) oxide; R = Me, Et, Ph, Pom 
The proposed mechanism involves an organotin intermediate which is 
hydrolysed on work up to afford the free acid. 
A deprotection reaction was attempted using bis(tributyltin) oxide. After acidic 
work-up the '^F NMR spectrum of the resultant residue was complex and showed a 
number of products with apparent p-lactam cleavage and none of the desired 
deprotected acid. Mascaretti and co-workers had observed similar .problems in their 
attempts to deprotect Pom 6p-bromo-6a-fluoropenicillanate, which they attributed to a 
fluorodestaimylation reaction as a result of the hard tin atom interacting with the hard 
fluorine.'" 
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The problems incurred using the Pom esters were overcome by using a benzyl 
ester, for which there was good literature precedence for removal, to afford the acids.'^ "^  
Indeed, Mascaretti pubUshed details of the synthesis of the two C-6 fluorinated 
penicillins using benzyl ester protecting groups.'^ ^ Thus the modified synthesis to 6a-
fluoropenicillanic acid 78 is outlined in Fig. 3.18. 
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Fig. 3.18 Reagents and conditions: i, PhCHNz, CH2CI2, PTSA, EtOAc, 80%; i i , 
NaN02, PTSA, CH2CI2-H2O, 84%; i i i , 0.2 M HCIO4, acetone, 75%; iv, DAST, CH2CI2, 
65%; V, AICI3, CH3NO2, 95% 
Initial attempts to protect the carboxylic acid as a benzyl ester using benzyl 
bromide and benzyl chloroformate proved unsuccessful, however in the event, the 
benzylation was achieved in good yield using phenyldiazomethane (PhCHN2) in 
MeOH-CH2Cl2.'^^ Initial methods for the preparation of phenyldiazomethane involved 
the reaction of benzaldehyde tosyl hydrazone with sodium methoxide in pyridine.'" 
This however proved to be an unreliable method, with the major difficulty being 
removal of residual pyridine, used as the reaction solvent. With repeated attempts this 
often meant the production of large amounts of pyridine tosylate when the salt of the 
penicillin was isolated, and this frustrated satisfactory purification. 
A second, more reliable method for the preparation of phenyldiazomethane was 
evaluated involving the reaction of base (NaOMe) with A^-nitroso-A''-benzyltoluene-p-
sulfonamide. This was conveniently synthesised in large quantities from benzylamine 
and toluene-p-sulfonyl chloride to afford A^-benzyltoluene-p-sulfonamide which, in turn, 
was nitrosated using NaN02 in an acetic acid-acetic anhydride mix.'^^ Finally, reaction 
85 
with sodium methoxide in MeOH-CH2Cl2 gave a solution of phenyldiazomethane, 
which was used directly to benzylate 6-APA (Fig. 3.19). 
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Fig. 3.19 
Phenyldiazomethane is very toxic and potentially explosive; therefore at no time 
was any attempt made to purify or isolate it. However, successful benzylation was clear 
proof that it had been prepared. Unreacted 6-APA was removed from the reaction by 
filtration and in a similar maimer to the Pom ester, the benzylated penicillin was isolated 
as the stable crystalline toluene-p-sulfonate salt 87. Compound 87 was converted to 90 
as previously described for the Pom derivative (Fig. 3.18). Thus diazotisation was 
followed by hydrolysis to afford the 6a-hydroxy derivative 89, which was fluorinated 
with DAST. The benzyl group was successfully removed by treatment of the ester with 
aluminium trichloride in nitromethane, following the conditions of Tsuji, which gave 
the desired carboxylic acid 78 in good yield.'^^ Finally, 78 was secured as its 
cyclohexylammonium salt 91 by treatment of the free carboxylic acid with 
cyclohexylamine in EtOAc (Fig. 3.20). 
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Fig. 3.20 Reagents and conditions: i , cyclohexylamine, EtOAc, 95% 
3.6.3 Synthesis of benzyl 6/3-fluoropenicillanate 
The synthesis of 6p-fluoropenicillanic acid 79 was again reported by Mascaretti and is 
outlined below in Fig. 3.21. 
The initial steps towards the synthesis of 93 follow those described previously 
for the a-epimer. In order to synthesise the benzyl 6p-bromo-6a-fluoropenicillanate 92 
the diazopenicillanate was reacted formally with bromine monofluoride. Mascaretti 
reported that an earlier procedure using NBS and HF-pyridine had given rise to a 
complex mixture of products and had therefore investigated the use of NBS with a range 
of fluoride sources including TBAF, KF-18-crown-6 complex and CsF, all without 
success .The most reliable source of fluoride was found to be tetrabutylammonium 
bifluoride in CH2CI2. This fluorinating reagent was prepared by the method of Camps 
using an ionic exchange reaction between ammonium bifluoride and 
tetrabutylammonium chloride with a strongly basic Amberlite ion exchange resin. 
The salt, which is highly hygroscopic, was heated at 60 °C in vacuo prior to use, in order 
to remove all traces of moisture. 
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Fig. 3.21 Reagents and conditions: i , PhCFIN2, CH2CI2, PTSA, EtOAc, 80%; i i , 
NaN02, PTSA, CH2CI2-H2O, 84%; i i i , TBABF, NBS, CH2CI2-CH3CN, 45%; iv, 
(Me2PhCCH2)3SnH, AIBN, EtjO, 60% 
Subsequent treatment of 88 with NBS and TBABF in CH2CI2 at -40 °C resulted 
in a mixture of products. The major product from the reaction, identified by GC-MS, 
was the desired 6p-bromo-6a-fluoropenicillanate 92 and the minor product was 6,6-
dibromopenicillanate. The reaction exploits an electrophilic bromine and nucleophilic 
HF2" and proceeds stereoselectively with the electrophilic bromine occupying the 6p and 
the fluorine the 6a configuration. 
A third compound was occasionally identified as a component of the reaction 
mixture by GC-MS. This was the corresponding 6-bromo-6-chloro derivative (Fig. 
3.22). This compound arises as chloride is present from unreacted tetrabutylammonium 
chloride from the ion exchange preparation of TBABF when a deficiency of resin was 
used. Thus this side reaction could by minimised by using sufficient quantities of resin. 
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The mixture of 92 and the 6,6-dibromo compound was inseparable by column 
chromatography and was therefore progressed as a mixture to the next stage of the 
synthesis, the radical-induced reductive debromination using a tin hydride reagent. 
Initial attempts using tributyltin hydride afforded a mixture of the two epimers, 78 and 
79, in a 2:1 ratio of 6p over 6a. This was somewhat unsatisfactory and purification to 
remove the tributyltin products also caused difficulties. Mascaretti found that using a 
much more hindered tin hydride reagent tris(2-methyl-2-phenylpropyl)tin hydride 
(trineophyltin hydride) 96 had several advantages over alkyltin reagents.'^ ^ The reagent 
is a stable crystalline solid which is easy to handle, the reaction is rapid and clean, and 
the products are not contaminated with organotin residues. Most critically, the 
reducfion proceeded with a much higher level of diastereofacial selectivity than with 
tributyltin hydride. 
The synthesis of the (trineophyltin hydride)tin hydride reagent is outlined in Fig. 
3.23. Reaction of tin tetrachloride with a filtered Grignard solution from neophyl 
chloride gave trineophyltin chloride 94 as a white crystalline solid in 86% yield.'^^ 
Treatment of the chloride with a refluxing solution of sodium hydroxide in an ethanol-
water mix afforded the trineophyltin hydroxide 95, again in high yield and as a white 
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crystalline solid. Finally the tin hydroxide was reduced with borane in THF to give the 
required hindered tin hydride reagent.'^'' 
Reductive debromination of 92 with trineophyltin hydride lead almost 
exclusively (>12:1) to the 6p-fluoropenicillanate 93. 
Me 
Ph -CHj—MgCI + SnCl4 
Me 
(Me2PhCCH2)3SnCI 94 
NaOH 
f 
(MezPhCCHjlaSnOH 95 
BH3 
(Me2PhCCH2)3SnH % 
Fig. 3.23 
The resultant diastereoisomeric ratio arises as the intermediate radical is 
assumed to have the conformation shown in Fig. 3.24, where the ^-lactam ring is 
essentially planar and the thiazolidine ring has both the 2p and 3 a substituents pseudo-
axial with respect to the five-membered ring. Hydride delivery to the si face is then 
sterically preferred over delivery to the re face, thus giving the 6p-halopenicillin as the 
predominant product. The much bulkier trineophyltin hydride reagent is sterically more 
demanding than tributyltin hydride, which could account for the observed increase in the 
diastereoisomeric ratio. 
Hal 
Sn—H 
COjBn 
Fig 3.24 Radical-induced reductive debromination 
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With benzyl 6p-fluoropenicillanate 93 in hand attempts were made to remove 
the benzyl protecting group to generate the fi-ee carboxylic acid required for the studies 
with the p-lactamase. However, despite literature precedence for such a conversion' 
by catalytic hydrogenation over Pd-C, removal of the benzyl group proved 
unsuccessfial, with mixtures of products isolated. The use of AICI3 in nittomethane was 
also unsuccessful and the removal of the benzyl group fiaisttated the synthesis of the 
desired acid. 
Mascaretti had observed a difference in the stability of the two isomers in that 
formation of the salt of the 6p-fluoropenicillin had proven elusive, with hydrolysis 
products isolated from the reaction. With the benzyl esters 90 and 93 in hand a study of 
the methanolic hydrolysis was undertaken using both '^F NMR spectroscopic and 
spectrophotometric techniques to determine the relative rates of hydrolysis. 
3.7 Enzymatic hydrolysis of 6a-fluoropenicillaiiic acid 
Having prepared 6a-fluoropenicillanic acid 78, the interaction with the p-lactamase I 
from Bacillus cereus was studied by '^F NMR specttoscopy and UV-VIS specttometiy. 
The hydrolysis of the p-lactam was conveniently monitored by following the decrease in 
the carbonyl absorption at 235 imi in buffer (pH 7) at room temperature. The observed 
spectrum (Fig. 3.25) shows that after hydrolysis the absorbtion of the p-lactam ring at 
235 run is absent and a new band at 340 nm is observed. Under the conditions used 
there was no detectable loss in enzyme activity, which was demonsttated by the 
enzyme's continuing ability to hydrolyse additional substrate. 
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The enzyme reaction course was also followed by '^ F NMR spectroscopy in a 
buffer solution. The '^ F NMR spectra (Fig. 3.26) at an intermediate stage clearly shows 
that the fluorinated penicillin (8 -181.2) is cleanly hydrolysed to a single new 
fluorinated product at 6 -192.3, which is presumably the hydrolysed p-lactam. Upon 
complete hydrolysis of the penicillin this product remained stable for an extensive 
period of time, with no apparent decomposition to further products. 
J4_ 
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Fig. 3.26 
These observations are consistent with the results reported by Mascaretti for the 
interaction of 6a-fluoropenicillanic acid with the ^-lactamase 1, which showed that the 
penicillin was a substrate for the ^-lactamase but displayed only a slight inhibitory 
effect. Due to the lack of stability of the 6(3 carboxylate product this reaction could not 
be attempted with the other epimer. 
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3.8 Sodium methoxide mediated hydrolysis of 6a- and 6p-fIuoropenicillanates 
With the problems incurred in the synthesis of 6|3-fluoropenicillanic acid it was decided 
to undertake a comparative study of the chemical hydrolysis of the two fluorinated 
penicillin esters with sodium methoxide in MeOH. Using '^ F NMR spectroscopy and 
kinetic measurements, any difference in the rate of hydrolysis that existed between the 
two stereoisomers could be determined. The study was carried out under two sets of 
limiting conditions; firstly, where the methoxide was in excess of the penicillin, and 
secondly, the reverse with the penicillin in excess of the methoxide. 
The chemical reactivity of p-lactams towards nucleophilic attack has been 
widely explored, with much of the work reviewed by Page.'^ ^ The P-lactam ring is 
susceptible to nucleophilic attack because of the strain in the ring and the nonplanarity 
of the system inhibiting the usual amide resonance. 
The action of oxygen-containing nucleophiles is of particular interest, as P-
lactamases contain key serine residues which catalyse the hydrolysis of p-lactams, 
forming a penicillinoyl ester of the serine residue. Oxygen anions can catalyse the 
hydrolysis of penicillins by either acting as general bases or as nucleophiles. Basic 
anions act as nucleophilic catalysts, forming an intermediate penicilloyl ester via the 
tetrahedral intermediate 97. 
From the studies of the aminolysis of P-lactams the consensus is that the 
addition of the amine nucleophile is to the least hindered a-face of the carbonyl and it is 
a reversible process.''*'* For uncatalysed reactions the rate limiting step of aminolysis is 
C-N bond fission. 
The addition of an alkoxide ion to p-lactams will generate tetrahedral 
intermediate 97 (Fig. 3.27). The tetrahedral intermediate will breakdown via C-N bond 
fission at a rate 2^ to give the p-lactam ring-opened product which will then undergo 
rapid protonation from the solvent. 
MeO 
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Fig. 3.27 
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Previous studies on the chemical hydrolysis of benzylpenicillin have shown that 
the nature of the nucleophile can alter the rate limiting step of the hydrolysis. With 
hydroxide ion catalysed hydrolysis attack of the nucleophile, i.e. ki, is rate limiting, 
whereas alkoxide ions react with rate limiting breakdovra of the tetrahedral 
intermediate.'^^ 
3.8.1 '^F NMR spectroscopic study of hydrolysis 
The hydrolyses of the two 6-fluoropenicillins using sodium methoxide were carried out 
separately in the first instance to determine the nature of the hydrolysis products. The 
penicillin ester was dissolved in [^Htjmethanol and an excess of sodium methoxide 
added to the mixture. The progress of the reaction was monitored by '^F NMR 
specttoscopy. Both the 6a- and 6p-fluoropenicillanates were observed to form 
instantaneously (NMR time scale) an initial hydrolysis product, 6a at 8 -195.5 and 6p at 
8 -190.2. These initial products of hydrolysis then reacted fiirther, forming in the 6a 
case a second unidentified product at 8 -190.0. The 6p isomer was seen to give a much 
more complex spectrum. Notably, no fluoride ion elimination was detected, therefore 
fluorine was not being displaced from C-6 (cf Br). The '^F NMR spectrum also showed 
some evidence for the incorporation of deuteriimi at the C-6 position by a shift of 0.5 
ppm and a loss of coupling in the fluorine signal of the first hydrolysed product. There 
was, however, no evidence for the epimerisation of the C-6 position in the starting 
compounds as has been previously observed with other penicillins.'^^ The initial 
product observed in the '^F NMR spectrum was assumed to be that of the ring opened 
ester 98 and is consistent with that observed in the enzymatic reaction. This was 
confirmed by isolation and characterisation of the initial products of hydrolysis by ' H 
and '•'C NMR and IR specttoscopy, which were all consistent vsith the formation of 98. 
However, in such a basic solution it is not unreasonable for this penicilloyl ester moiety 
to undergo fiirther reaction and break down to other products via opening of the 
thiazolidine ring and formation of the enamine 99 (Fig. 3.28). 
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3.8.2 Competitive hydrolysis study 
Fig. 3.28 
With the initial products of hydrolysis of the two isomers identified in the '^ F NMR 
spectrum, the relative rates of hydrolysis of the two fluorinated penicillins with 
methanolic sodium methoxide was investigated. A 1:1 mixture of the two isomers was 
prepared in methanol (33 mM), this was treated wdth small quantities (5 of a 0.03 M 
NaOMe solution and the '^F NMR spectrum of the solution taken. The results of the 
competitive hydrolysis study are outlined in Table 3.1. The ratios of product and 
starting material were calculated by simple integration of the observed NMR spectra. 
An illustrative '^F NMR spectrum from the competitive study is shown in Fig. 3.29. 
Table 3.1 Competitive hydrolysis of fluoropenicillinanates 
a Substrate reacted (%) p Substrate reacted (%) Ratio a:P remaining 
0 0 1:1 
0 18 1.22:1 
0 22 1.28:1 
0 35 1.53:1 
23 66 2.28:1 
26 81 3.90:1 
28 83 4.23:1 
31 88 5.75:1 
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Fig. 3.29 '^F NMR spectrum from competitive hydrolysis of 6a- and 6p-
fluoropenicillanates 
The competitive hydrolysis study by '^ F NMR specttoscopy demonstrates that 
the p-isomer of the fluorinated penicillin was hydrolysed preferentially over the a-
isomer. Clearly the resuUs from the initial stages of this study are the most significant 
because with time the relative concenttation of the two epimers changes. The results 
show that greater than 35% of the ^-isomer is hydrolysed before any reaction of the a-
isomer has taken place. It is also apparent that the MeO" is acting catalytically as much 
less than one equivalent was required to hydrolyse all the ^-lactam present. 
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3.8.3 Kinetic analysis of hydrolysis 
The competitive hydrolysis experiment by '^F NMR spectroscopy demonstrated 
qualitatively that the P-isomer was preferentially hydrolysed with respect to the a-
isomer. In order to obtain quantitative data a kinetic analysis of the hydrolysis reaction 
was undertaken. Initial reactions demonstrated that on addition of methanolic sodium 
methoxide to the substrate in methanol an increase in absorbance occurred at 310 nm, 
which corresponded to the formation of the penicilloyl ester moiety 98. The rate 
constants of the reaction were therefore determined by following the rate of increase in 
absorbance at 310 nm (Fig. 3.30) under two sets of limiting conditions; (i) substrate in 
excess of methoxide, and (ii) methoxide in excess of substrate. 
In the latter case, with methoxide in excess, the measurements were made using 
stopped-flow spectrometry (see Appendix 1) as the rates were too fast to measure by 
conventional methods. The software used to run the stopped flow apparatus calculated 
the observed rate constants (^obs)- The results were precisely fitted to a first order rate 
equation. 
The reaction rates with the fluoropenicillanate in excess were assessed by 
conventional spectrophotometric methods. The reactions were initiated by the addition 
of substtate to a solution of methoxide in methanol of known concentration in a 2.5 cm^ 
cuvette. The changes in absorbance with time were entered into a software package to 
determine ^ o b s values. Again the data corresponded precisely to first order kinetics. 
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3.8.4 Kinetic results 
(i) Substrate in excess of methoxide 
The values obtained for kobs of both the 6a and 6p fluorinated penicillanates are shown 
in Tables 3.2 and 3.3. In both cases the [sub] was 1.5 mM. 
Table 3.2 6a-Fluoropenicillanate: Abs„ 0.65 
[MeO-]/M 0.0002 0.0005 0.0007 0.0010 0.0015 
2.3 X 10"^  6.3 X 10-^  7.9 X 10"^  10.5 X 10"^  16.2 X 10"^  
0.020 
kobs/s-1 
0.010 H 
y = 0.000 + 10.609X r"2 = 0.995 
• k o b s / s - 1 
0.000 i I i I 
0.0000 0.0005 0.0010 
[ M e O - ] / M 
0.0015 
Second order rate constant for hydrolysis of 6a-fluoropenicillanate = 10.6 dm^ mol"' s"' 
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Table 3.3 6(3-Fluoropenicillanate: Abs„ 1.1 
[MeO-]/M 0.0002 0.0005 0.0007 0.0010 0.0015 
o^bs/s 0.0011 0.0030 0.0041 0.0077 0.0094 
0 . 0 1 0 
0 . 0 0 8 H 
0 . 0 0 6 
k o b s / s - 1 
0 . 0 0 4 
0 . 0 0 2 
0 . 0 0 0 
y = - 0 . 0 0 0 + 6 . 6 5 2 X t'1 = 0 . 9 7 3 
• k o b s / s - l 
0 . 0 0 0 0 0 . 0 0 0 5 0 . 0 0 1 0 0 . 0 0 1 5 
[ M e O - ] / M 
Second order rate constant for hydrolysis of 6p-fluoropenicillanate = 6.6 dm^ mol"' s"' 
100 
(ii) Methoxide in excess of substrate 
The values obtained for ko^s of both the a and p fluorinated penicillanates are shown in 
Tables 3.4 and 3.5. In both cases the [sub] was 0.15 mM. 
Table 3.4 6a-Fluoropenicillanate: Abs„ 0.15 
[MeO-]/M 0.05 0.10 0.15 0.20 
0.64 1.30 2.28 2.82 
k o b s / s - l 
y = - 0 . 0 5 0 + 1 4 . 6 0 0 X I'l = 
0 . 9 9 3 
V 
• k o b s / s l 
0 . 0 0 0 .10 
[ M e O - ] / M 
0 . 2 0 
Second order rate constant for hydrolysis of 6a-fluoropenicillanate = 14.6 dm^ mol ' s ' 
Table 3.5 6(3-Fluoropenicillanate: Abs^O.ll 
[MeO-]/M 0.001 0.003 0.005 0.05 0.10 
o^bs/S 0.012 0.041 0.066 0.123 0.131 
0 . 2 0 
k o b s / s - l 
0 . 1 0 
0 . 0 0 
0 . 0 0 
• k o b s / s - l 
0 . 0 5 
[ M e O - ] / M 
0 .10 
Rate of hydrolysis of 6p-fluoropenicillanate 
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3.8.5 Discussion of kinetic analysis 
Examination of the results obtained by kinetic analysis of the hydrolysis of the two 
isomers of benzyl 6-fluoropenicillanate with sodium methoxide gave a number of 
interesting results. 
(i) The methoxide is acting catalytically as the hydrolysis is seen to go to 
completion with much less than an equivalence of methoxide added. 
(ii) At low concentrations of methoxide, for both the 6a and 6p substrates the 
first order rate constants, o^bs, increase linearly with methoxide concentration. 
(iii) At low concentrations of methoxide the observed rate, o^bs, is greater for the 
a-isomer. 
(iv) At higher concentrations of methoxide, values of ^bs for the 6a isomer 
continue to increase linearly with methoxide concentration. However, the 6p-isomer is 
seen to behave differently and values of o^bs become independent of methoxide 
concentration at high concentrations of methoxide. 
By consideration of the mechanism of the reaction (Fig. 3.27) of the methoxide 
with the penicillin, a suitable rate equation may be derived (Appendix 1) linking k^hs 
with the equilibrium constant . ^ i , kj and [MeO~]. 
k,K,[MeO\ 
o^bs = , . r> , ^-1 0-1) 
1 + Ky[MeO 
(i) P-Isomer 
When the substrate was in excess of methoxide a linear dependence of o^bs on 
methoxide was observed. This indicates from eqn. (3.1) that 1 » A^i[MeO"] and 
therefore: 
ko,s = k2Ki[McO-] 
:. ^ 2 ^ 1 « 6 . 6 d m ^ m o r ' s - ' 
However, when methoxide was in excess a curvilinear dependence on methoxide 
concentration was found. The initial reaction slope was 13 dm^ mol' ' s''. At higher 
concentrations of methoxide the graph reaches a limit where A'i[MeO'] » 1 and 
therefore: 
o^bs = 't2 = 0.13 s-' 
Initial slope = k2K\ = 13 dm'^  mol"' s"' 
.-. Ki = m dm^mor' 
I f initial methoxide attack were the rate limiting step then a straight line graph 
with a first order dependence on methoxide would be expected. 
(ii) a-Isomer 
I f the mechanism remains the same for the a-isomer then eqn. (3.1) is equally valid for 
this isomer. With the substrate in excess of the methoxide a linear dependence on 
methoxide is observed, indicating 1 » 7Ci[MeO-]. Therefore: 
.: k2Ki = 10.6 dm^mol-'s"' 
When the methoxide is in excess, again ko^s increases linearly with methoxide 
concentration: 
/ t 2 / ^ , = 14.6dm^mol-'s-' 
As a linear plot is obtained 1 » A:i[MeO-]: 
^ i [ M e 0 1 < 1 when [MeQ-] = 0.2 mol dm"^ 
.-. ^ 1 <5dm^mol-' 
IfkiKy « 12 ± 2 dm^ mol"' s"', kj must .-. be > 2.4 dm^ mol"' s"'. 
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Therefore to summarise the results: 
kj/dmVor's-' Ki/dm^ mor' 
a >2.4 <5 
0.13 100 
These results indicate that the tetrahedral intermediate formed between the |3-
isomer and methoxide is more stable than the corresponding intermediate for the a-
isomer, but that the rate of C-N bond fission (^ 2^) is faster in the case of the a substrate. 
The results of the kinetic experiments can also be used to explain the 
observations of the competitive hydrolysis experiment using '^ F NMR spectroscopy. I f 
the systems were at equilibrium then it might be expected from the k2K\ values to 
observe similar reaction velocities and indeed this is the case. 
ytz^i a = 1 2 ± 2 d m ^ m o l - ' s - ' 
yt2/^i p = 1 0 ± 3 dmVol- ' s - ' 
However i f k_i is not very much greater than kj then the rate of initial attack of 
methoxide k\ may determine the reaction pathway. To this end the observation that 
Ki[^] » Ki[a] would imply that k\^ » kia. This would in turn account for the 
observation of the p-isomer being hydrolysed at a faster rate than the a-isomer in the 
competitive hydrolysis experiment. 
3.9 Conclusions 
The results from the '^ F NMR spectroscopic experiments show that the p-isomer is 
hydrolysed in a competitive experiment preferentially over the a-isomer. The kinetic 
analysis of the two substrates with methoxide gave absolute values for the rates of 
hydrolysis which were almost identical within experimental error. However, the much 
larger equilibrium constant for the (3-isomer is consistent with the observations in the 
NMR experiment. This indicates that the tetrahedral intermediate formed with the p-
isomer and the methoxide is much more stable that that of the a-substrate. 
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The reason for the increased stability of the p-isomer is not immediately obvious 
and no conclusions about this have yet been drawn. 
The observed results are, however, in accordance with those predicted by 
applying an Anh-Eisenstein model to the hydrolysis, with the ^-isomer being 
hydrolysed at a greater rate relative to the a isomer. However, it would be inappropriate 
Co draw a conclusion that the observed differences are arising solely due to this type of 
interaction. 
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Chapter Four 
The Synthesis of a-Fluoro Ketones by 1,4-Additions of 
Monofluorinated Enamines to Michael Acceptors 
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The Synthesis of a-Fluoro Ketones by 1,4-Additions of 
Monofluorinated Enamines to Michael Acceptors 
4.1 Introduction 
The inhibition of proteolytic activity by low-molecular weight synthetic inhibitors 
serves mainly to control undesirably high levels of proteases within biological systems. 
The mode of catalytic acceleration and inhibition of hydrolysis of a peptide bond by 
serine proteases has been studied intensively for more than 30 years.'^ ^ More than 130 
serine proteases have been classified which, despite mechanistic similarities, are 
involved in a broad range of important biological processes (Table 4.1). 
Table 4.1 Some biological processes performed by serine proteases 165 
Type of reaction Enzyme(s) Physiology Pathology 
Activation of Trypsin, Coagulation of Thrombosis, 
zymogens chymotrypsin blood pancreatitis. 
Fibrinolysis Plasmin Destruction of Cell invasion 
blood clots 
Degradation of highly Elastases, Proteolysis of Pulmonary emphysema. 
cross-linked proteins caphepsin G elastins arthritis 
Inhibition of the proteases is commonly achieved by a slow binding of the 
inhibitor to the enzyme, forming a tightly-bound enzyme-inhibitor complex [El] which 
is slowly hydrolysed. The designs of synthetic inhibitors are based mainly on peptide 
aldehydes. 
Peptide and amino acid analogues containing aldehydic functional groups have 
been shown to be good inhibitors of hydrolytic enzymes such as serine and cysteine 
proteases. For example, papain is inhibited by 100 (Ki= 5 Q, 10"^  M)'^ ^and elastase is 
inhibited by 101 (^i = 8 ^ 10"^  M).'^' 
Ac—Phe—Gly 
100 
O O 
H Ac-Pro—Ala—Pro—Ala-" ~-H 
101 
108 
170 
In aqueous solution aldehydes exist predominately as hydrates, and therefore it is 
likely that the aldehyde in the active site exists bound to the serine oxygen as a 
hemiacetal 102. Indeed, NMR spectroscopy has provided evidence for the formation of 
a bound hemiacetal.'^^''^^ Wolfenden suggested that the hemiacetal replaces the 
tetrahedral intermediate that is formed during the hydrolysis of peptide substrates and 
therefore the aldehydic peptides are transition-state analogue inhibitors. 
HO ,0—Ser 
102 
Aldehydes are also known to be efficient inhibitors of metalloproteases, e.g. 103, 
which is an inhibitor of carboxypeptidase A. '^ ' The inhibitory species is likely to be the 
hydrated form 104, which resembles the tetrahedral adduct formed when H2O adds to 
the carbonyl group of a peptide substrate. 
HO OH 
103 104 
Although efficient inhibitors, these aldehydic peptides have limitations, 
principally that the aldehyde functionality can be placed only on the carboxy-terminal 
side of peptides. Since proteases interact with groups on both sides of the scissile 
peptide bond, protease inhibitors that make use of these long-range interactions are 
likely to have a higher degree of specificity toward targeted proteases. Peptide 
derivatives that contain recognition structures on both sides of an internal ketone can be 
prepared, however, due to the low tendency of ketones to hydrate in solution or form a 
hemiketal with an active-site nucleophile, the utility of these compounds as inhibitors is 
limited. On the other hand, the introduction of an electronegative atom on the a-carbon 
increases the ketones susceptibility to hydration and attack by nucleophiles. Thus 
fluoro ketones have been extensively studied as potent inhibitors of hydrolytic 
enzymes.'^ '^'^ ^ Both di- and tri-fluoromethyl ketones exist in water almost entirely in 
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the hydrated form, and inhibition is therefore probably due to the formation of a stable 
hemiketal with the active site serine residue. Fig. 4.1 shows how trifluoromethyl 
ketones, e.g. 105, in aqueous solvents are 97-100% hydrated, which can be compared to 
<1% for the corresponding methyl ketones 106.'^ '' 
/ \ 
K = = / C F , 
105 1% 
H2O / \ 
OH 
-CF, 
OH 
99% 
\ = = / CH, 
106 >99% 
H2O 
Fig. 4.1 
OH 
-CH, 
OH 
Replacement in substrates of proteolytic enzymes of the scissile amide bond by 
perfluoromethyl or difluoromethylene ketones has generated a number of potent 
transition state type inhibitors (Fig. 4.2) 175 
scissile bond 
Difluoromethylene ketones have a potential advantage in terms of affinity and 
selectivity over C-terminal trifluoromethyl ketones (Type A inhibitors. Fig. 4.2) in that 
they may occupy additional binding sites on the leaving group side (S' subsites).'^ ^ 
Much of the early work relied on the incorporation of difluorostatones 114 (Type B), 
which led to the discovery of efficient pepsin and renin inhibitors. The mtroduction of 
difluoromethylene ketones through incorporation of a spacer group (Type C) have been 
applied to the inactivation of a-chymotrypsin and elastase.True dipeptide isosteres 
(Type D), though, are rare due to the difficulty of developing general and readily 
accessible chemistry along, with the potential reactivity of intermediates and final 
compounds. 
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Fluoro ketone substrate analogues have been found to be inhibitors of 
acetylcholine esterase, zinc metaloproteases like carboxypeptidase A and angiotensin-
converting enzyme''^ (Table 4.2). 
Table 4.2 Inhibitors of acetylcholinesterase 
No. Compound Ki/nM No. Compound A:i/nM 
107 16 I l l 1.6 
108 310 000 112 
F F 
600 
109 1 HO H 
410 000 113 >10^ 
110 8 000 
The trifluoromethyl ketone 107 is an effective, reversible inhibitor of acetyl-
cholinesterase. The observed K, value is 2 ^ lO'^ '-foId lower than that for the 
corresponding methyl ketone 108. The trifluoromethyl ketone 110, which is shorter 
than 107 by a single methylene group, is a poorer inhibitor. However it is the 
difluoromethyl ketone 111 which in this study emerged as the best inhibitor of the 
enzyme. 
I l l 
Similarly aspartyl proteases like pepsin are inhibited by a synthetic analogue of 
pepstatin containing difluorostatone 114. 
COjH 
NHjF F 
114 
'^C NMR analysis of the difluorostatone containing peptide in [^H6]DMSC)-D20 
(4:1) demonstrated that it exists predominately in the hydrated form and is an extremely 
potent inhibitor of pepsin (Ki=6 Q> 10'" M ) . 
In all the cases outlined, the fluoro ketones are seen to be much more effective 
inhibitors than their non-fluorinated analogues and display a strong affinity to remain 
associated with their target enzymes. The strong binding of fluoro ketones in the case of 
angiotensin-converting enzyme suggests their potential use as antihypertensives. 
Brodbeck et al. reported the time-dependent inhibition of acetylcholine esterases 
1 78 
from several sources using trifluoromethyl ketones. It is noteworthy that the 
corresponding - C C H 3 analogues are simple reversible inhibitors with no irreversible 
features. An excellent example of inhibition is outlined in Fig. 4.3. m-Trimethyl-
aminophenyl trifluoromethyl ketone forms a tremendously stable covalent enzyme 
tetrahedral adduct. The accumulating species is indeed very stable since dialysis for 
eight days resulted in regaining only 20% of the catalytic activity. 
(Me)3N^ 
/ \ 
OH 
-CF, 
OH 
(Me)3N (Me)3N^ 
very slow \ / 
OH 
-CF, 
Ser—Enz 
Ser-Enz 
Fig. 4.3 
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4.2 Synthesis of fluorinated ketones 
With the biological potential of a-fluorinated ketones as outlined-in 4.1, it is not 
surprising that such compounds have received attention as key substances for the 
preparation of medicines and agrochemicals. As such, a number of synthetic methods 
have been established for the formation of a-fluoro ketones, many of which were 
reviewed by Rozen and Filler'^^and some of which are outlined below. The reactions 
are categorised as either nucleophilic or electrophilic fluorination, or the reaction of 
compounds which contain fluorine. However, new and efficient methods for the 
preparation of a-fluoro ketones are continually sought. 
A common method widely employed for the synthesis of a-fluoro ketones 
involves reaction of diazo ketones with hydrogen fluoride-pyridine at 0 °C.^^ When the 
reaction is performed in the presence of added halide ions, e.g. by using A^ -
halosuccinimides, the fluorohalo ketones 115 are obtained (Fig. 4.4). 
R 
N2 
HF-py 
HF-py 
R ' ^ ' NXS ^ 
Fig. 4.4 
Other nucleophilic sources of fluorine exploited in the synthesis of a-
fluorocarbonyl compounds include metal and tetraalkylammonium fluorides,'^^ nitrosyl 
1 fid 
fluoride (NOF), which converts double bonds to fluoro ketones in two steps, and 
reagents that contain a P-F bond, e.g. PhPF4.'*' 
The use of electrophilic fluorinating reagents by reaction with metal enolates has 
also proven an effective method in the production of a-fluoro ketones. Much recent 
work has focussed on improvements to the efficiency and stability of the electrophilic 
reagents. One of the earliest electrophilic fluorinating reagents, perchloryl fluoride 
(FCIO3), is extremely hazardous, and regularly gave rise to mixtures of products. 
182 
113 
Acetyl hypofluorite has also been employed as an electrolphilic fluorinating reagent and 
reacts as outlined in Fig. 4.5 via the enolate 116 183 
OLi 
R1 
R2 LDA 
R1 
R2 AcOF^ 
R1 
116 
Fig. 4.5 
R2 
More recently a number of new 7V-fluoro compounds have been developed which 
provide an easier to handle and more stable source of F^. These include iV-fluoro-2-
pyridone ll?,'^"* various iV-fluoro sulfonamides 118 and enantioselective reagents 185 
like the A^-fluoro sultam 119 186 
f\ _f>L-
k \ _ / II I 
^ N - ^ O ^ ^ O F 
117 118 0 O 
119 
Elemental fluorine has also been used in the synthesis of a-fluoro ketones, 
initially Purrington found success by reacting silyl enol ethers with 5% F2 in N2 to obtain 
the desired fluorinated products.2-Fluoro-l,3-dicarbonyl compounds 121 have 
aroused considerable interest as small molecules that provide building blocks for the 
preparation of larger biologically active compounds. The electrophilc fluorinating 
reagent F-TEDA-BF4 (TEDA = triethylenediamine) 120 efficiently reacts with 1,3-
dicarbonyl compounds at room temperature to give the a-fluoro derivatives in good 
yield 188 
114 
.CI 
(BF4-)2 
120 
More recentiy, Chambers et. al. have shown that fluorine gas can be used 
directiy to prepare 2-fluoro 1,3-diketones 121 and keto esters,'^' giving a mixture of 
products shown in Fig. 4.6. 
O O o o 
R ' ^ "TT R" 
R 
R ' ^ ^ ^ ^ ^ ^ ^ R " + R" 
O O O O 
CHjF + R ' ^ ^K' 
R F F 
121 
Fig. 4.6 Reagents and conditions: i , 0.05 mol F2 (10% N2), formic acid, 10-15 °C 
The reaction of electrophiles with a-fluorinated enolate anions'^°or aza enolates, 
generated afl;er deprotonation of imines of fluoroacetone'^' (Fig. 4.7), has proven 
moderately successfiil. In their extensive study of fluorinated azaenolates, Welch and 
Eswarakrishnan demonstrated how variation in base and reaction temperature affected 
the regiospecificity of deprotonation of fluoroacetone and the subsequent product of 
alkylation (Table 4.3) 192 
N 
F 
l l - I V 
R R 
Fig. 4.7 Reagents and conditions: i , cyclohexylamine, K2CO3; i i , base; i i i , RX; iv, HsO"" 
115 
Table 4.3 
Alkyl halide Base^ rrc RCHFCOCH3 CH2FCOCH2R Yield (%) 
CH3I A -30 11 89 48 
CH3I B -80 96 4 43 
CH2=CHCH2Br A -30 9 91 62 
CH2=CHCH2Br B -80 97 3 69 
" A = LHMDS; B = LDA. 
Finally, a-fluoro ketones have been successfully synthesised by hydrogen fluoride-
mediated isomerisation of 2-fluorooxiranes, although this methodology is limited to 
appropriate systems (Fig. 4.8).'^^ 
O 
Fig. 4.8 Isomerisation of 2-fluorooxiranes 
It became attractive to investigate the application of Stork enamine type 
chemistry to develop a new method for the synthesis of a-fluoro ketones via the 
alkylation of fluoro enamines.* '^* Such an approach would offer a neutral and mild 
method towards the formation of a-fluorinated ketone compounds. Stork enamine 
chemistry appears in most xindergraduate textbooks, but interestingly no examples using 
2-fluoro ketones have been reported in the literature. This aspect of the project aimed to 
assess i f this particular application was problematic or i f it had just been overlooked. 
4.3 Stork enamine chemistry 
The reactivity of enamines has been known since 1883, when first Collie, and then 
Benary and Robinson described the C-alkylation of aminocrotonic esters.''^ However, 
the wide-ranging applicability of the reaction of enamines with electrophiles was not 
realised until Stork's pioneering work in 1954. The Stork enamine reaction involves the 
C-alkylation or -acylation of carbonyl compounds via an enamine intermediate 122, and 
116 
since 1954 it has become a common synthetic strategy. '^ ^ hi the definitive paper Stork 
considered factors affecting the structure and reactivity of enamines and their alkylation 
and acylation.'^' The Stork method generally leads almost exclusively to monoalkylated 
products with alkylation directed towards the less substituted side of the ketone 123 
(Fig. 4.9). 
N 
122 123 
Fig. 4.9 Reagents and conditions: i , pyrrolidine, molecular sieves; i i , RX; i i i , H3O* 
The enamines of ketones are readily prepared in high yield by the condensation 
reaction of the appropriate ketones and amines in a suitable solvent such as benzene, 
toluene or xylene. The eliminated water is usually removed either by means of a Dean-
Stark head or molecular sieves.'^^ Alternatively, a chemically inert drying agent, e.g. 
K2CO3 or MgS04, may be suspended in the reaction mixture. The most commonly used 
amines are the cyclic amines piperidine 124, morpholine 125 and pyrrolidine 126. 
I 
H 
124 
125 
I 
H 
126 
Using enamine methodology the reaction of a-fluoroacetophenones with various 
amines was explored along with the subsequent alkylation of the derived enamines to 
afford a-fluoro ketone compounds. 
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4.4 Synthesis of a-fluoroacetophenones and enamines 
The required a-fluoroacetophenones 127-130 were readily prepared (Fig. 4.10) from 
the appropriately substituted acid chlorides, firstly by reaction with diazomethane to 
generate the corresponding diazo ketones. The diazo ketones were then treated in situ 
with hydrogen fluoride in pyridine to yield the desired a-fluoroacetophenones in 
relatively good yields. This one-pot procedure gave rise to a mixture of both the a-
fluoro and a-chloro-acetophenones, which were readily separable by column 
chromatography. The desired a-fluoro compounds all gave satisfactory analytical data. 
CI 
N, 
127 R = H 
128 R =p-Br 
129 R =P-NO2 
130 R =;7-0Me 
Fig 4.10 Reagents: i , CH2N2, Et20; i i , HF-pyridine, Et20, 45-63% 
The a-fluoroacetophenones were heated under reflux with a number of amines 
including pyrrolidine 126, diisopropylamine and diethylamine in a variety of solvents. 
In the reactions using the acyclic amines, no indication of enamine formation was 
detected by '^F NMR spectroscopy. Only with pyrrolidine was the formation of the 
enamine intermediates observed. The generated enamines were a mixture of E and Z 
isomers (Fig. 4.11) which were easily distinguishable by '^F NMR spectroscopy of the 
reaction mixture. This meant that the extent of conversion could be readily monitored. 
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Fig 4.11 Reagents and conditions: i , 126, 4 A molecular sieves, benzene, heat, 95% 
The enamine formation was assessed in a range of solvents and the relative ratio 
of the geometric isomers determined directly by integration of the observed signals in 
the *^ F NMR spectra of the reaction mixtures. The results, compiled in Table 4.4, show 
that in most cases conversion to the enamine intermediate was high. There was 
however only a limited effect on the isomer ratio by substitution of the aromatic ring, 
with the largest observed ratio occurring with substitution of a p-nitro group. 
Table 4.4 E/Z ratios as determined by '^F NMR spectroscopy 
Substituent Solvent Conversion (%) Ratio E:Z 
H 
H 
H 
NO2 
OMe 
Br 
Et20 
CCI4 
CfiHe 
CeHe 
CeHe 
CeHg 
100 
76 
96 
70 
69 
95 
1.22 
1.11 
1.27 
1.65 
1.45 
1.44 
1.0 
1.0 
1.0 
1.0 
1.0 
1.0 
In all the cases the predominant signals observed in the '^F NMR spectra were to 
lower frequency (between 8 -166.3 and -173.0) with those to higher frequency in the 
range 8 -154.5 to -160.3. The signals to lower frequency were assigned to the E 
isomers, consistent with the previous assignment of the E/Z isomers of the structurally 
related enol ether systems 131 and 132 199,200 
119 
(£)-131R = MeOCH2 (6 -162.9) (Z)-131 R = MeOCH2 (8-154.0) 
(E)-132 R = SiMezBu' (8 -164.7) (Z)-132 R = SiMe2Bu' (8 -157.2) 
The reason for the preference towards the E isomer remains unclear and may 
arise from either electronic or steric factors. One possible explanation may be that the 
fluorine is interacting electrostatically with the ortho aromatic proton, thereby 
preferentially stabilising the E isomer. This interaction should increase with the 
introduction of a p-mtw group which would render the proton more 8"^ , increasing the 
observed ratio, consistent with the experimental result. 
The polarity of the reaction solvent had little bearing on the observed ratio of 
geometric isomers. A l l attempts to isolate the enamine intermediates resulted in 
decomposition back to starting materials and as a result the enamine products were 
never isolated or purified. 
120 
4.5 Alkylation of fluoroenamines 
The mixture of E/Z fluoroenamines derived from the reaction of pyrrolidine and the ot-
fluoroacetophenones 127-130 were treated in situ, under refluxing conditions, with a 
variety of potential Michael acceptors. The consumption of the enamine, presumably 
via an iminium species 133 (Fig. 4.12), lead to the generation of the new alkylated 
enamines 134 after treatment with acrylonitrile 135, methyl vinyl ketone 136 and methyl 
acrylate 137. 
135 
Me 
136 
OMe 
137 
The accumulation of the alkylated enamines was again monitored directly by '^ F 
NMR specfroscopy of the reaction mixture. There now appeared to be a significant 
stereochemical bias {ca. 8:1) in favour of one of the geometric isomers. The 
predominant signals were again to low frequency (up-field) (8 -145.5 to -164.0) and by 
correlation were assigned to the E isomer. This preference is again presumably due 
either to unfavourable steric interactions between the aromatic proton and the R group 
or an electronic effect between the fluorine and aromatic proton. 
127-130 R-
133 134 
135-142 
Fig 4.12 Reagents: i , Michael acceptor; i i , HsO^ 
These reaction intermediates were, however, not isolated, but subjected to acidic 
work up to afford the desired ketones 138-143 in moderate overall yields (48-60%) 
(Fig. 4.13). 
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138 139 
OMe 
140 R = H 
141 R =/?-Br 
142 R =;?-N02 
143 R =p-OMe 
Fig. 4.13 
Reaction of the enamine with cyclohexenone gave after work-up the a-fluoro 
ketone 144 as a 2:3 mixture of diastereoisomers, and the reaction with methyl 
methacrylate' generated 145 as a 1:1.2 mixture of diastereoisomers (Fig. 4.14). The 
reaction of the enamine with methyl methacrylate was observed by '^F NMR 
specfroscopy to proceed at a significantly slower rate than with the other Michael 
acceptors, typically taking several days to react compared with just several hours in the 
other cases. This observation is consistent with the methyl group of the methylacrylate 
deactivating the double bond to attack by nucleophiles. 
OMe 
F Me 
145 
Fig. 4.15 
The Michael acceptors used to generate these products provided a range of 
a-fluoro ketones with pendant functional groups which have the potential to be further 
elaborated. Problems, however, were encountered when the methodology was extended 
to other alkylating reagents. The enamine did not undergo reaction with methyl 
122 
cinnamate 146, possibly due to steric hindrance of the phenyl group. Reaction with 
methyl propiolate 147 under similar conditions generated a complex mixture of 
fluorinated products which were not isolated. 
OMe 
146 
O 
OMe 
147 
Alkylation reactions with various alkyl halides including methyl iodide, allyl 
bromide and ethyl bromoacetate were unsuccessful, and no alkylated products were 
isolated using reagents of this type. 
In conclusion we have demonsfrated for the first time that a range of a-fluoro 
ketones can be prepared using Stork-enamine chemistry. The methodology worked well 
for Michael acceptors but did not extend to more sfraightforward alkylation reactions. It 
became appropriate at this stage to investigate i f the Stork enamine reaction could be 
carried out asymmetrically, with a homochiral pyrrolidine base. 
4.6 Asymmetric induction via Stork enamine methodology 
Asymmetric induction was first observed by Yamada in the alkylation of chiral 
enamines derived from various esters of proline (Fig. 4.16).'^°' The resultant 2-
substituted cyclohexanones were shown to have the S configuration, with typical 
enantiomeric excesses of 10-30%, which could be increased by use of a bulky ester to 
50-60% ee. The observed induction in the product arises from a kinetically controlled 
enantioselective alkylation of the enamine intermediate. 
+ ^ C O j R • 
H 
,„R' 
Fig. 4.16 Reagents: i, CH2=CHCOCH3 
123 
The degree of enantioselectivity was substantially increased by the use of an 
amine wdth a C2 axis of symmetry. Using the cyclohexanone enamine 148 derived from 
(+)-/ran5-2,5-dimethylpyrrolidine, Whitesell and Felman achieved optical yields in 
excess of 80%, but with the opposite absolute configuration predominating. 202 
148 
H 
R = Me ee = 83% 
R = Pr ee = 93% 
R = CH2CH=CH2 ee = 82% 
Of particular interest was the use of (25)-(diphenylmethyl)pyrrolidine 151 as a 
potential chiral amine for the formation of the enamines. An efficient synthesis of this 
pyrrolidine derivative has been developed recently in Durham and is outlined in Fig. 
4.17. 203 
I 
H 
H 
151 
Ph 
N ^COjMe 
"OB 
149 
N 
150 
Ph 
Ph 
Fig. 4.17 Reagents: i , EtCOCl, MeOH, 91%; i i , PhMgBr, THF, 82%; i i i , Pd-C, MeOH, 
H2, 67% 
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The amine (25)-(diphenylmethyl)pyrrolidine was prepared in good overall yield 
from (5)-proline. (5)-Proline was firstly freated with ethyl chloroformate in methanol, 
affording 149 in 91%, and subsequent treatment with two equivalents of 
phenylmagnesium bromide in THF gave the cyclic carbamate 150, which was 
recrystallised from diethyl ether in 82%) yield. Finally, hydrogenation of the carbamate 
produced the desired product in an overall yield of 50% from (5)-proline. 
The reaction of a-fluoroacetophenone 127 with the amine (25)-
(diphenylmethyl)pyrrolidine 151 was attempted under the same conditions as those 
previously employed. However, despite several attempts with varying conditions no 
reaction, as judged by '^F NMR spectroscopy of the reaction mixture, was observed. It 
was therefore concluded that the diphenylmethyl group was sterically too demanding for 
successful reaction to occur and attempts at asymmetric induction were discontinued. 
Of course the potential exists to explore other homochiral pyrrolidine bases. 
4.7 Potential uses of the methodology 
4.7.1 Fluorinated lactones 
With the range of compounds prepared, elaboration of the pendant functional group 
could be envisaged to produce a series of novel fluorinated lactones by reduction and 
cyclisation to give lactones such as 152. 
OMe 
NaBH4 
PTSA* 
By refinement of the fluoro ketone precursor by, for example, the use of 
fluoroacetone to replace a-fluoroacetopheone, and using suitable Michael acceptors, a 
series of fluorinated lactones could be assessed that are fluorinated analogues of insect 
pheromones such as 153. 
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Chapter Five 
Preliminary Studies into the Effect of Fluorine with 
Transketolase and Glycerol-3-Phosphate Dehydrogenase 
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Preliminary Studies into the Effect of Fluorine with 
Transketolase and Glycerol-3-Phosphate Dehydrogenase 
Part A. Preliminary Studies with Transketolase 
A5.1 Introduction 
The enzyme fransketolase (B.C. 2.2.1.1) belongs to the group of enzymes known as the 
fransferases that catalyse the fransfer of a molecular group from one molecule to 
another. In vivo transketolase catalyses a vital step in the pentose phosphate pathway 
which oxidises glucose-6-phosphate to carbon dioxide and a five carbon sugar 
phosphate. The carbon atoms of the pentose are then rearranged by two enzymes— 
transaldolase and fransketolase—^which catalyse fransfers of two or three carbon units 
between molecules. The major functions of the pentose phosphate pathway are the 
generation of NADPH and supply of ribose-5-phosphate. Transketolase catalyses the 
transfer of a two carbon ketol group from D-xylulose-5-phosphate to D-ribose-5-
phosphate, generating D-sedoheptulose-7-phosphate (Fig. A5.1). 204 
= 0 
—OH 
—O—P 
glyceraldehyde-S-
phosphate 
wlubse-5-phosphate 
— O H i — O - P 
ribose- 5 -phosphate 
—OH 
—OH 
—OH sedoheptutose-7 
phosphate 
Fig. A5.1 
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Transketolase is one of several enzymes which catalyse reactions involving 
intermediates with a negative charge on what was initially a carbonyl carbon atom. The 
enzjone requires magnesium(ll) ions and thiamine pyrophosphate (TPP) as co-factors. 
The transketolase reaction is initiated by addition of thiamine pyrophosphate anion to 
the carbonyl of a ketose phosphate (xylulose-5-phosphate). The adduct undergoes an 
aldol like cleavage, retaining C-1 and C-2 on the enzyme surface in the form of the 
glycoaldehyde derivative of TPP. This intermediate can exist as a resonance stabilised 
carbanion, and can condense with the carbonyl of another aldolase. The products of the 
reaction with ribose-5-phosphate are sedoheptulose-7-phosphate and 3-phosphate-
glyceraldehyde (Fig. A5.1). The fransketolase activity has also been shown to play an 
important role in the biosjaithesis of aromatic amino acids like L-phenylalanine and 
related metabolites from D-glucose.'^ ^^ 
In the last few years, an increasing number of papers dealing with enzymatic 
synthesis of monosaccharides by aldol reactions have demonstrated the usefubiess of 
such enzymes.^ ^^ The isolated enzyme itself, however, has also been shown to have 
signiflcant synthetic potential.'^ "^ The use of hydroxypyruvate 155 as the ketol makes 
the reaction more efficient and also, by the release of carbon dioxide, irreversible. The 
products of the reaction are the trihydroxylated compounds 156 with the D-threo 
configuration (Fig. A5.2). 
OH O 
OH ^ 0 1 ^ o / ' ^ - ^ . - J k / O " + CO2 
Mg2+ OH 
154 155 156 
Fig. A5.2 
It had initially been thought that only the a-hydroxy aldehydes of the D-
configuration 154 were potential aldehyde acceptors, but a study by Demuynck et al. 
has shown that some simple a-unsubstituted aldehydes are substrates for 
transketolase.^^^ This study demonstrated that aliphatic aldehydes were good substrates 
for the enzyme and that the presence of a hydroxy group or oxygen atom at the a and/or 
P position had a positive effect on the observed rate of reaction. For example, 
glycoaldehyde 157 was shown to be a better substrate than acetaldehyde 158. Steric 
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hindrance near the aldehyde group also reduced the reactivity of the aldehyde {c.f. 159 
and 160). 
Table A5.1 Relative reactivities of aldehydes (RCHO) with hydroxypyruvate in yeast 
transketolase-catalysed carbon-carbon bond formation 
H 
O 
A. 
Compound R Frel 
157 HOCH2- 1 
158 CH3- 0.25 
159 {R,S) CH3CH(OH)CH2- 0.29 
160 {R,S) CH3CH(OBz)CH2- 0.14 
161 iR,S) CH2FCH(0H)- 0.47 
Demuynck. also demonstrated that transketolase displays enantioselectivity on 
reaction of racemic a-hydroxy aldehydes with hydroxypyruvate in that L-glyceraldehyde 
was not a suitable substrate for the enzyme. This confrasts with fructose 1,6-
diphosphate aldolase, which accepts both isomers as substrates. 
In a similar study, using transketolase obtained from an over expressed E. coli 
transformant carrying the transketolase gene, the aldehyde specificity was again shown 
9 no 
to be relatively low. a-Hydroxy aldehydes were again the best substrates, however 
aldehydes such as propionaldehyde and pyruvaldehyde were also converted into the 
corresponding products. The low substrate specificity for the aldehyde component 
together with the high stereoselectivity for the carbon-carbon bond formation make the 
enzyme a potentially useful catalyst for asymmetric synthesis. 
A5.2 Reaction of an a-fluoro aldehyde with transketolase 
The previous studies with racemic a-hydroxy aldehydes demonstrated the enzyme's 
ability to show diastereoselectivity between the isomers of the aldehyde. The results of 
the studies also indicated that the presence of an a-D-hydroxy group enhanced the rate 
of reaction, and that the reaction was subject to steric effects. The introduction, 
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therefore, of an a-fluorine atom would be predicted to induce several effects on the 
reactivity of the aldehyde. I f the increased rate observed in the a-D-hydroxy compounds 
arose due to the electronegativity of the hydroxy group then the introduction of the 
fluorine atom would serve to increase this effect. Indeed, as discussed previously in 
Chapter 4, the presence of an a-fluorine would be expected to stabilise the tetrahedral 
intermediate formed in the reaction between the carbanion equivalent and the 
fluorinated aldehyde. Clearly, as discussed previously, the infroduction of an a-fluorine 
would not introduce a significant steric effect compared to an a-hydroxy aldehyde, 
however with the infroduction of an a-fluorine atom there exists the possibility of a 
stabilising stereoelectronic effect which may confrol the diastereoselectivity of the 
enzymic fransformation. In the previous analyses an Anh-Eisenstein type stabilisation 
between the a* orbital of the C-F bond and the attacking carbon nucleophile is 
predicted to favovir one diastereoisomeric fransition state over the other (Fig A5.3). 
I — O H 
E n z — C — O H R O 
I — O H 
E n z — C — O H R .0 
A5.3 Aims of investigation 
Fig. A5.3 
The aim of the initial investigation was to determine whether the transketolase activity 
would process an a-fluorinated aldehyde substrate with any diastereoselectivity. The a-
fluoro aldehyde chosen for investigation was 2-fluorohexanal. Previous studies have 
shown that butyraldehyde is a substrate for the enzyme and that increasing the length of 
the carbon chain lowered the reactivity of the enzymatic transformation.However, in 
order to obtain a material that was relatively easy to handle, a compromise between 
chain length and volatility was reached with 2-fluorohexanal 165. 
The anticipated products of the reaction of 2-fluorohexanaI with hydroxy-
pyruvate and fransketolase are shown below in Fig. A5.4. It was envisaged that any 
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diastereoselectivity could be analysed directly by F NMR analysis of the product 
mixture. 
OH OH 
F O 
transketolase, TPP 
Mg2+ 
OH OH 
F O 
Fig. A5.4 
A5.4 Synthesis of 2-fluorohexanal 
The synthetic route established for the synthesis of 2-fluorohexanal is outlined below 
(Fig. A5.5). The synthesis began with commercially available methyl hexanoate, which 
was conveniently brominated at the a position following the procedure of Pogany.'°' 
Thus methyl hexanoate was heated at 80 °C with a mixture of bromine and red 
phosphorus for 16 h to afford 162 in high yield as a colourless oil after distillation. 
Fluorination to give 163 was achieved by nucleophilic halogen replacement of bromide 
using silver(i) fluoride in wet acetonitrile.'°' This transformation was the limiting step 
in the synthetic sequence due to the amount of silver fluoride required to achieve 
synthetically useful yields and the high cost (£35 for 5 g) of the silver fluoride. After 
removal of the silver salts and purification by column chromatography, the product 163 
was isolated in 80% yield. The fluorinated ester was then reduced to 2-fluorohexanol 
164 by reaction with lithium aluminium hydride in diethyl ether. This product was 
obtained in 77% yield after purification by column chromatography. Finally, the alcohol 
was oxidised to the target aldehyde 165 by stirring with pyridinium chlorochromate and 
3 A molecular sieves in CH2Cl2.^''' 
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OMe "OMe 
III 
F 
164 
^OMe 
Fig. A5.5 Reagents: i , Bra, red phosphorus, MeOH, 86%; i i , AgF (4.5 equiv.), M e C N -
H2O, 80%; i i i , LIAIHA, EtiO, 77%; iv , PCC, 3 A molecular sieves, CH2CI2, 64% 
Aldehyde 165 was characterised by formation o f its 2,4-dinitrophenylhydrazone 
derivative 166 after treatment wi th an acidic solution o f 2,4-dinitrophenylhydrazine. 
166 
132 
A5.5 Results and discussion 
The enzyme reactions were initiated by the addition o f a solution o f hydroxpyruvic acid 
and aldehyde 165 in glycylglycine buffer to a solution o f magnesium chloride, thiamine 
pyrophosphate and transketolase in glycylglycine buffer adjusted to pH 7.6. The 
reaction was placed in on orbital shaker at 29 °C and was monitored by '^F N M R 
spectroscopy. Control reactions were also undertaken with identical solutions prepared 
but without the addition o f enzyme. 
A5.5.1 Results from NMR data for enzyme and control reaction 
The enzyme reaction was repeated twice, varying the amount o f TPP used in the 
reactions; however, both runs gave similar overall results. Importantly, the controls 
showed that no reaction took place in the absence of transketolase. The only observable 
change in the '^F N M R spectra o f the controls was the formation o f a peak at 8 -120, 
which was assigned to the elimination o f fluoride from the aldehyde. 
On the other hand, the enzyme reactions did generate a number of novel 
fluorinated products. The resultant '^F N M R spectrum (250 MHz) after 15 h at 29 °C 
clearly shows five peaks. The reaction was frozen at this point to arrest further reaction 
and a high field ^^ F N M R spectrum (470 MHz) was recorded (Fig. A5.6). This again 
showed the five peaks observed previously along with a number o f smaller, previously 
unobserved, signals which could either have formed in the time between the reaction 
and observation o f the high field N M R spectrum or were just not visible at lower field. 
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TT-rp-rTTT 
-184 -186 -188 -190 -192 -194 -196 -198 -200 -202 -204 ppm 
Fig. A5.6 '^F N M R spectrum o f the reaction solution of 2-fluorohexanal with 
transketolase after 15 h at 29 °C 
The observed '^F N M R spectrum is clearly complex, with the formation of a 
number o f fluorinated compounds. The major signals were tentatively assigned as 
outlined in Table A5.2. 
Table A5.2 '^F N M R data for the reaction o f 2-fluorohexanal with transketolase 
8 (ppm) Assignment 
-201.7 Fa Condensation product 168 
-201.3 Residual 2-fluorohexanal 165 
-198.8 Diastereoisomeric product 167 
-194.2 Fb Condensation product 168 
-186.2 Diastereoisomeric product 167 
-120.0 Fluoride 
The results from the N M R experiments appear to indicate the formation of three 
major products, the two diastereoisomeric products 167 arising from the addition of 
hydroxypyruvate to the aldehyde and a self-condensation product from the aldehyde 
168. 
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The observed ratio between the two diastereoisomeric products from the '^F 
N M R spectrum appears to be as high as 9:1. The fluoride content is also much greater 
in the presence o f the enzyme than in the control reactions, indicating a much more 
facile fluoride elimination. 
When the reaction was left to proceed for a longer period o f time (90 h) the 
observed ratio (250 M H z ) between the two diastereoisomers fel l to approximately 2:1. 
Such an observation is indicative o f an enzymatic kinetic resolution whereby one 
enantiomer o f the a-fluoro aldehyde is processed more rapidly than the other. 
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A5.6 The chemistry of the enzyme reactions 
A5.6.1 Formation of diastereoisomeric products 
A mechanism for the formation o f the two diastereoisomers by the addition of 
hydroxypyruvate to 2-fluorohexanal is outlined below (Fig. A5.7). The diastereo-
selectivity w i l l depend on the relative energies o f the diastereoisomeric transition states 
in the condensation 
Fig. A5.7 
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A5.6.2 Formation of the self-condensation product 
The formation o f the observed self-condensation product 168 can be accounted for by 
the mechanism outlined below. The TPP anion, instead of reacting with hydroxy-
pyruvate, condenses directly wi th the a-fluoro aldehyde. This adduct may then react 
wi th a second molecule o f the a-fluoro aldehyde to generate the proposed self-
condensation product 168 (Fig. A5.8). 
Fig. A5.8 
A5.6.3 Elimination of fluoride 
In both the enzyme and the control reactions the elimination of fluoride was observed. 
The amount o f fluoride increased with time, which suggests the formation is either due 
to instability o f the product or as a consequence o f TPP chemistry. There exist three 
possible mechanisms by which fluoride elimination may be induced. 
(i) Fluoride is generated in the control reactions, which must come from 
decomposition o f 2-fluorohexanal. A non-enzymatic reaction between TPP and 2-
fluorohexanal may generate the adduct 169 shown below (Fig. A5.9), which would then 
be able to eliminate fluoride. 
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CH, 
Fig. A5.9 
( i i ) In the enzymatic reaction, fluoride elimination may occur from the 
diastereoisomeric products o f hydroxypyruvate addition to 2-fluorohexanal (Fig. A5.10). 
It may also be the case that the diastereoisomers have differing stability towards F' 
elimination. 
HO H 9 " 
O o 
OH OH 
O OH 
Fig. A5.10 
( i i i ) The proposed difluoro condensation product 168 may also undergo fluoride 
elimination (Fig. A5.11) 
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Fig. A5.11 
A5.7 Conclusions and future work 
The enzymatic reaction between 2-fluorohexanal and transketolase has been studied. 
The resultant high f ield '^F N M R spectrum o f the enzymatic reaction indicated the 
formation o f a number o f novel fluorinated compounds. Importantly, no reaction 
products were seen in the absence of enzyme. The anticipated diastereoisomeric 
products have been tentatively assigned in the '^F N M R spectrum in a 9:1 ratio. It was, 
however, not possible to assess the rates o f reaction or levels o f conversion attamed. 
There was also apparent a second major product, which was considered to arise from the 
self-condensation o f two aldehyde molecules. 
The work performed here on the interaction o f a-fluorinated aldehydes with 
transketolase forms a basic introduction to the use o f fluorinated subsfrates with the 
transketolase enzyme. This preliminary study was conducted towards the end of the 
research prograirmie wi th the assistance o f a final year imdergraduate student. No 
compounds were isolated or purified. Further work is currently being undertaken to 
extend this study. 
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Part B . The enzymatic oxidation of mono- and di-fluoromethylenephosphonate 
analogues of glycerol-3-phosphate 
B5.1 Introduction 
Phosphonates have been widely studied as phosphate mimics for many years.'^" The 
replacement o f the bridging oxygen by a CH2 moiety renders the phosphonate resistant 
to phosphatase hydrolysis. While the substitution maintains a similar conformation, 
which is important for protein binding, the electronic consequences can prove 
detrimental as the electronegativity o f oxygen is not matched by the CH2. This is clearly 
demonstrated by analysis o f the pATa values for the second deprotonation of the 
phosphate, which has a value o f 6.4 compared to 7.6 for the phosphonate.'^'^ The acidity 
o f the phosphonate can be increased by the introduction o f fluorine onto the methylene 
group (Table B5.1). 
Table B5.1 Various pKa values for second deprotonation 
0 
II II 
\ OH 
OH 
X 
0 6.4 
CH2 7.6 
CHF 6.5 
CF2 5.4 
The introduction o f a single fluorine (CHF) increases the acidity of the 
phosphonate, generating a pK^ which is essentially identical to that of the phosphate 
(6.5),^'^ without greatiy altering the geometry o f the molecule. This modification gives 
rise to compounds that are much closer analogues to the parent phosphonate. Indeed, a 
recent theoretical analysis predicted a close relationship between the electrostatic 
profiles o f the CHF phosphonate and the phosphate groups.'^''' 
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The geometry o f the phosphonates has been studied by X-ray analysis of suitable 
compounds. A particularly interesting correlation can be found with the C-X-P bond 
angles as one and two fluorine atoms are introduced (Table B5.2).^'^ 
Table B5.2 C - X - P angles o f the phosphate and phosphonates as determined by X-ray 
crystallography" 
0 
II II 
~ ^ x / ^ o -
OH 
X C-X-P (°) 
0 118.7 
CH2 112.1 
CHF 113.3 
CF2 116.5 
R = NH3^ in all cases except when X = 0 , where R = CHaNHs:". 
The data obtained from the X-ray structure analyses o f aminophosphonates 
shows that, in the case o f the CHF phosphonate, the observed C-X-P angle is similar to 
that for the parent phosphonate but that the introduction o f a CF2 group results in 
significant angle widening. Despite the obvious advantages o f the CHF-phosphonate in 
terms o f its steric and electrostatic profile these compounds have received suprisingly 
little attention as potential phosphonate mimics. 
The synthesis and evaluation o f fluorinated phosphonates as mimics for 
monophosphonates in the glycolj1;ic pathway has been studied previously.^'^'^'^ 
Initially, a racemic sample o f the CF2-phosphonate 173, an analogue o f 5«-glycerol-3-
phosphate 170, was demonsfrated to be a subsfrate for NADH-linked glycerol-3-
phosphate dehydrogenase.^'^ Perhaps suprisingly, these studies suggested that 173 was 
in fact a poorer substrate than both 5n-glycerol-3-phosphate 170 and the CH2-phosphate 
analogue 171. The difluorophosphonate was apparently turned over by the enzyme at 
one-sixth the rate o f that o f the natural subsfrate. 
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In a more recent study, the CHF-phosphonate 172 was synthesised along with a 
homochiral sample o f 173 and both were assessed as substrates for the enzyme glycerol-
3-phosphate dehydrogenase (G-3-P). '^ '^  The results are summarised below in Table 
B5.3. 
Table B5.3 Values o f Km and Vre\ for the oxidation o f 170 and phosphonates 171-173 
by G-3-P dehydrogenase.^'^ 
OH 
H O ^ O- G-Z^^ " 0 \ ^ ^ X - p / ° " 
NAD+ NADH 
X KJvoM V, rel 
O 0.20 1.0 
CH2 0.18 0.8 
CHF 0.17 0.9 
CF2 0.73 0.8 
The results show that both o f the fluorinated phosphonates analogues are good 
substrates for the enzyme, however the CHF-phosphonate was a significantly better 
substiate than the CF2 phosphonate {K^ 172 = 0.17 mM, 173 = 0.73 mM). A l l of the 
substiates had similar maximal rates (Frei) relative to 170 at substrate saturation levels, 
however the CF2-phosphonate emerged uniquely as a poorer substrate by K^. This was 
argued to be due to an adverse electrostatic interaction with the enzyme surface caused 
by the second fluorine atom. 
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Within this study a comparison o f the rates o f enzymatic oxidation of the 
diastereoisomers o f the CHF-phosphonate 172 was also undertaken. 
OH F H 
HO 
OH H F 
HO 
172a 172b 
The '^F N M R signals for 172a and 172b are resolved in the '^F N M R spectrum 
o f the mixture o f the diastereoisomers, although no assignment of the signals has been 
made. Analysis o f the change in ratio o f the integrals o f the signals associated with each 
diastereoisomer, over time, showed that one o f the isomers apparently decreased relative 
to the other by 20% over a period o f 65 min (Fig. B5.1). 
Enzyme+65min. 
J 
I 
-203.5 -204-0 -204.5 -205.0 
Fig. B5.1 
It was, however, not possible within the study to accurately calculate the extent 
o f conversion. The oxidised product o f the reaction, which under the conditions of the 
assay is the hydrazone 174 (hydrazine pH 9.5), did not appear to accumulate as it was 
not apparent by '^F N M R spectroscopy. One possibility is that the product decomposed 
under the basic conditions o f the assay. The '^F N M R profile o f the reaction indicated 
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that the dehydrogenase could distinguish between the diastereoisomers o f 172 and that 
this discrimination arose from a kinetic preference by the enzyme for one o f the 
diastereoisomers. 
NH, 
I ' 
N F H 
H O . ^ ^ „ / 0 -
r ^ o -
174 
A short study was initiated using samples previously prepared (by Dr Jens 
Nieschalk)^'^ to investigate the reaction o f the CHF and CF2 phosphonate analogues o f 
glycerol-3-phosphate wi th G-3-P dehydrogenase. The key issue here was to monitor the 
reactions at neutral p H to try to arrest decomposition o f the reaction products. Thus 
hydrazine was removed and a co-factor recycling protocol was established. 
B5.1.1 Coupled enzyme co-factor recycling 
As previously described in Chapter 2, the major practical problem associated with the 
use o f enzymes in organic synthesis is the expense o f co-enzymes like N A D H . This can 
be overcome by using catalytic quantities o f the co-enzyme and recycling it in situ to the 
active form in a coupled enzyme system. Whitesides demonstrated that NAD(P)H could 
be recycled on up to a mole scale using several enzymes, each with differing catalytic 
activities, i n the same vessel without one interfering with the others.^''^^ Thus, in 
coupled enzyme recycling protocols an auxiliary enzyme system, which may be a single 
or multiple enzyme system, is used to regenerate the co-enzyme. In Fig. B5.2 the 
HLADH-catalysed reduction o f 2-methylcyclohexanone is shown. The co-enzyme is 
recycled by a glyceraldehyde-3-phosphate dehydrogenase (GAPDH) catalysed oxidation 
o f glyceraldehyde-3-phosphate. This auxiliary substrate is formed from an aldolase-
') 1 S 
catalysed cleavage o f fructose-1,6-diphosphate. 
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Fig. B5.2 Coupled enzyme recycling of N A D H co-factof 
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B5.2 Enzymatic oxidation of CF2-phosphonate 173 
With a sample o f the CF2-phosphonate analogue 173 o f 5«-glycerol-3-phosphate in hand 
a study o f its oxidation wi th G-3-P dehydrogenase was undertaken at neutral pH. '^F 
N M R spectroscopy was used to fol low the reaction course and to determine the nature 
o f the products. The application o f enzyme coupled co-factor recycling was also 
investigated using fluoropyruvate 175 with lactate dehydrogenase (LDH). 
Fluoropyruvate is a good substrate for L D H and the introduction o f a fluorine atom gave 
a convenient handle wi th which to calculate the extent o f conversion by '^F N M R 
spectroscopy (Fig. B5.3). 
Initial control reactions wi th 5/7-glycerol-3-phosphate and NAD"^ using 
fluoropyruvate demonstrated that the conversion could be followed by '^F N M R 
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spectroscopy via integration o f the signals for fluoropyruvate (triplet, 8 -228.5) and 
fluorolactate (doublet o f tiiplets, 8 -229.5). 
OH F F 
HO 
F F 
G-3-P HO 
173 
NAD+ NADH 
176 
OH 
O F 
LDH 
Fig. B5.3 
O F 
175 
Glycerol-3-phosphate dehydrogenase was added to a solution of pH 7 buffer 
containing the difluorophosphonate 173 and fluoropyruvate 175 in a 1:1 ratio, with 
NAD"^ and lactate dehydrogenase. The reaction was maintained at 30 °C and the 
progress was monitored by removal o f aliquots for '^F N M R analysis (Fig. B5.4). 
* 
-K -133 -13S - l ! 3 - ! ! • ; 
Fig. B.5.4 
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A t neutral pH the reaction was extremely slow but stable, turning over the 
phosphonate for several days. '^F N M R spectroscopy enabled analysis o f the products 
formed on enzymatic oxidation. Clearly the expected product from the oxidation was 
the ketone 176. It was not however apparent that this product was accumulating, but a 
new peak (doublet o f doublets) emerged at 8 -93 in the '^F N M R spectrum, which was 
assigned to the fluorovinylmethylenephosphonate 177, and also a large singlet 
became apparent at 8 -117 which was assigned to the accumulation o f fluoride (Fig. 
B5.4). However, closer analysis o f the '^F N M R spectrum showed that there was a 
change in the coupling pattern o f the signal associated with the starting material. 
Further analysis o f the '^F N M R spectrum revealed that the ketone 176 was indeed 
being generated but that its '^F N M R signal was coincident wi th the signal of the 
starting CF2-phosphonate 173. This oxidised product was then breaking down via the 
elimination o f hydrogen fluoride, giving 177 and fluoride ion in solution. That this was 
indeed the case was confirmed by the addition o f base to the reaction solution, after 
which the observed coupling pattern for the CF2-phosphonate was restored, along with 
an increase i n the fluoride concentration. Thus in basic conditions hydrogen fluoride 
elimination is induced and all o f the ketone 176 decomposed to reveal unreacted starting 
material at 8 -108.5. It is not clear, however, why 177 did not accumulate to any extent, 
and we have to deduce that i t is also labile to fluoride elimination. A Michael-type 
addition o f water to 177 could result in fluoride release, as shown below in Fig. B5.5. 
OH F F 
HO 
HO 
173 
OH 
P 4 -
G-3-P 
HO 
- F -
O F F 
176 6 
-P-
OH, 
II ° 
177 ° 
Fig. B5.5 
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B5.3 Enzymatic oxidation of CHF-phosphonate 
Using the same protocol as described for the CF2-phosphonate, the enzymatic oxidation 
of the CHF-phosphonate 172 analogue of 5«-glycerol-3-phosphate was investigated. 
The reaction, although again slow, was quicker than that observed with 173 and the 
reaction took typically 24 h to go to completion. The reaction progress was again 
monitored by '^F NMR spectroscopy, and as the reaction proceeded the predominant 
signal was agam that assigned to fluoride generated by elimination, however the 
anticipated ketone product 178 was not apparent. It was therefore postulated that the 
ketone was forming but was subsequently undergoing rapid elimination in solution (Fig. 
B5.6). 
OH F H 
HO 
p 4 -
G-3-P^  
F H 
^ HO 
172 178 
HO 
P C ? -
179 
Fig. B5.6 
The depletion of both diastereoisomers of 172 was apparent, however it initially 
appeared that the enzyme was showing a significant level of discrimination between the 
two diastereoisomers. Fig. B5.7 shows the high field 'H-decoupled '^F NMR spectrum 
of the oxidation of 172. 
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-204.5 -205.0 -205.5 -206.0 -206.5 -207.0 -207.5 -208.0 -208.5 -209.0 ppm 
Fig. B5.7 '^F NMR spectra of the reaction solution of 172 with G-3-P dehydrogenase 
After several runs it became apparent, by careful integration of the observed '^ F 
NMR spectra, that the expected oxidation product was again coincident with one of the 
diastereoisomers of the starting CHF-phosphonate. This made it impossible therefore to 
quantitatively evaluate any diastereoisomeric discrimination during the oxidation of the 
CHF phosphonate. 
B5.4 Conclusions 
The en2ymatic oxidations of the fluorinated glycerol-3-phosphate analogues 172 and 
173 were successfully carried out at neutral pH employing a coupled enzyme co-factor 
recycling protocol. By this study and for the first time, a number of the secondary 
products of the enzymatic oxidation of the fluorinated glycerol-3-phosphate analogues 
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172 and 173 have been identified. This is the first case where the behaviour and 
products of any CF2-phosphonate analogue has been studied, and it emerges that in this 
situation, although good substrates, the fluorine is metabolically labile. 
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Chapter Six 
Experimental 
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Experimental 
6.1 General 
Nuclear magnetic resonance (NMR) spectra were obtained on Varian Gemini 200 ( ' H at 
199.975 MHz, '^ C at 50.289 MHz), Varian XL-200 ( ' H at 200.057 MHz), Bruker AC-
250 ( ' H at 250.133 MHz, '^ C at 62.257 MHz, '^F at 235.342 MHz), Varian VXR-
400(S) ( ' H at 399.952 MHz, '^C at 100.577 MHz, '^ F at 376.291 MHz) and Bruker 
AMX-500 ('^F at 470.528 MHz) spectrometers with deuteriochloroform as solvent, 
unless otherwise stated (residual CHCI3 : 6H 7.26, 8c 77.0). Chemical shifts are 
recorded in ppm (6 units). '^ F NMR spectra are referenced to an extemal standard of 
C F C I 3 (8 0). Signal splitting patterns are described as singlet (s), doublet (d), triplet (t), 
quartet (q) or multiplet (m). Infrared (IR.) spectra were recorded on a Perkin-Elmer FT-
IR 1720X spectrometer using conventional techniques in four scans. Low resolution 
mass spectra were recorded on a VG Analytical 7070E Organic Mass Spectrometer, and 
gas chromatography-mass spectra (GC-MS) recorded using a Hewlett-Packard 5890 
Series I I gas chromatograph, equipped with a 25 m SE30 column, connected to a VG 
Mass Lab Trio 1000. High resolution mass spectra were performed by the EPSRC 
service at the University of Swansea. Flash Colurrm Chromatography was performed 
using silica gel (60-240 mesh). Melting points were determined using a Gallenkamp 
melting point apparatus and are uncorrected. 
Al l non-aqueous reactions were carried out under an atmosphere of dry nitrogen 
in pre-dried glassware. Al l solvents were distilled prior to use. Light petroleum refers 
to the fraction boiling in the range 40-60 °C. Solvents were dried from the following 
reagents under a nitrogen atmosphere: tetrahydrofuran and ether (sodium and 
benzophenone); benzene, hexane and dichloromethane (calcium hydride); chloroform 
and carbon tetrachloride (phosphorus pentoxide); methanol (magnesium methoxide); 
ethanol (magnesium ethoxide). All other reagents were reagent grade and used as 
supplied unless otherwise stated. 
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6.2 Experimental to Chapter Two 
Methyl 3- and 6-bromocyclohex-l-enecarboxylates 45,46'° '^"^^ 
A^-Bromosuccinimide (1.99 g, 11.2 mmol) was added to a solution of methyl cyclohex-
l-enecarboxylate (1.52 g, 10.9 mmol) in carbon tetrachloride (30 ml). AIBN (0.21 g, 
1.3 mmol) was added and the solution stirred under the light of two 100 W bulbs. 
Stirring was continued until succinimide was observed floating on the top of the 
solution. The reaction mixture was diluted with water (50 ml), extracted into diethyl 
ether (3 x 50 ml) and washed with water (50 ml), 5% aqueous sodium sulfite (50 ml), 
water (50 ml) and brine (50 ml). The organic layer was dried (MgS04) and the solvent 
removed under reduced pressure. The crude residue was purified over silica gel eluting 
with light petroleum-diethyl ether (90:10). Active firactions were combined to give 45 
(0.19 g, 16.2%) and 46 (0.24 g, 20.4%) as colourless oils. 
6-Bromocyclohex-l-enecarboxylate 46: 8H(CDC13) 7.04 ( IH, dd, C H ) , 5.20 ( IH , 
d, CHBr), 3.75 (3H, s, CH3), 1.70-2.60 (6H, m, CH2); SdCDCb) 165.5 (CO), 142.6 
(CH), 131.9 (C) , 51.8 (MeO), 45.0 (CHBr), 31.7 (CH2), 25.4 (CH2), 16.5 (CH2); 
vniax(neat)/cm-' 2952, 1718, 1649, 1436; m/z (EI+) 220.9 (Ivf, 37.3%), 218.9 ( M ^ 
39.1%), 139.0 (M^-Br 100%). CgHi202Br (MH^) requires 219.002066. Found: 
219.00207. 
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Methyl 3-oxocyclohex-l-enecarboxylate 50 110,111 
O 
OMe 
A solution of chromium trioxide (4.46 g, 44.7 mmol) in acetic anhydride (25 ml) and 
glacial acetic acid (50 ml) was added dropwise over 35 min to a stirred solution of 
methyl 1-cyclohexenecarboxylate (2.03 g, 14.5 mmol) in benzene (50 ml) at. 18-20 °C. 
Stirring was continued at this temperature for an additional 10 min and then benzene (50 
ml) was added and the reaction cooled in an ice bath. The reaction was cautiously 
neutralised with concentrated KOH (100 ml). The two phase mixture was poured into 
water (200 ml) and extracted into diethyl ether (3 x 100 ml). The diethyl ether extracts 
were washed with saturated sodium hydrogen carbonate (3 x 100 ml) and brine (2 x 100 
ml) and dried (MgS04). The solvent was removed under reduced pressure to yield 
crude product as a yellow oil. Purification over silica gel, eluting with CH2CI2, gave the 
title compound as a colourless oil (1.25 g, 56%): 8H(CDC13) 6.70 ( IH, s, CH), 3.80 (3H, 
s, OMe), 2.56 (2H, dt, CH2), 2.43 (2H, t, CH2), 2.03 (2H, p, CH2); 8c(CDCl3) 200.2 
(CO), 167.2 (CO), 149.2 (C), 133.3 (CH), 52.9 (MeO), 38.0 (CH2), 25.2 (CHj), 22.5 
(CH2); vmax(neat)/cm-' 2950, 1724, 1686, 1616, 1437, 1256, 1229; m/z (E1+) 154 ( M ^ 
61.5%), 126 (M^-28, 100%). 
Methyl 3-hydroxycyclohex-l-enecarboxylate 51 112 
O 
OMe 
OH 
NaBH4 (0.36 g, 9.5 mmol) was added to a solution of methyl 3-oxocyclohex-l-
enecarboxylate (1.37 g, 8.9 mmol) and CeCl3-7H20 (9.95 g, 26.7 mmol) dissolved in 
methanol (66 ml). There was an initial effervescence accompanied by an increase in 
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temperature. Stirring was continued for 30 min, at which time the methanol was 
removed under reduced pressure and the mixture extracted into diethyl ether (3 x 50 
ml). The ethereal extracts were combined, dried (MgS04) and the solvent removed 
under reduced pressure to give a yellow oil. Purification over silica gel (70:30 diethyl 
ether-light petroleum) gave the title compound as a colourless oil (1.11 g, 80%): 
8H(CDC13) 6.86 ( IH , d, CH), 4.32 ( IH, br m, CHOH), 3.72 (3H, s, OMe), 1.45-2.30 
(6H, m, CH2); 8c(CDCl3) 167.7 (CO), 140.0 (CH), 132.1 (C), 65.8 (CHOH), 51.8 
(OMe), 31.0 (CH2), 24.1 (CH2), 19.0 (CH2); Vniax(neat)/cm-' 3413, 2945, 1717, 1649, 
1437, 1263, 1239; m/z (CI+) 156.0 (M^, 100%), 174.0 ( M V 1 8 , 77.1%). C8H,203 (M*) 
requires 156.07864. Found: 156.0786. 
Methyl 3-fluorocyclohex-l-enecarboxylate 48 72 
O 
OMe 
A solution of methyl 3-hydroxycyclohex-l-enecarboxylate (0.92 g, 5.9 mmol) in CH2CI2 
(5 ml) was added dropwise to a stirred solution of diethylaminosulfur trifluoride 
(DAST) (1.00 g, 6.2 mmol) in CH2CI2 (5 ml) at -78 ° C under nitrogen. The reaction 
was then allowed to warm to room temperature, and water (20 ml) was added. The 
organic layer was separated, washed with water and then dried (MgS04). The crude 
material was purified over silica gel (90:10 light petroleum-diethyl ether) to give 48 as a 
colourless oil (0.65 g, 69%); 6H(CDC13) 6.88 ( I H , dm, C H ) , 5.13 ( IH, dm, J 48 Hz, 
C H F ) , 3.76 (3H, s, OMe), 1.50-2.50 (6H, m, CH2); 8c 166.2 ( C O ) , 134.2 (C) , 133.9 (d, 
J 19.3 Hz, C H ) , 85.1 (d, J 164 Hz C H F ) , 51.3 (OMe), 27.7 (d, J 19.3 Hz, CH2), 23.5 
(CH2), 17.5 (CH2); 8F(CDC13) -172.04 (br d, J 45.6 Hz); Vn,ax(neat)/cm-' 2951, 1716, 
1649, 1263, 1246, 1246; m/z (E1+) 158.1 (M^, 40.2%); (C1+) 176.1 (M^+18, 22.2%), 
139.1 ( M ^ - H F , 100%). CgHii02F(M^) requires 158.07430. Found: 158.0743. 
155 
3-Fluorocyclohex-l-enecarboxylic acid 39 
O 
OH 
Methyl 3-fluorocyclohex-l-enecarboxylate (1.19 g, 7.5 mmol) was added to a solution 
of KOH (1 g) in methanol (20 ml) and stirred at room temperature. The reaction was 
monitored by TLC (80:20 light petroleum-diethyl ether). When the starting material 
had disappeared the reaction was acidified with dilute aqueous HCl and extracted into 
diethyl ether (3 x 50 ml). The ethereal layers were combined, dried (MgS04) and the 
solvent removed under reduced pressure to give a white solid, which 'was recrystallised 
from diethyl ether with light petroleum (0.83 g, 77%); mp 62-64 °C; &H(CDC13) 11.05 
( IH , br s, CO2H), 7.04 ( IH , dm, CH), 5.15 ( IH, dm, / 4 7 Hz, CHF), 1.55-2.5 (6H, m, 
CH2); 8c(CDCl3) 172.3 (CO), 137.0 (d, J 19.55 Hz, CH), 134.5 (d, J9.3 Hz, C), 85.7 (d, 
J 164.82 Hz, CHF), 28.2 (d, J 19.3 Hz, CH2), 23.8 (d, J2.1 Hz, CH2), 18.1 (d, J2.6 Hz, 
CH2); 8F(CDC13) -173.27 (d, J 44.7 Hz); Vmax(CHCl3)/cm-' 3029, 2951, 1697, 1651, 
1276, broad acid region; m/z (EI+) 144.1 (M^, 29.5%), 99.1 (M*-C02H, 100%). 
C7H9O2F requires C, 58.31; H, 6.30. Found: C, 57.97; H, 6.15%. 
Ethyl 6-oxocyclohex-I -enecarboxylate 52 115 
^OEt 
Dry pyridine (1.20 g, 15.2 mmol) was added to a solution of phenylselenium chloride 
(2.68 g, 14.0 mmol) in CH2CI2 (25 nil), cooled to 0 °C and stirred for 15 min. A 
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solution of ethyl 2-oxocyclohexanecarboxylate (2.02 g, 11.5 mmol) in CH2CI2 (5 ml) 
was added and the reaction complex allowed to stir for an additional 15 min. The 
organic layer was washed with a \0% aqueous HCl ( 2 x 1 0 ml), re-cooled to 0 °C and 
then H2O2 (30%, 0.1 ml) was added. After 10 min an additional aliquot of H2O2 (0.1 
ml) was added and again after another 10 min. After a further 10 min, water (10 ml) 
was added and the organic layer separated and washed with NaHC03 (10 ml). The 
organic extracts were dried (MgS04) and the solvent removed under reduced pressure to 
afford the title compound. Purification over silica gel (60:40 light petroleum-diethyl 
ether) gave the product as a clear colourless oil (1.83 g, 95%); 8H(CDC13) 7.59 (IH, t, 
CH), 4.19 (2H, q, J7.1 Hz, CH2), 2.43 (4H, m, CH2), 1.99 (2H, p, CH2), 1.24 (3H, t, J 
7.1 Hz, CH3); 8c(CDCl3) 195.2 (CO), 165.1 (CO), 156.3 (CH), 133.6 (C) , 61.5 (OCH2), 
39.2 (CH3), 26.5 (CH2), 22.6 (CH2), 14.6 (CH2); Vn,ax(neat)/cm-' 1738, 1684, 1619, 
1374, 1270, 1224; m/z (EI+) 169.0 (M^+l, 100%). 
Ethyl 6-hydroxycyclohex-l-enecarboxylate 53 116 
OH 
OEt 
A small quantity (0.5 ml) of saturated potassium carbonate (31 g, in 35 ml water) was 
added to 25% aqueous glutaraldehyde (61.72 g, 0.2 M) . Triethyl phosphonoacetate 
(22.43 g, 0.1 M ) was then added slowly over 2 h with simultaneous slow addition of 
aqueous potassium carbonate (1.6 ml, 0.1 equiv.) at 20 °C. The remaining aqueous 
basic solution was then added slowly (2 h) and the solution was stirred for 48 h at room 
temperature. The solution was then extracted into diethyl ether (4 x 100 ml), washed 
with brine (100 ml) and dried (MgS04). Removal of the solvent under reduced pressure 
gave a yellow oil which was purified over silica gel (50:50 light petroleum-diethyl 
ether) to afford the title compound (3.57 g, 21%); 8H(CDC13) 7.06 (IH, t, CH), 4.51 
( I H , br m, CHOH), 4.20 (2H, q, J7.1 Hz, CH2), 1.5-2.5 (6H, m, CH2), 1.28 (3H, t, J 
7.1 Hz, CH3); 8c(CDCl3) 167.6 (CO), 143.0 (CH), 132.8 (C), 63.3 (CHOH), 60.8 
(OCH2), 30.4 (CH2), 26.4 (CH2), 17.6 (CH2), 14.6 (CH3); v^ax(neat)/cm-' 3474, 1714, 
1647; m/z (C1+) 170.0 (M^, 100%); (EI+) 153.0 (M^-OH, 100%). 
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Ethyl 6-fluorocyclohex-l-enecarboxylate 55 72 
O 
OEt 
A solution of ethyl 6-hydroxycyclohex-1-enecarboxylate (0.79 g, 4.6 mmol) in CH2CI2 
(5 ml) was added dropwise to a stirred solution of diethylaminosulfur trifluoride 
( D A S T ) (0 .97 g, 6.0 mmol) in CH2CI2 (5 ml) at - 7 8 ° C under nitrogen. The reaction 
was then allowed to warm to room temperature, and water (20 ml) was added. The 
organic layer was separated, washed with water and dried (MgS04), and the crude 
material purified over silica gel ( 9 0 : 1 0 light petroleum-diethyl ether) to give 55 as a 
colouriess oil (0.45 g, 2.6 mmol, 5 7 % ) ; 6H(CDC13) 7.30 ( I H , m, C H ) , 5.41 ( I H , dm, J 
46.8 Hz, C H F ) , 4 .24 ( 2 H , q, J 7 . 1 Hz, CH2), 1.5-2.5 ( 6 H , m, CH2), 1.31 ( 3 H , t, J 7 . 1 
Hz, CH3); 8c(CDCl3) 165.8 ( C O ) , 146.4 (d, J 6 . 4 Hz, C H ) , 128.7 (d, J 1 7 Hz, C) , 82.2 
(d, J 165 Hz, C H F ) , 60.6 (OCH2), 28.4 (d, J 2 2 Hz, CH2), 25.8 (d, J 3 Hz, CH2), 15.8 
(CH2), 14.2 (CH3); 8F(CDC13) - 1 6 5 . 9 8 (t, J 4 4 Hz); Vmax(neat)/cm-' 1720, 1654, 1437, 
1266, 1243, 1090; m/z ( E I + ) 173.1 ( M ^ l 29, 4 % ) , 153.1 (M^-HF , 100%). 
C9H17O2FN (MNH4'') requires 190.1243. Found: 190.1243. 
Methyl 6-hydroxycyclohex-1-enecarboxylate 49 116 
OH O 
A small quantity (0.5 ml) of aqueous potassium carbonate (31 g, 0.23 M in 35 ml) was 
added to 25% aqueous glutaraldehyde (60.99 g, 0.15 M). Trimethyl phosphonoacetate 
(18.21 g, 0.1 M ) was then added slowly over 2 h with simultaneous slow addition of 
aqueous potassium carbonate (1.6 ml, 0.1 equiv.) at 20 °C. The remaining aqueous 
basic solution was then added slowly (2 h) and the solution was stirred for 48 h at room 
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temperature. The solution was then extracted into diethyl ether (4 x 100 ml), washed 
with brine (100 ml) and dried (MgS04). Removal of the solvent gave a yellow oil 
which was purified by distillation (66 °C, 0.2 mmHg) to afford the title compound (3.14 
g, 20%); bp 64-66 °C (0.2 mmHg); 8H(CDC13) 7.09 ( IH, t, CH), 4.52 ( IH, br m, 
CHOH), 3.76 (3H, s, OMe), 1.5-2.5 (6H, m, CH2); 8c(CDCl3) 166.5 (CO), 143.7 (CH), 
132.9 (C), 63.9 (CHOH), 52.2 (OMe), 30.4 (CH2), 26.6 (CH2), 17.9 (CH2); 
Vn,ax(neat)/cm-' 3480, 2947, 1716, 1647, 1437; m/z (EI+) 157.0 (M^+1, 100%), 139 
(M^-OH, 82.7%). C8Hi303(Mir) requires 157.0864. Found: 157.0865. 
Methyl 6-fluorocyclohex-l-enecarboxylate 47 72 
^OMe 
A solution of methyl 6-hydroxy-l-cyclohexenecarboxylate (0.97 g, 6.2 mmol) in CH2Ci2 
(5 ml) was added dropwise to a stirred solution of diethylaminosulfur trifluoride 
(DAST) (1.12 g, 6.95 mmol) in CH2CI2 (5 ml) at -78 °C under nitrogen. The reaction 
was then allowed to warm to room temperature, and water (20 ml) was added. The 
organic layer was separated, washed with water and dried (MgS04). The crude product 
was purified over silica gel (80:20 light petroleum-diethyl ether) to give 47 as a 
colourless oil (0.46 g, 47%); 8H(CDC13) 7.32 ( IH, m, CH), 5.40 ( IH, dt, J 47.8 Hz, 
CHF), 3.79 (3H, s, OMe), 1.45-2.50 (6H, m, CH2); 8c 166.8 (CO), 147.3 (d, 76.5 Hz, 
CH), 129.0 (d, J 17.1 Hz, C), 82.7 (d, J 165.8 Hz, CHF), 52.3 (OMe), 28.9 (d, J 21.9 
Hz, CH2), 26.4 (d, J 2.9 Hz, CH2), 16.2 (CH2); 8F(CDC13) -166.00 (t, J 45 Hz); 
vmax(neat)/cm-' 2952, 1720, 1649, 1436; m/z (EI+) 158.2 ( M ^ 15.6%); (CI+) 176.2 
(M^+18, 100%). C8Hi502FN(MNH4^) requires 176.10867. Found: 176.1087. 
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3-Fluorocyclohex-l-enecarbonyl-CoA 41 117 
0 
SCoA 
3-Fluoro-l-cyclohexenecarboxylic acid (10 mg, 0.07 mmol) was added to a solution of 
triethylamine (10 |j,l) in THF (2 ml) and stirred for 5 min. Ethyl chloroformate (8 yi\) 
was added and a precipitate formed. The reaction was stirred under nitrogen for 10 min 
(solution 1). In a separate flask, co-enzyme A (13 mg, 0.016 mmol) was added to a 
solution of NaHC03 in water (2 ml) (solution 2). Solution 1 was filtered through glass 
wool and added to solution 2, and the reaction stirred for 45 min. The pH was then 
decreased to 2 and the THF evaporated under reduced pressure. The aqueous phase was 
extracted into an equal volume of diethyl ether ( 3 x 4 ml) and t|;ien the pH of the 
aqueous phase was raised to 4-5 and then fi-eeze dried to give a white powder; 5F(D20) 
-170.25, -123.64 (F~). No further analysis was carried out and this preparation was 
used directly in enzyme assays. 
-Dipropionylcystamine 57 219 
Propionyl chloride (20.34 g, 220 mmol) was added dropwise to an ice cooled solution of 
cystamine dihydrochloride (22.5 g, 100 mmol) in water (20 ml). The pH of the reaction 
was kept above pH 8.2 throughout the addition of the propionyl chloride by addition of 
aqueous KOH (12.5 M , 35 g of KOH and 50 ml). The resulting white precipitate was 
collected by filtration and washed thoroughly with cold water. Upon drying, the white 
solid of A^,A^'dipropionylcystamine (9.52 g, 36%) was stored in a dessicator; mp 92-93 
°C (lit.,^'^ 92-94.2 °C); 8H(CDC13) 6.60 (2H, br s, NH), 3.53 (4H, dt, J6.3 Hz and 5.8 
Hz, CH2), 2.81 (4H, t, J6.5 Hz, CH2), 2.24 (4H, q, J7.6 Hz, CH2), 1.13 (3H, t,./7.6 Hz, 
CH3); 8c(CDCl3) 175.0 (CO), 38.9 (CH2), 38.3 (CH2), 30.0 (CH2), 10.3 (CH3), 
Vmax(Nujol)/cm-' 3260, 3060, 1625,1545; m/z (CI+) 265 ( M V i , 2.64%). 
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3% Sodium amalgam 
Distilled mercury (430 g, 2.1 mol) was carefully dropped onto small pieces of sodium 
(13 g, 0.6 mol) under an inert atmosphere of nitrogen. The reaction was kept hot with 
the aid of a Bunsen burner to ensure continuous reaction. The hot liquid was poured 
into a glass dish and cut up into small pieces before the sodium amalgam cooled and 
solidified as a block. 
'H-Propionylcystamine 58^ '^  
O 
, , / X ^ S H 
3%) Sodium amalgam (13 g) was added to a solution of A';A'''-dipropionylcystamine 
(1.32 g, 5 mmol) in dry methanol (50 ml) under nitrogen, and the reaction mixture 
stirred for 90 min at room temperature. The remaining mercury was removed by 
filtration, and the solution added to dilute HCl (50 ml). The product was extracted into 
CH2CI2 (3 X 50 ml), dried (MgS04) and the solvent removed under reduced pressure to 
afford 7>/-propionylcystamine (0.66 g, 49%)) as a colourless oil; 8H(CDC13) 6.05 ( IH, br 
s, NH), 3.36 (2H, dt, J7.9 and 6.6 Hz, CH2), 2.66 (2H, dt, J8.1 and 6.6 Hz, CH2), 2.18 
(2H, q, J 7.6 Hz, CH2), 1.35 ( IH, t, J 8.5 Hz, SH), 1.10 (3H, t, J 7.6 Hz, CH3); 
8c(CDCl3) 174.7 (CO), 42.9 (CH2), 30.0 (CH2), 25.0 (CH2), 10.4 (CH3); Vn,ax(neat)/cm-' 
3293, 3077, 2976, 2938, 2547, 1650, 1548; m/z (E1+) 134 (M^+1, 28.29). 
S-(N-propionamidoethyl) 3-fluorocyclohex-1 -enethiocarboxylate 59 
Carbonyldiimidazole (67 mg, 0.41 mmol) suspended in THF (2 ml) was added to a 
solution of 3-fluorocyclohex-1-enecarboxylic acid (50 mg, 0.34 mmol) dissolved in 
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THF (2 ml) and the mixture stirred under N2 for 30 min. A solution of A^ -
propionylcystamine (68 mg, 0.51 mmol) in THF (2 ml) was added and the mixture was 
stirred overnight under N2. Removal of the THF under reduced pressure gave an oil that 
was purified over silica gel (80:20 CH2Cl2-EtOAc). The active fractions were 
combined and the solvent removed under reduced pressure to give the product as a 
colourless oil (53 mg, 59%); 8H(CDC13) 6.85 ( IH, m, CH), 5.85 ( IH, br s, NH), 5.15 
( I H , dm, JAl Hz, CHF), 3.47 (2H, q, 76.2 Hz, CH2), 3.10 (2H, t, J6.5 Hz, CHj), 1.50-
2.50 (6H, m, CH2), 2.20 (2H, q, 7 7.6 Hz, CH2), 1.14 (3H, t, J7.6 Hz, CH3); 8c(CDCl3) 
193.2 (CO), 173.9 (CO), 142.2 (d, J9 Hz, C), 132.9 (d, / 2 0 Hz, CH), 85.6 (d, J165 Hz, 
CHF), 39.4 (CH2), 29.6 (CH2), 28.4 (d, J 20 Hz, CH2), 28.4 (CH2), 24.0 (d, J 2.6 Hz, 
CH2), 18.0 (d, J 4.9 Hz, CH2), 9.73 (CH3); 8F(CDC13) -172.22 (dm, J 45.2 Hz); 
vmax(neat)/cm-^ 3290, 2938, 1654, 1647, 1543, 1147; m/z (CI+) 260.5 (MH^, 32%), 240 
(M*-19, 23%,). Ci2H,902SNF (MH*) requires 260.11205. Found: 260.1121. 
6.3 Experimental to Chapter Three 
Pivaloyloxymethyl 6-aminopenicillanate hydrotosylate 83*'** 
T s - H3N 
COjPom 
Triethylamine (3.5 ml, 24.9 mmol) was added to a suspension of 6-aminopenicillanic 
acid (3.52 g, 16.6 mmol) in dry DMF (30 ml), and the reaction stirred for 30 min. 
Chloromethyl pivalate (4.8 ml, 33.2 mmol) was added and the solution was stirred for 4 
h at room temperature. The mixture was diluted with EtOAc and the precipitated 
Et3N-HCl removed by filtration. The filtrate was washed with water (4 x 100 ml) and 
then the organic layer was dried (MgS04) and the volume concentrated to approximately 
half under reduced pressure. Treatment of the stirred solution of the crude ester with 
TsOH in EtOAc (0.5 M , 40 ml) at room temperature precipitated the crystalline toluene-
p-sulfonate, which was filtered, washed with EtOAc and Et20 and dried to afford 83 as 
a white crystalline solid (6.25 g, 75%); mp 154-155 °C (decomp.) [lit.,^^* 150-151 °C 
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(decomp.)]; 8H(CDC13) 7.45 (4H, AB, J7.9 Hz, Ph), 5.76 (2H, AB, J5.4 and 13.4 Hz, 
OCH2O), 5.39 ( IH , d, J4.0 Hz, CH), 4.96 ( IH, d, J4.0 Hz, CH), 4.44 ( IH, s, CHCO2), 
2.33 (3H, s. Me), 1.44 (3H, s. Me), 1.37 (3H, s, Me), 1.19 (9H, s. Me); Vniax(KBr)/cm-' 
3250, 2950, 1760, 1730, 1480, 1215. C21H30N2O8S2 requires C, 50.19; H, 6.02; N, 5.57. 
Found: C, 50.24; H, 6.13; N , 5.58%. 
Pivaloyloxymethyl 6-diazopenicillanate 84 149 
COjPom 
Sodium nitrite (1.73 g, 25.1 mmol) was added to an ice cooled solution of 83 (0.65 g, 
1.38 mmol) in a mixture of water (60 ml) and CH2CI2 (60 ml). The solution was stirred 
vigorously for 5 min, after which fime toluene-p-sulfonic acid (0.37 g, 1.93 mmol) was 
added in portions over a 20 min period. Stirring was continued for an additional 10 
min, and the solution transferred into an ice cold separating fiinnel. The organic layer 
was removed, washed with brine, dried (MgS04) and the solvent removed under 
reduced pressure to afford the product as an amber glass (0.37 g, 79%); 8H(CDC13) 6.15 
( I H , s, CH), 5.79 (2H, AB, J5.6 Hz, OCH2O), 4.36 ( IH, s, CHCO2), 1.61 (3H, s. Me), 
1.42 (3H, s, Me), 1.18 (9H, s, Me); 8c(CDCl3) 176.6 (CO), 166.7 (CO), 166.2 (CON), 
79.7 (CH2), 70.1 (C), 68.5 (CH), 63.6 (C), 38.7 (C), 33.7 (Me), 26.8 (Me), 25.7 (Me), 
20.7 (CN2); Vn,ax(neat)/cm-' 2970, 2083 (N=N=C), 1800, 1760, 1480, 1450, 1215. 
Pivaloyloxymethyl 6a-hydroxypenicillanate 85^ ^^ ^ 
C02Pom 
A solution of perchloric acid (1 M, 10 ml) in water (40 ml) was added with swirling to 
an ice cold solufion of pivaloyloxymethyl 6-diazopenicillanate (0.53 g, 1.55 mmol) in 
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acetone (50 ml). The solution was kept at 5 ° C for 1 2 h and was then extracted into 
CH2CI2 (3 X 50 ml). The organic extracts were combined and washed with saturated 
aqueous sodium hydrogen carbonate (2 x 30 ml) and water (2 x 50 ml), dried (MgS04) 
and the solvent removed under reduced pressure. Purification over silica gel, eluting 
with CHzCb-EtOAc (90:10) afforded the title compound as a yellow oil (0.42 g, 82%); 
8H(CDC13) 5.83 ( 2 H , AB system, J 5.6 Hz, OCH2O), 5.25 ( I H , d, J 1.4 Hz, C H ) , 4.82 
( I H , d, J 1.4 Hz, C H ) , 4 .47 ( I H , s, CHCO2), 1.55 ( 3 H , s. Me), 1.47 ( 3 H , s, Me), 1.21 
( 9 H , s. Me); S^CDCb) 176.9 ( C O ) , 171.1 ( C O ) , 166.2 ( C O ) , 85.1 ( C O H ) , 79.7 (CH2), 
71.1 ( C H S ) , 68.5 (C) , 63.9 (C) , 38.8 (C) , 33.2 (Me), 26.8 (Me), 25.6 (Me); 
Vniax(neat)/cm-' 3420 ( O H ) , 2979, 1760 (broad C=0), 1479, 1450, 1215; mJz (EI+) 331 
( M ^ 1.4%), 274 (5 .3%) . 
Pivaloyloxymethyl 6a-fluoropenicillanate 86 220 
COjPom 
A solution of pivaloyloxymethyl 6a-hydroxypenicilIanate (0.45 g, 1.35 mmol) in dry 
CH2CI2 (5 ml) was added to a solution of DAST (0.27 ml, 2.03 mmol) in dry CH2CI2 (5 
ml) cooled to -78 °C under nitrogen. The reaction was allowed to warm to room 
temperature and was stirred overnight. The reaction was quenched by the addition of 
water (10 ml) and the organic layer was separated, washed with water (3 x 20 ml), dried 
(MgS04) and the solvent removed under reduced pressure. Purification over silica gel 
afforded the title compound as a colourless oil (0.37 g, 82%); 8H(CDC13) 5.80 (2H, AB 
system, /5 .6 Hz, OCH2O), 5.45 ( IH, dd, J 1.2 and 5.2 Hz, CH), 5.34 (IH, dd,y 1.2 and 
53 Hz, CHF), 4.52 ( IH, s, CH), 1.53 (3H, s, Me), 1.46 (3H, s. Me), 1.19 (9H, s, Me); 
8c(CDCl3) 176.5 (CO), 165.7 (CO), 165.2 (d, J22 Hz, CO), 98.2 (d, J235 Hz, CHF), 
79.7 (OCH2O), 68.7 (d, y 24 Hz, CHS), 68.7 (CH), 64.1 (C), 38.7 (CMes), 33.6 (Me), 
26.8 (Me), 25.3 (Me); 8F(CDC13) -181.7 (dd, J 53 and 5.1 Hz); v,^ a.x(neat)/cm-' 2960, 
1800, 1760 (broad), 1480, 1215; m/z (CI+) 334 (M^+1, 8.2%), 276 (M^+l-Bu', 45%). 
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N-Benzyltoluene-p-sulfonamide 159 
CH3—d y—SO2NH-CH2-
Toluene-/7-sulfonyl chloride (40 g, 0.21 M ) was added cautiously to a solution of 
benzylamine (20 g, 0.19 M ) in dry pyridine (50 ml). The addition was accompanied by 
an increase in temperature and a change in colour. The solution was stirred for 1 h and 
poured into ice water. The oily precipitate, which solidified on agitation, was removed 
by filtration and washed with copious amounts of water. Purification by 
recrystallisation from methanol gave the product as clear colourless crystals (14.65 g, 
69%); mp 114-115 °C (lit.,'^^ 114 °C); Vniax(KBr)/cm-' 3268 (NH), 3100, 2950, 1598, 
1495, 1454, 1422. CnHisNOaS requires C, 64.34; H, 5.79; N , 5.36. Found: C, 64.16; 
H,5.80; N,5.13%. 
N-Nitroso-N-benzyltoluene-p-sulfonamide 159 
NO ~ 
Sodium nitrite (60 g, 0.85 M ) was added in portions over 6 h to a solution of N-
benzyltoluene-/?-sulfonamide (10.5 g, 0.04 M ) in glacial acetic acid (50 ml) and acetic 
anhydride (200 ml) cooled to 0 °C. The reaction temperature was kept below 10 °C 
throughout the addition, and the mixture became green in colour. After the addition of 
sodium nitrite was completed the reaction was stirred overnight at room temperature. 
The mixture was poured into ice water and cooled for 1 h. The pale yellow precipitate 
was filtered, washed several times with water and dried in vacuo. The crude product 
was recrystallised from ethanol to afford the title compound as a yellow crystalline solid 
(10.1 g, 85%); mp 88-89 °C (lit.,'^^ 90-92 °C); Vn,ax(KBr)/cm-' 3110, 2950, 1594, 1496, 
1383 (N-NO). C14H14N2O3S requires C, 57.92; H, 4.86; N, 9.65. Found: C, 58.01; H, 
4.98; N, 9.54%. 
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Phenyldiazomethane 
CHN, 
A^-Nitroso-A^-benzyltoluene-p-sulfonamide (3.43 g, 11.8 mmol) was added in portions 
over a period of 1 h to a stirred solution of sodium methoxide (0.64 g, 11.8 mmol) in 
CHiCh-MeOH (6:1) at room temperature. The mixture was stirred under reflux for 20 
min, allowed to cool, transferred to a separating fiinnel and water (100 ml) was added to 
dissolve the salts. The organic solution was repeatedly washed with water (3 x 100 ml), 
dried (MgS04) and was then used directly. 
Benzyl 6j3-aminopenicillanate 
COjBn 
A solution of phenyldiazomethane in CH2CI2 (50 ml) was added to a suspension of 6-
aminopenicillanic acid (6-APA) (1.14 g, 5.2 mmol) in methanol (20 ml) at room 
temperature, and the reaction was stirred vigorously. The disappearance of the red 
colour of the phenyldiazomethane was accompanied by effervescence due to the 
evolution of nitrogen. After 1 h the solution was filtered to remove unreacted 6-APA 
(0.37 g, 1.7 mmol), the filtrate was then washed with water (3 x 100 ml), dried (MgS04) 
and the solvent removed under reduced pressure to afford the product as a yellow oil; 
8H(CDC13) 7.33 (5H, s, Ph), 5.46 ( IH, d, J4.3 Hz, CH), 5.14 (2H, s, CH2), 4.51 ( IH, d, 
J4.3 Hz, CH), 4.39 ( IH , s, CH), 1.85 (2H, br s, NH2), 1.57 (3H, s, CH3), 1.38 (3H, s, 
CH3); 8c(CDCl3) 177.6 (CO), 167.8 (CO), 134.6, 128.5, 128.4, 69.8, 69.8, 67.2, 63.8, 
62.7, 31.6 (CH3), 26.8 (CH3); Vmax(neat)/cm-' 3388, 3329, 3033, 2966, 2931, 1778, 
1745. 
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Benzyl 6P-aminopenicillanate hydrotosylate 87 
I s - H3N, 
COjBn 
A solution of toluene-/?-sulfonic acid in EtOAc (0.5 M, 40 ml) was added to a solution of 
benzyl 6(3-aminopenicillanate in EtOAc (10 ml) and the reaction stirred at room 
temperature. After a short time a precipitate formed which was collected by filtration 
and washed successively with EtOAc and diethyl ether, and dried in vacuo. The product 
was recovered as an amorphous white solid (0.91 g, 45%); mp 154-155 °C (lit.,^^' 155-
158 °C); 6H(CDC13) 7.42 (4H, AB system, J8.0 Hz, Ts), 7.34 (5H, s, Ph), 5.43 ( IH, d, J 
4.3 Hz, CH), 5.14 (2H, s, CH2), 4.95 ( IH, d, J4.3 Hz, CH), 4.45 ( IH, s, CH), 2.30 (3H, 
s, CH3), 1.43 (3H, s, CH3), 1.28 (3H, s, CH3); C22H26N2O6S2 requires C, 55.21; H, 5.48; 
N, 5.85. Found: C, 55.05; H, 5.55; N, 5.63%. 
Benzyl 6-diazopenicillanate 88 149 
C02Bn 
Sodium nitrite ( 2 . 1 5 g, 31.2 mmol) was added to an ice cooled solution of benzyl 6-
aminopenicillanate tosylate (0.39 g, 0.83 mmol) in a mixture of water (60 ml) and 
CH2CI2 (60 ml). The solution was stirred vigorously for 5 min, after which time 
toluene-p-sulfonic acid (0 .24 g, 1.24 mmol) was added in portions over a 20 min period. 
Stirring was continued for an additional 10 min, and the solution transferred into an ice 
cold separating funnel. The organic layer was removed, washed with brine, dried 
(MgS04) and the solvent removed under reduced pressure to afford the product as an 
amber glass (0 .21 g, 8 4 % ) ; 8H(CDC13) 7.36 ( 5 H , s, Ph), 6.15 ( I H , s, C H ) , 5 .16 ( 2 H , s, 
CH2), 4 .39 ( I H , s, C H ) , 1.60 ( 3 H , s, CH3), 1.35 ( 3 H , s, CH3); 8c(CDCl3) 167.9 (CO) , 
166.3 ( C O ) , 134.8, 134.7, 128.6, 128.5, 70.0 (CH2), 68.8 (C) , 67.3 ( C H ) , 63.9 (C) , 33.8 
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(CHs), 25.7 (CH3), 21.4 (C); Vmax(neat)/cm-' 3064, 3033, 2970, 2083 (C=N=N), 1746 
(broad, C=0), 1455, 1390. 
Benzyl 6a-hydroxypenicillanate 89 150 
HO ^ 
C O j B n 
A solution of perchloric acid (1 M , 10 ml) in water (40 ml) was added with-swirling to 
an ice cold solution of benzyl 6-diazopenicillanate (0.51 g, 1.6 mmol) in acetone (50 
ml). The solution was kept at 5 C for 12 h and was then extracted into CH2CI2 (3 x 50 
ml). The organic extracts were combined and washed with saturated aqueous sodium 
hydrogen carbonate (2 x 30 ml) and water (2 x 50 ml), dried (MgS04) and the solvent 
removed under reduced pressure. Purification over silica gel, eluting with CH2CI2-
EtOAc (90:10) afforded the title compound as a yellow solid (0.37 g, 75%); mp 161-
162 °C (lit.,'^° 162-163 °C); 8H(CDC13) 7.37 (5H, s, Ph), 5.28 ( IH, d, J 1.2 Hz, CH), 
5.18 (2H, s, CH2), 4.82 ( IH , d, J1.3 Hz, CH), 4.50 ( IH, s, CH), 1.52 (3H, s, CH3), 1.37 
(3H, s, CH3); 8c(CDCl3) 172.1 (CO), 168.1 (CO), 135.3, 129.3, 129.2, 85.7 (COH), 
71.7, 69.4, 68.1, 64.6 (C), 33.9 (CH3), 26.2 (CH3); Vmax(neat)/cm"' 3420, 3019, 2980, 
1775, 1745, 1457, 1381, 1215; w/z(CI+) 325 (NH4M^ 1.7%), 308 (MH^ 6.9%). 
Benzyl 6a-fluoropenicillanate 90 155 
COjBn 
A solution of benzyl 6a-hydroxypenicillanate (0.25 g, 0.81 mmol) in dry CH2CI2 (5 ml) 
was added to a solution of DAST (0.22 ml, 1.62 mmol) in dry CH2CI2 (5 ml) cooled to 
-78 °C under nitrogen. The reaction was allowed to warm to room temperature, was 
stirred overnight and was then quenched by the addition of water (10 ml). The organic 
168 
layer was separated and washed with water (3 x 20 ml), dried (MgS04) and the solvent 
removed under reduced pressure. Purification over silica gel afforded the title 
compound as a colourless oil (0.16 g, 65%); 8H(CDC13) 7.37 (5H, s, Ph), 5.46 (IH, dd, J 
5.2 and 1.6 Hz, CH), 5.33 ( I H , dd, J53 and 1.6 Hz, CHF), 5.19 (2H, s, CH2), 4.54 ( IH, 
s, CH), 1.53 (3H, s, CH3), 1.39 (3H, s, CH3); 8c(CDCl3) 166.7 (CO), 165.5 (d, J 20.6 
Hz, CO), 134.5, 128.7, 128.7, 128.6, 98.2 (d, J237 Hz, CHF), 68.9 (d, /24.7 Hz, CH), 
67.5 (CH), 64.2 (C), 33.9 (CH3), 25.3 (CH3); 8F(CDC13) -181.6 (dd, J53.0 and 5.2 Hz); 
Vmax(neat)/cm-' 3110, 3010, 2950, 1790, 1745; m/z (CI+) 327 (MNH4^ 100%); (EI+) 
309 (M^, 10%). C15H16FNO3S ( M ^ requires 309.0835. Found: 309.0835. 
6a-Fluoropenicillanic acid 78 155 
-N 
COjH 
A solution of aluminium trichloride (100 mg, 0.75 mmol) in anhydrous nitromethane (1 
ml) was added to a solution of benzyl 6a-fluoropenicillanate (52 mg, 0.17 mmol) in 
CH2CI2 (4 ml) cooled to 0 ° C and the reaction stirred for 1 h. The reaction solution was 
diluted with EtOAc (5 ml), washed with hydrochloric acid (0.5 M, 5 ml) and the aqueous 
phase extracted with EtOAc (3 x 10 ml). The combined organic extracts were dried 
(MgS04) and the solvent removed under reduced pressure to afford the title compound 
as a yellow oil (43 mg, 82%); 8H(CD30D) 8.20 ( IH, br s, CO2H), 5.46 (IH, dd, J 1.6 
and 4.9 Hz, CH), 5.38 ( IH , dd, J 53 and 1.6 Hz, CHF), 4.59 ( IH, s, CH), 1.60 (3H, s, 
CH3), 1.57 (3H, s, CH3); 8c (CD30D) 170.4 (CO), 167.8 (d, J21 Hz, CO), 99.2 (d, J 
237 Hz, CHF), 70.6 (CH), 70.0 (d, J 24.4 Hz, CH), 65.0 (C), 33.5 (CH3), 26.0 (CH3); 
6 F ( C D 3 0 D ) -182.40 (dd, J53.2 and 5.3 Hz). 
169 
Cyclohexylammonium 6a-fluoropenicillanate 91 
A solution of cyclohexylamine (53 mg, 0.55 mmol) in EtOAc (5 ml) was added to a 
stirred solution of 6a-fluoropenicillanic acid (98 mg, 0.45 mmol) in EtOAc (5 ml). 
Upon addition a white precipitate formed which was removed by filtration, washed 
repeatedly with EtOAc and dried in vacuo to afford the title compound as a white 
amorphous solid (88 mg, 62%); mp 165-166 °C; 8H(D20) 5.38 ( IH, dd, J50.8 and 1.6 
Hz, CHF), 5.37 ( IH, dd, /4 .8 and 1.6 Hz), 4.19 ( IH, s, CH), 4.00 ( IH, m, CH), 1.83 
(2H, m, CH2), 1.65 (2H, m, CH2), 1.50 (2H, m, CH2), 1.37 (3H, s, CH3), 1.35 (3H, s, 
CH3); 8c(D20) 173.5 (CO), 168.3 (d, /20.2 Hz, CO), 96.1 (d, J 233 Hz, CHF), 71.4 
(CH), 67.9 (d, J 24.4 Hz, CH), 63.5 (C), 50.1 (C), 31.9 (CH2), 30.1 (CH3), 25.0 (CH2), 
24.1 (CH2), 23.6 (CH3); 8F(D20) -184.16 (dd, /52.7 and 4.5 Hz); Vmax(neat)/cm-' 3420, 
2933, 2860, 1790, 1610, 1450. C14H23FN2O3S requires C, 52.81; H, 7.28; N, 8.80. 
Found: C, 52.79; H, 7.54; N, 8.55%. 
Tetrabutylammonium bifluoride (TBABF) 161 
A 0.7 M solution of ammonium bifluoride was slowly passed through Amberlite IRA-
140 ion exchange resin (40 g). The process was continued until the eluent gave a 
negative test for chloride ions with silver nitrate. The resin was sequentially washed 
with distilled water (150 ml) and acetonitrile (150 ml) and was then dried under vacuum 
(18 mmHg). A solution of tetrabutylammonium chloride (1 g) in acetonitrile (20 ml) 
was then passed through the resin and the operation repeated three times. The resin was 
then washed with acetonitrile (20 ml), all the organic extracts were combined and the 
solvent was removed under reduced pressure to give the title compound as a viscous oil 
which solidified on cooling; 6H(CDC13) 3.28 (8H, m, CH2), 1.60 (8H, m, CH2), 1.38 
(8H, m, CH2), 0.93 (12H, t, J 7.2 Hz, CH3); 8F -156.5 (br s). 
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Benzyl 6f3-bromo-6a-fluoropenicillanate 92 155 
COjBn 
A solution of A^-bromosuccinimide (0.17 g, 0.94 mmol) in CH2CI2-CH3CN (5 ml, 4:1) 
and a solution of TBABF (0.34 g, 1.18 mmol) in CH2CI2 (5 ml) were added dropwise 
simultaneously to a solution of benzyl 6-diazopenicillanate (0.25 g, 0.78 mmol) in 
anhydrous CH2CI2 (5 ml) cooled to ^ ^0 °C. The reaction was allowed to warm to room 
temperature and stirring was continued for 2 h, after which time the reaction was 
quenched by the addition of water (10 ml). The organic layer was separated, washed 
with water ( 3x10 ml), dried (MgS04) and the solvent removed under reduced pressure 
to give a dark oil. The crude residue was purified over silica gel eluting with CH2CI2-
light petroleum (60:40) to afford the product as a yellow oil (0.13 g, 43%)). The product 
was identified as a mixture of the title compound and the corresponding benzyl 6,6-
dibromopenicillanate. 
Benzyl 6p-bromo-6a-fluoropenicillanate: 8H(CDC13) 7.38 (5H, s, Ph), 5.62 ( IH, 
d, J5.6 Hz, CH), 5.20 (2H, s, CH2), 4.55 ( IH, s, CH), 1.56 (3H, s, CH3), 1.39 (3H, s, 
CH3); 8c(CDCl3) 166.3 (CO), 162.3 (d, J 22.4 Hz, CO), 134.4, 128.6, 128.5, 107.9 (d, J 
305 Hz, CBrF), 77.1 (d, J 26.8 Hz, CH), 69.0 (CH), 67.5 (CH2), 64.1 (C), 33.3 (CH3), 
25.5 (CH3); vmax(neat)/cm-' 3030, 2966, 2930, 1790, 1745, 1460; m/z (GC-MS) (EI+) 
387 ( M ^ 3.3%), 389 (M^+2, 3.3%), 296 (M^-91 0.5%), 298 (M*+2-91, 0.5%). 
Benzyl 6,6-dibromopenicillanate: 5H(CDC13) 7.33 (5H, s, Ph), 5.76 ( IH, s, CH), 
5.16 (2H, s, CH2), 4.53 ( IH, s, CH), 1.60 (3H, s, CH3), 1.36 (3H, s, CH3); m/z (GC-MS) 
447 (M"", 1.3%), 449 ( M M , 2.8%), 451 {VC+A, 0.9%). 
Trineophyltin chloride 94'^ ^ 
(PhMe2CCH2)3SnCI 
A solution of stannic chloride (16.3 g, 62.4 mmol) in diethyl ether (100 ml) was added 
to a filtered Grignard solution prepared fi-om neophyl chloride (43 g, 0.26 mol) and 
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magnesium turnings (23.5 g, 0.98 g atom) in dry diethyl ether (300 ml). The reaction 
was heated under reflux for 1 h and left standing overnight. Benzene (200 ml) was 
added to the slurry and the excess Grignard was decomposed by the addition of 
methanol. The material was filtered and the residue was washed twice with benzene. 
The solvent was then removed under reduced pressure to give a white solid which was 
purified by recrystallisation from hexane-benzene (7:3) to afford the title compound as a 
white crystalline solid (19.6 g, 41%); mp 117.5-118.2 ° C ( l i t . , ' " 117.5-118.5 °C) . 
C3oH39SnCl requires C, 65.07; H, 7.10. Found: C, 65.07; H, 6.82%. 
Trineophyltin hydroxide 95*" 
(PhMe2CCH2)3SnOH 
Trineophyltin chloride (6.5 g, 11.8 mmol) was added to a solution of NaOH (3.5 g, 87.5 
mmol) in ethanol-water (250 ml. of 95% ethanol) and the reaction was heated under 
reflux for 15 h. The volatiles were removed under reduced pressure and the residue was 
washed with water until neutral. The dry solid was recrystallised from hot heptane to 
afford the title compound as a white crystalline solid (4.1 g, 67%); mp 145.5-146.6 °C 
( l i t . , ' " 145-146 ° C ) . C3oH4oSnO requires C, 67.31; H, 7.53. Found: C, 67.54; H, 
7.41%. 
Trineophyltin hydride 96 164 
(PhMezCCHzlaSnH 
A solution of borane in THF (1.0 M, 7.6 ml, 7.6 mmol) was added to a solution of 
trineophyltin hydroxide (4.1 g, 7.6 mmol) in THF (30 ml) and the reaction heated under 
reflux for 1 h. The solvent was removed under reduced pressure, then diethyl ether (30 
ml) and water (10 ml) were added and the mixture stirred for 10 min. The aqueous layer 
was removed and the process repeated three times to remove inorganic boron 
compounds. The diethyl ether layer was then dried (MgS04) and the solvent removed to 
give a white solid. Recrystallisation from diethyl ether afforded the title compound as a 
white crystalline solid (3.7 g, 93%); mp 49.5-50.5 ° C (lit.,'^" 50-51 °C) ; 5H(CDCI3) 
7.22 (15H, m, Ph), 4.54 ( IH, m, H), 1.31 (18H, s, CH3), 1.04 (6H, d, J 49 Hz, CH2); 
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8c(CDCl3) 151.0 (d, J34.2 Hz), 128.0, 125.4, 125.3, 37.5 (d, J20.3 Hz), 32.1 (d, J34.2 
Hz), 30.4 (d, J 343 Hz). C3oH4oSn requires C, 69.37; H, 7.76. Found: C, 69.55; H, 
7.81%. 
Benzyl 6/3-fluoropenicillanate 93 155 
0 ^ 
bOjBn 
A solution of trineophyltin hydride (0.48 g, 0.92 mmol) in diethyl ether (5 ml) was 
added to a solution of benzyl 6p-bromo-6a-fiuoropenicillanate (178 mg, 0.45 mmol) 
and AIBN (10 mg) in diethyl ether (5 ml) and the reaction stirred at room temperature 
for 3 h. The solvent was removed under reduced pressure and the crude product 
purified over silica gel eluting with CH2Cl2-light petroleum (75:25). The active 
fractions were combined and the solvent was removed under reduced pressure to afford 
the title compound as a clear oil (83 mg, 60%); 8H(CDC13) 7.26 (5H, s, Ph), 5.74 (IH, 
dd, J54 and 3.4 Hz, CHF), 5.50 ( IH, dd, /3 .6 and 3.5 Hz, CH), 5.20 (2H, s, CH2), 4.54 
( I H , s, CH), 1.64 (3H, s, CH3), 1.43 (3H, s, CH3); SdCDClj) 169.2 (d, J21 Hz, CO), 
167.1 (CO), 134.5, 128.8, 128.7, 91.9 (d, J225 Hz, CHF), 70.8 (CH), 67.5 (CH2), 66.5 
(d, J 21.5 Hz, CH), 64.1 (C), 31.6 (CH3), 26.3 (CH3); 8F(CDC13) -196.2 (dd, J54.8 and 
3.6 Hz); Vn,ax(neat)/cm-' 3110, 3030, 2965, 1790, 1745; m/z (GC-MS) (EI+) 309 ( M ^ 
10%). C15H16FNO3S (M^) requires 309.0835. Found: 309.0835. 
6.4 Experimental to Chapter Four 
Preparation of Diazomethane 
A solution of A^-methyl-A^-nitrosotoluene-p-sulfonamide (18.77 g, 87.6 mmol) in diethyl 
ether (200 ml) was added dropwise to a solution of 2-(2-ethoxyethoxy)ethanol (20 ml) 
containing KOH (5.38 g, 96 mmol), H2O (10 ml) and diethyl ether (10 ml) at 70°C. The 
vapours from the reaction were collected by bubbling through two diethyl ether traps 
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maintained at 0 °C. When the reacfion mixture had become colourless, the solutions in 
the traps were combined and used immediately. 
General procedure for the synthesis of afluoroacetophenones 
A solution of pyridinium poly(hydrogen fluoride) was added to an ethereal solution at 
-15 °C containing the desired diazoacetophenone, prepared in situ from benzoyl 
chloride and diazomethane. The reaction was allowed to warm to room temperature and 
was stirred for 4 h under an atmosphere of N2. The product was extracted into hexane 
(3 x 100 ml) and hydrogen fluoride removed by treatment of the extract with anhydrous 
KF until neutral. The combined extracts were dried (MgS04), and the solvent removed 
under reduced pressure. Purificafion over silica gel, eluting with CHaC^-light 
petroleum (40:60), afforded the a-fluoroacetophenones. 
a-Fluoroacetophenone 127 76 
The product was recovered as a clear oil (2.20 g, 45%); 8H(CDC13) 7.45-7.95 (5H, m, 
Ph), 5.53 (2H, d, J 46.8 Hz, CH2F); 6c(CDCl3) 193.3 (d, J 15.3 Hz, CO) , 134.0, 133.5, 
128.8, 127.7, 83.4 (d, J 182 Hz, CH2F); 8F(CDC13) -231.8 (t, J46 Hz), Vn,ax(neat)/cm-' 
3063, 2935, 1706, 1597; m/z (GC-MS) (EI+) 138 ( M ^ 6.8%), 105 (M''-CH2F, 100%). 
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a-Fluoro-p-nitroacetophenone 129 
The product was recovered as an orange solid, (3.63 g, 63%); mp 90-92 °C; 8H(CDC13) 
8.35 (2H, d, J8.8 Hz, Ph), 8.09 (2H, d, J8.9 Hz, Ph), 5.54 (2H, d, J 46.7 Hz, CH2F); 
6c(CDCl3) 192.5 (d, J8.5 Hz, C O ) , 138.1, 129.8, 129.2, 124.0, 83.7 (d, J 184.7 Hz, 
CH2F); 8F(CDC13) -229.9 (t, 7 47.0 Hz); Vn,ax(CHCl3)/cm-' 3111, 2937, 2111, 1709, 
1598, 1524, 1345; m/z (EI+) 183 (M^, 0.65%), 164 (M^-HF, 1.9%), 149 (M^-CH2F, 
100%). C8H6O3NF requires C, 52.47; H, 3.30; N , 7.65. Found: C, 52.12; H, 3.27; N , 
7.43%. 
a-Fluoro-p-methoxyacetophenone 130 
MeO 
The product was recovered as a white solid (2.45 g, 54%); mp 78-79 °C (lit., 78.5-
79.4 °C); 8H(CDC13) 7.85 (2H, d, J8.9 Hz, Ph), 6.92 (2H, d, J8.9 Hz, Ph), 5.44 (2H, d, 
/47.0 Hz ,CH2F), 3.83 (3H, s, OMe); 5c(CDCl3) 192.6 (d, J 15.5 Hz, CO), 164.7, 130.7, 
127.1, 114.6, 83.9 (d, J 183 Hz, CH2F), 56.0 (OMe); 8F(CDC13) -228.9 (t, J 46.8 Hz); 
vmax (CHCy/cm-' 3110, 2935, 1695, 1598; m/z (CI+) 169 (M^+l), 186 (M^+18); (E1+) 
168 (M^), 135 (M+-CH2F). C9H9O2F requires C, 64.28; H, 5.39. Found: C, 64.35; H, 
5.52%. 
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p-Bromo-afluoroacetophenone 128 
The product was recovered as a white solid (2.04 g, 47%); mp 71-72 °C (lit.,'^^^ 70-72 
°C); 6H(CDC13) 7.76 (2H, d, J 8.6 Hz, Ph), 7.63 (2H, d, J 8.6 Hz, Ph), 5.47 (2H, d, J 
46.9 Hz, CH2F); 8c(CDCl3) 192.6 (d, J 15.9 Hz, CO), 132.3, 132.2, 129.3, 129.3, 83.5 
(d, J 186 Hz, CH2F); 8F(CDC13) -230.49 (t, J 46.1 Hz); Vn,ax(CHCl3)/cm-' 3115, 2945, 
1687, 1588; m/z ( E I + ) 216, 218 ( M ^ ) , 183, 185 (M' ' -CH2F) . CgHeBrFO requires C, 
44.27; H, 2.79. Found: C, 44.38; H, 2.80%. 
General procedure for formation of Michael adducts 
Pyrrolidine (1.5 mmol) was added to a solution of a-fluoroacetophenone (1 mmol) in 
benzene over 4 A molecular sieves (5 g). The solution was heated under reflux and the 
progress of the reaction monitored by '^ F NMR spectroscopy. Upon consumpfion of the 
ketone, the appropriate Michael acceptor (10 mmol) was added and the solution heated 
under reflux for 12h. Water (10 ml) was added and the solution heated for a fiirther Ih. 
After cooling, the reaction was filtered through Celite and the product extracted into 
diethyl ether. The ethereal extracts were combined and washed successively with dilute 
HCl (25 ml), NaHC03 (25 ml) and water (25 ml), dried (MgS04) and the solvent 
removed under reduced pressure. Purification over silica gel eluting with CH2Cl2-light 
petroleum (40:60) afforded the desired a-fluoro ketones 138-145 as clear oils (45-
63%). 
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4-Fluoro-5-oxo-5-phenylpentanenitrile 138 
The product was recovered as a clear oil (103 mg, 55%)); 8H(CDC13) 2.30 (2H, m, CH2), 
2.62 (2H, m, CH2), 5.74 ( IH , ddd, J48.4, 8.9, 3.6 Hz, CHF), 7.49-7.98 (5H, m, Ph); 
8c(CDCl3) 13.0 (d, J 5.0 Hz, CH2), 28.0 (d, 721.8 Hz, CH2), 90.7 (d, J 185 Hz, CHF), 
118.4 (CN), 128.9, 129.0, 133.7, 134.4, 194.6 (d, J20.1 Hz, CO); 8F(CDC13) -190.95 
(ddd, J 48.5 and 29.0 Hz); Vmax(neat)/cm-' 3110, 2985, 2248, 1698, 1597; m/z (CI+) 191 
(M^, 9.5%), 209 (M^+18, 100%). CnHuNOF (MH^) requires 192.0825. Found: 
192.0827. 
5-Fluoro-6-oxo-6-phenylhexan-2-one 139 
The product was recovered as a clear oil (127 mg, 52%); 8H(CDC13) 2.13 (3H, s, Me), 
2.20 (2H, m, CH2), 2.67 (2H, m, CH2), 5.68 ( IH, ddd, / 49.6, 9.0 and 3.6 Hz, CHF), 
7.42-7.99 (5H, m, Ph); 6c(CDCl3) 26.4 (d, J 21.3 Hz, CH2), 29.9 (Me), 37.6 (d, J 3.4 
Hz, CH2), 91.7 (d, J 181.6 Hz, CHF), 128.6, 128.7, 128.7, 133.9, 195.9 (d, J 18.3 Hz, 
C O ) ; 8F(CDC13) -193.46 (ddd, J 50.0 and 19.2 Hz); Vmax(neat)/cm-' 2923, 1710, 1702, 
1597; m/z ( C I + ) 209 (M^+1, 100%), 226 (M^+18, 82.8%). C,2Hi402F (MH^) requires 
209.0978. Found: 209.0975. 
;77 
Methyl 4-fluoro-5-oxo-5-phenylpentanoate 140 
OMe 
The product was recovered as a clear oil (137 mg, 60%); 8H(CDC13) 2.25 (2H, m, CH2), 
2.58 (2H, m, CH2), 3.69 (3H, s, OMe), 5.75 ( I H , ddd, 7 49.2, 9.2 and 3.2 Hz, CHF), 
7.45-8.01 (5H, m, Ph); 8c(CDCl3) 27.6 (d, J 21.4 Hz, CH2), 28.6 (d, J 3.4 Hz, CH2), 
51.8 (OMe), 91.8 (d, J 182.8 Hz, CHF), 128.8, 128.8, 128.8, 133.9, 173.0 (C02Me), 
195.7 (d, J 18.7 Hz, CO); 8F(CDC13) -193.02 (ddd, J50.8 and 19.2 Hz); Vn,a.x(neat)/cm-' 
2953, 1737, 1700, 1597; m/z (CI+) 225 (M^+1, 100%), 242 (M''+18, 72.4%). 
C Z H H O J F ( M H * ) requires 225.092697. Found: 225.092700. 
Methyl 5-(4-bromophenyl)-4-fluoro-5-oxopentanoate 141 
OMe 
The product was recovered as a clear oil (79 mg, 57%); 8H(CDC13) 2.18 (2H, m, CH2), 
2.54 (2H, m, CH2), 3.72 (3H, s, OMe), 5.70 ( IH, ddd, J 49.2, 8.9 and 3.7 Hz, CHF), 
7.65 (2H, d, J 8.6 Hz, Ph), 7.90 (2H, d, J 8.6 Hz, Ph); 8c(CDCl3) 195.0 (d, J 19.1 Hz, 
CO), 173.0 (C02Me), 132.6, 132.2, 130.4, 129.3, 92.0 (d, J 183.2 Hz, CHF), 51.9 
(OMe), 28.5 (d, J 3.4 Hz, CH2), 27.6 (d, J 21.3 Hz, CH2); 8F(CDC13) -192.3 (ddd, J 
50.0 and 32.3 Hz); Vn,ax(neat)/cm-' 2950, 1735, 1700, 1585, 1437, 1399, 1219, 1175; 
m/z ( C I + ) 303, 305 (M*+l, 63%), 320, 322 ( M V 1 8 , 100%). C,2Hi603BrFN (M+NH4^) 
requires 320.0298. Found: 320.0298. 
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Methyl 4-fluoro-5-(4-mtrophenyl)-5-oxopentanoate 142 
OMe 
The product was recovered as a clear oil (85 mg, 45%); 8H(CDC13) 2.21 (2H, m, CH2), 
2.57 (2H, m, CH2), 3.66 (3H, s, OMe), 5.67 ( I H , ddd, J 49.0, 8.9 and 3.6 Hz, CHF), 
8.21 (2H, d, J 8.8 Hz, Ph), 8.35 (2H, d, J 8.8 Hz, Ph); 8c(CDCl3) 194.8 (d, J 10 Hz, 
CO), 172.9 (C02Me), 150.6, 138.4, 130.1, 123.9, 92.4 (d, J 183.6 Hz, CHF), 51.9 
(OMe), 28.4 (d, J 3.4 Hz, CH2), 27.3 (d, J 21.4 Hz, CH2); 8F(CDC13) -192.0 (ddd, J 
50.0 and 32.7 Hz); Vmax(neat)/cm-' 2952, 1733, 1706, 1603, 1525, 1438, 1347, 1218, 
1173; m/z (GC-MS) (EI+) 269 ( M ^ 6%), 238 (M^-31, 15%); (CI+) 287 ( M V I 8 , 82%). 
C12H12O5FN (M*) requires 269.0699. Found: 269.0700. 
Methyl 4-fluoro-5-(4-methoxyphenyl)-5-oxopentanoate 143 
MeO 
OMe 
The product was recovered as a clear oil (75 mg, 51%); 6H(CDC13) 2.19 (2H, m, CH2), 
2.53 (2H, m, CH2), 3.65 (3H, s, OMe), 3.81 (3H, s, OMe), 5.64 ( IH, ddd, J49.5, 9.6 
and 3.6 Hz, CHF), 6.90 (2H, d, J 9.2 Hz, Ph), 7.96 (2H, d, J 9.2 Hz, Ph); 8c(CDCl3) 
194.1 (d, J 18.3 Hz, CO), 173.2 (COjMe), 164.1, 131.3, 126.8, 114.0,91.8 (d, J 182.0 
Hz, CHF), 55.5 (OMe), 51.8 (OMe), 28.7 (d, J3.8 Hz, CH2), 27.8 (d, J21.4 Hz, CH2); 
8F(CDC13) -192.4 (ddd, J 50.0 and 32.3 Hz); Vma,x(neat)/cm-' 2955, 1735, 1700, 1685, 
1601, 1261, 1174; m/z (EI+) 254 ( M \ 2%); (CI+) 255 ( M > 1 , 12%). Ci3H,604F (MH^) 
requires 255.1033. Found: 255.1033. 
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3-(l-Fluoro-2-oxo-2-phenylethyl)cyclohexanone 144 
The product was recovered as a clear oil (125 mg, 48%) and as an inseparable mixture 
of diastereoisomers (62:38). 
Major diastereoisomer: 8H(CDC13) 5.53 ( IH, dd, J 48.8 and 3.6 Hz, CHF); 
8c(CDCl3) 209.6 (CO), 195.4 (d, J 19.8 Hz, COCHF), 95.6 (d, J 188.4 Hz, CHF); 
8F(CDC13) -199.27 (dd, J48.5 and 24.1 Hz). 
Minor diastereoisomer: 8H(CDC13) 5.42 ( IH, dd, J 48.6 and 3.2 Hz, CHF); 
8c(CDCl3) 209.7 (CO), 195.5 (d, J 19.5 Hz, COCHF), 95.6 (d, J 188.4 Hz, CHF); 
8F(CDC13) -199.6 (dd, J48.5 and 24.8 Hz). 
vmax(neat)/cm-' 3115, 2942, 1709, 1597; m/z (CI+) 235 (M^+1, 19.3%), 252 
(M^+18, 100%). C,4H,602F(MH*) requires 235.1134. Found: 235.1137. 
Methyl 4-fluoro-2-methyl-5-oxo-5-phenylpentanoate 145 
OMe 
The product was recovered as a clear oil (95 mg, 40%) and as an inseparable mixture of 
diastereoisomers (52:48). 
Major diastereoisomer: 8H(CDC13) 1.25 (3H, d, J 7.2 Hz, Me), 3.67 (3H, s, 
OMe), 5.65 ( IH, ddd, /46.6, 9.0 and 3.4 Hz, CHF); 6c(CDCl3) 195.6 (d, J 17.9 Hz, 
COCHF), 175.9 (COiMe), 91.6 (d, J 183.9 Hz, CHF); 8F(CDC13) -189.2 (ddd, J 50.0, 
33.9 and 16.6 Hz). 
Minor diastereoisomer: 8H(CDC13) 1.30 (3H, dd, / 7.2 and 0.8 Hz, Me), 3.75 
(3H, s, OMe), 5.77 ( IH , ddd, J49.8, 10.8 and 2.4 Hz, CHF); 6c(CDCl3) 196.0 (d, J 19.4 
180 
Hz, COCHF), 176.2 (C02Me), 91.3 (d, J 181.2 Hz, CHF); 6F(CDC13) -193 .4 (ddd, J 
50.0, 38.0 and 15.1 Hz). 
vn,ax(neat)/cm-' 3110, 2985, 1732, 1701, 1597; m/z (CI+) 239 (M^'+l, 100%), 
256 ( M V I 8 , 78%) . CnHijOaF (MH^) requires 239.1083. Found: 239.1084. 
Methyl (2S)-N-ethoxycarbonylpyrrolidme-2-carboxylate 149 ,203 
O ^ O E t 
A solution of (5)-(-)-proline (25.0 g, 217.0 mmol) in dry methanol (150 ml) was added 
to anhydrous K2CO3 (28.6 g, 2 1 7 mmol) followed by the addition of ethyl chloroformate 
(49.0 g, 434 mmol) over 5 min at 25 °C. The reaction mixture was stirred for 12 h at 0 
°C and then the excess MeOH was removed under reduced pressure and water (100 ml) 
was added. The reaction was extracted into chloroform (3 x 50 ml) and the combined 
organic extracts were washed with brine (2 x 30 ml) and then dried over MgS04. 
Removal of the solvent under reduced pressure gave the title compound (as a 1:1 
mixture of two conformers by NMR analysis) (39.5 g, 91%) as a colourless oil; 
6H(CDC13) 4 . 1 2 ( 2 H , m, CH2), 3.92 ( 2 H , m, CH2), 3.49 ( 3 H , s, OMe), 3.33 ( IH, m, 
CH), 1.9 ( 4 H , m, CH2), 1.03 ( 3 H , m, CH3); 6c(CDCl3) (two conformers 1:1) 172.7, 
172.6, 154.5, 154.0, 60.7, 58.5, 58.2, 51.5, 4 6 . 1 , 45.7, 30.3, 29.3, 23.7, 22.9, 14.1, 14.0; 
v„,ax(neat)/cm-' 2980, 2 8 8 1 , 1748, 1704, 1414, 1381, 1348, 1277; m/z (CI+) 202 (M+H, 
100%), 142 ( 1 2 % ) ; ( E I + ) 201 ( M ^ 1.3%). 
l,l-Diphenyl-5,6,7,7a-tetrahydro-]H,3H-pyrrolo[],2-c][],3]oxazol-3-om 150 
A solution of phenylmagnesium bromide in THF (1.0 M , 386 ml, 386 mmol) was added 
to a solution of methyl (2<S)-jV-ethoxycarbonylpyrroIidine-2-carboxylate (39.0g, 193 
mmol) in THF (100 ml) under an inert atmosphere of N2 at 0 °C. The solution was 
warmed to room temperature and heated under reflux for 3 h. The reaction was then 
added to an ice cold solution of NH4CI, and the aqueous layer extracted into ethyl 
acetate (4 x 100 ml). The combined organic extracts were dried over MgS04 and the 
solvent removed to afford the title compound (44.0g, 82%) as a white solid, which was 
recrystallised from diethyl ether; mp 148-149 °C (lit.,^^^ 147-148 ° C ) ; 8H(CDC13) 7.53-
7.21 (lOH, m, Ph), 4.53 ( IH , m, CH), 3.64, 3.31 (2H, AB, CH2N), 1.83 (4H, m, CH2), 
1.15 ( IH , m, CH); 8c(CDCl3) 160.3, 143.1, 140.1, 128.4, 126.6, 125.0, 85.7, 69.0, 45.9, 
28,8, 24.7; Vmax(KBr)/cm-' 2969, 2863, 1976, 1757, 1583, 1492, 1447, 1374, 1255; m/z 
(EI) 279.1 ( M \ 27%), 105.0 (100%). CigHnNOj requires C, 77.38; H, 6.14; N, 5.02. 
Found: C, 77.55; H, 6.15; N , 5.10%. 
(2S)-2-(Diphenylmethyl)pyrrolidme 151 
I 
H 
Ph 
Ph 
A mixture of l,l-Diphenyl-5,6,7,7a-tetrahydro-l//,3//-pyrrolo[l,2-c][l,3]oxazol-3-one 
(5.0 g, 17.9 mmol) and Pd/C (1.0 g) (10%) in methanol (100 ml) was hydrogenated at 
ambient temperature for 48 h. The catalyst was filtered off and the methanol removed 
under reduced pressure. Purification, firstly over silica gel eluting with ethyl acetate and 
then methanol, followed by distillation, gave the title compound (2.8 g, 67%i) as a 
colourless oil; [ah -7.84 (c 2.05, CHCI3) [lit., -7.8 (c 2.11, CHCI3)]; 5H(CDC13) 7.28 
(lOH, m, Ph), 3.89 (2H, m, CH), 2.93, 2.85 (2H, AB, CH2N), 1.69 (4H, m, CH2), 1.37 
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( IH , m, CH2); 8c(CDCl3) 142.9, 142.8, 128.6, 128.4, 128.0, 126.4, 62.1, 57.2, 45.6, 
30.5, 24.3; Vn,ax(neat)/cm-' 3405, 2962, 1596, 1494, 1450, 1399, 1348; m/z (CI) 238.4 
( M ^ 39%). 
6.5 Experimental to Chapter Five 
Methyl 2-bromohexanoate 162 
Bromine (17.06 g, 5.5 ml, 0.11 mmol) was added dropwise to a mixture of methyl 
hexanoate (3.5 g, 27.0 mmol) and red phosphorus (1.25 g, 40.5 mmol) at 80 °C. The 
reaction was kept at 80 °C for 16 h and was then cooled to 0 °C. Methanol (50 ml) was 
added dropwise over 1 h, the reaction was allowed to warm to room temperature and 
was then heated to 80 °C until the evolution of HBr ceased. The mixture was poured 
into light petroleum (200 ml), and NaHS03 (2 g) in water (150 ml) was added. The 
aqueous layer was separated and washed with water until neutral (4 x 100 ml). The 
organic extracts were dried (MgS04) and the solvent removed under reduced pressure, 
giving a yellow oil. Purification by distillation (53 °C, 0.1 mmHg) afforded the title 
compound as a colourless oil (4.8 g, 86%); 8H(CDCI3) 4.22 ( IH, t, J 7.4 Hz, CHBr), 
3.78 (3H, s, OMe), 2.04 (2H, m, CH2), 1.36 (4H, m, CH2), 0.91 (3H, t, J7.0 Hz, CH3); 
8c(CDCl3) 170.4 (CO), 52.9 (OMe), 45.7 (CHBr), 34.6 (CH2), 29.4 (CH2), 21.9 (CH,), 
13.8 (CH3); Vmax(neat)/cm-' 2956, 2932, 2872, 1745, 1436, 1154; m/z (GC-MS) (EI+) 
208 ( M ^ 0.25%) 210 (M''+2, 0.25%), 152 (M^-56, 100%), 154 (M^+2-56, 100%). 
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Methyl 2-fluorohexanoate 163 
Silver(l) fluoride (2.5 g, 19.7 mmol) was added to a solution of methyl 2-
bromohexanoate (0.96 g, 4.6 mmol) in acetonitrile (20 ml) containing water (0.5 ml), 
and the slurry was stirred vigorously for 24 h at 80 °C. The reaction was allowed to 
cool and was then filtered through Celite to remove the remaining silver salts. The 
filtrate was washed with water and extracted into CH2CI2 (3 x 50 ml). The organic 
extracts were combined, dried (MgS04) and the solvent removed 'under reduced 
pressure to give a yellow oil. Purification over silica gel, eluting with light petroleum-
diethyl ether (90:10), afforded the title compound as a colourless oil (0.55 g, 80%); 
8H(CDC13) 4.90 ( I H , dt, J48 and 6.5 Hz, CHF), 3.78 (3H, s, OMe). 1.87 (2H, m, CH2), 
1.38 (4H, m, CH2), 0.91 (3H, t, J6.9 Hz, CH3); 8c(CDCl3) 170.5 (d, J 23.7 Hz, CO), 
89.0 (d, 183 Hz, CHF), 52.2 (OMe), 32.1 (d, J 20.8 Hz, CH2), 26.4 (d, J 3 Hz, CH2), 
22.1 (CH2), 13.7 (CH3); 8F -192.6 (dt, J46.5 and 24.0 Hz); Vmax(neat)/cm-' 2960, 2932, 
2870, 1757, 1197; m/z (GC-MS) (EI+) 149 (MH^, 1%), 92 (M^-56,100%). 
2-Fluorohexanol 164 
A solution of methyl 2-fluorohexanoate (0.65 g, 4.4 mmol) in diethyl ether (10 ml) was 
added dropwise to a solution of LiAlH4 (0.33 g, 8.7 mmol) in diethyl ether (25 ml). The 
reaction was stirred at room temperature until the starting material was consumed (TLC) 
and then it was cooled to 0 °C and water cautiously added. The alkaline solution was 
neutralised with hydrochloric acid and the aqueous phase extracted into diethyl ether (3 
X 50 ml). The ethereal extracts were combined, dried (MgS04), and the solvent 
removed under reduced pressure. Purification over silica gel eluting, with light 
petroleum-diethyl ether (70:30), afforded the title compound as a clear oil (0.41 g, 
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77%); 8H(CDC13) 4.57 ( I H , dm, J48 Hz, CHF), 3.68 (2H, dd, J21 and 6 Hz, CH2OH), 
2.20 ( I H , br s, OH), 1.24-1.75 (6H, m, CH2), 0.90 (3H, t, J 6 Hz, CH3); 8c 94.7 (d, J 
167 Hz, CHF), 64.7 (d, J21.7 Hz, CH2OH), 30.6 (d, J20.2 Hz, CH2), 26.9 (d, J4.7 Hz, 
CH2), 22.4 (CH2), 13.8 (CH3); 8F (CDCI3) -190.0 (septet, J 46.6 and 22.2 Hz); 
Vmax(neat)/cm-' 3354, 2956, 2932, 2872, 2862, 1466, 1058; m/z (GC-MS) (EI+) 102 
(M^-18, 0.3%), 88 (3.3%), 69 (28%). 
2-Fluorohexanal 165 
A solution of 2-fluorohexanol (0.35 g, 2.9 mmol) in CH2CI2 (5 ml) was added to a 
suspension of pyridinium chlorochromate (1.24 g, 5.8 mmol) and dry powdered 3 A 
molecular sieves (4 g) in CH2CI2 (40 ml), and the reaction stirred under N2 at room 
temperature for 2 h. The reaction mixture was filtered through a silica gel pad and was 
washed with CH2CI2 (250 ml) to remove chromium salts. The solvent was removed 
imder reduced pressure to give the title compound as a clear oil (0.22 g, 64%)); 
8H(CDC13) 9.75 ( I H , d, J6.4 Hz, CHO), 4.95 ( IH, dt, J48.5 and 6.7 Hz, CHF), 1.10-
1.75 (6H, m, CH2), 0.90 (3H, t, J6.8 Hz, CH3); 8F -200.0 (dt, J48.5 and 24.7 Hz); 
Vmax(neat)/cm-' 2957, 2925,2850,1735,1436,1340. 
2-Fluorohexanal l-(2,4-dinitrophenyl)hydrazone 166 
A solution of 2,4-dinitrophenylhydrazine in 2 M hydrochloric acid (10 ml) was added to 
2-fluorohexanal (100 mg, 0.85 mmol) and the mixture shaken to coagulate and left to 
stand for 15 min. An orange precipitate formed, which was collected by filtration, 
washed with water and dried in vacuo to afford the title product as an orange solid (125 
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mg, 49%); mp 69.5-70.5 °C (lit . , '" ' 70-71 °C); 8h(CDC13) 11.10 ( I H , s, N H ) , 9.13 ( IH, 
dd, J21 Hz, CH), 8.31 ( IH , m, Ph), 7.92 ( IH, d, J 9 Hz, Ph), 7.53 ( IH, m, Ph), 5.15 
( IH , dm, J 48 Hz, CHF), 1.25-2.05 (6H, m, CH2), 0.95 (3H, t, J 6.9 Hz, CH3); 
8c(CDCl3) 152.7, 147.4 (d, J27 Hz, CH), 137.6, 129.8, 128.6, 123.4, 116.5, 91.3 (d, J 
167 Hz, CHF), 33.0 (d, J22.0 Hz, CH2), 26.4 (d, J4 Hz, CH2), 22.4 (CH2), 13.9 (CH3); 
8f -182.9 (dm, J 47.6 and 20 Hz); Vn,ax(CHCl3)/cm-' 3290, 3019, 2960, 1793, 1617, 
1594, 1467, 1381, 1216; m/z (EI+) 298 ( M ^ 0.81%), 279 (M^-19, 5%). C,2H,5FN404 
(M^) requires 298.1077. Found: 298.1077. 
6.6 General protocol for enzyme assays 
Cyclohex-l-enylcarbonyl-CoA reductase 
A solution of cyclohex-l-enylcarbonyl-CoA (10 |xl, 10 mM stock) was added to a 
solution containing NADPH (10 10 mM stock), cyclohex-l-enylcarbonyl-CoA 
reductase (CHCR) (2 \i) and a phosphate buffer (978 \x\, 50 mM potassium phosphate 
buffer at pH 7.3 containing 10%) glycerol). The reaction was followed by monitoring 
the depletion of NADPH spectrophotomerically at 340 nm. Initial rates were 
determined fi-om the obtained plots. 
^Lactamase I 
A solution of ^-lactamase 1 from Bacillus cereus (100 [xl, 10 units) was added to a 
solution of cyclohexylammonium 6a-fluoropenicillanate (1 ml, 1 mM stock) in 
phosphate buffer (pH 7) in a cuvette. The hydrolysis reaction was monitored 
spectrophotomerically at 240 nm. 
Methanolic hydrolysis of 90 and 93 
A solution of methanolic sodium methoxide (125 \x\, 0.5 mM) was added to a solution of 
benzyl 6a-fluoropenicillanate (170.5 (j,l, 1.5 mM) in methanol (2.2045 ml) in a cuvette. 
The hydrolysis reaction was monitored spectrophotomerically at 310 nm and the rates 
calculated from the obtained plots. 
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Transketolase 
A solution of hydroxypyruvic acid (110 mg, 1 mmol) and 2-fluorohexanal (50mg, 0.4 
mmol) in glycylglycine buffer (20 ml, 100 mmol dm"'^ , pH 7.6) was added to a solution 
of magnesium chloride (1 mg, 6 mmol), thiamine pyrophosphate ( 11.25 mg, 
0.025mmol) and transketolase (50 U) in glycylglycine buffer (0.5 ml, 100 mmol dm'^, 
pH 7.6). The pH of the solution was then adjusted to 7.6 with NaOH (0.1 mol dm"^). 
The reaction was allowed to proceed at 29 °C on an orbital shaker and was monitored by 
'^F NMR spectroscopy. 
Glycerol-3-phosphate dehydrogenase 
A solution of glycerol-3-phosphate (290 \xl, 100 U) was added to a solution containing 
monofluorophosphonate 172 (11.4 mg, 29.5 \xmo\), p-fluoropyruvic acid (5.7 mg, 44.3 
nmol), NAD* (18.5 mg, 25 [imol) and lactate dehydrogenase (400 (xl, 2000 U) in 
phosphate buffer (pH 7, 500 jxl). The reaction was allowed to proceed at 30 °C and the 
reaction was monitored by '^ F NMR spectroscopy. 
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Chapter Seven 
Appendices 
[88 
Appendices 
7.1 Appendix 1 
7.1.1 Derivation of equation (3.1) 
-1 fest 
P + MeO ^ P.OMe FN" ^ 
MeOH 
PNH + MeO" 
I f we assume that the C-N bond breaking is rate limiting then. 
d[PNH] , 
- d ^ = ' ^ 
P.OMe" (Al ) 
[P] + [p. O M e ] + [PNH] = constant 
d P d P.OMe d[PNH] 
—— + — — ; + ; = 0 
dt dt dt 
(A2) 
P.OMe"! , , [P.OMe-
P][MeO" K,[MeO-' 
d[p] 1 d[p.OMe-
dt ~K, [MeO-] dt 
(A3) 
Substituting eqns. ( A l ) and (A3) into eqn. (A2) gives 
1 
Ki [MeO-] dt 
dfp.OMe-] dfp.OMe ] , [ o ^ . , -! - i i + - I J + P.OMe = 0 
dt ^ 
dfP.OMe l ( 1 
^ ^ 1 + dt K, [MeO-] j 
+ A;2[P.0Me"] = 0 
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-d[P.OMe-
dt = -t„,JP.OMe-
••obs 1 + [ K,[MeO-
k, =0 
^obs ~ 
^,Ki[MeO-
l + Ki[MeO" 
(3.1) 
7.1.2 Stopped-flow spectrometry 
For measurement of rate constants too fast to measure by conventional methods, a High-
Tech SF-3 series stopped-flow spectrometer was used. This is shown schematically in 
Fig. 7.1. 
Reservoirs 
Drive 
Piston 
Light Source 
Monochromator 
Waste Reservoir 
Solution A 
Trigger 
Solution B 
;M = Mixing Point 
iO = Observation Point; 
! T = Three Way Tap 
Photomultiplier 
r 
Amplifier ' L 
Oscilloscope 
Data 
Collection 
System 
Back Stop 
Fig. 7.1 
The two solutions to be reacted, A and B, are stored in reservoirs and are drawn 
into two identical syringes so that equal volumes are mixed. The syringes are 
compressed simultaneously, and mixing occurs at point M extremely rapidly. The dead 
time of this machine is estimated to be 2 ms so reactions with half-lives smaller than 
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this carmot be measured by stopped-flow techniques. The mixture flows into a 
thermostatted 2 mm path length quartz cell at point O. The plunger of the third syringe 
will hit a stop and the flow of solution will be stopped. Hitting the stop also triggers the 
acquisition of data from the reaction. The reaction is observed by passing a beam of 
monochromatic light of an appropriate wavelength through the cell by fibre-optic cable. 
The light is passed through a photomultiplier and the change in voltage measured due to 
a change in absorbance of the solution is observed. The software used to run the 
stopped-flow machines also transforms voltage/time data into absorbance/time data. It 
also calculates the observed rate constants. 
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7.2 Appendix 2 
7.2.1 Requirements for the Board of Studies 
The Board of Studies in Chemistry requires that each postgraduate research thesis 
contains an appendix Hsting:-
(i) Al l research colloquia, seminars and lectures arranged by the Department of 
Chemistry during the period of the author's residence as a postgraduate student. 
(ii) Lectures organised by Durham University Chemical Society. 
(iii) Details of the Postgraduate induction course. 
(iv) Al l research conferences attended and papers presented by the author during the 
period when research for the thesis was carried out. 
7.2.2 Colloquia, lectures and seminars from invited speakers 
1993-1994 (August 1-July 31) 
September 13 Prof Dr. A. D. Schliiter, Freie Universitat Berlin, Germany 
Synthesis and Characterisation of Molecular Rods and Ribbons 
September 13 Dr. K. J. Wynne, Office of Naval Research, Washington, USA 
Polymer Surface Design for Minimal Adhesion 
September 14 Prof J. M. DeSimone, University of North Carolina, Chapel Hill, USA 
Homogeneous and Heterogeneous Polymerisations in Environmentally 
Responsible Carbon Dioxide 
September 28 Prof. H. Ila, North Eastern Hill University, India 
Synthetic Strategies for Cyclopentanoids via Oxoketene Dithioacetals 
October 4 Prof F. J. Feher,t University of California, Irvine, USA 
Bridging the Gap between Surfaces and Solution with Sessilquioxanes 
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October 14 Dr. P. Hubberstey, University of Nottingham 
*Alkali Metals: Alchemist's Nightmare, Biochemist's Puzzle and 
Technologist's Dream 
October 20 Dr. P. Quayle,t University of Manchester 
* Aspects of Aqueous ROMP Chemistry 
October 21 Prof R. Adams,t University of South Carolina, USA 
* Chemistry of Metal Carbonyl Cluster Complexes: Development of 
Cluster Based Alkyne Hydrogenation Catalysts 
October 27 Dr. R. A. L. Jones,t Cavendish Laboratory, Cambridge 
Perambulating Polymers 
November 10 Prof M. N. R. Ashfold,t University of Bristol 
High Resolution Photofragment Translational Spectroscopy : A New 
Way to Watch Photodissociation 
November 17 Dr. A. Parker,^ Rutherford Appleton Laboratory, Didcot 
Applications of Time Resolved Resonance Raman Spectroscopy to 
Chemical and Biochemical Problems 
November 24 Dr. P. G. Bruce,''' University of St. Andrews 
Structure and Properties of Inorganic Solids and Polymers 
November 25 Dr. R. P. Wayne, University of Oxford 
* The Origin and Evolution of the Atmosphere 
December 1 Prof M. A. McKervey,t Queen's University, Belfast 
* Synthesis and Applications of Chemically Modified Calixarenes 
December 8 Prof O. Meth-Cohn,"!" University of Sunderland 
*FriedeTs Folly Revisited—A Super Way to Fused Pyridines 
193 
December 16 Prof R. F. Hudson, University of Kent 
Close Encounters of the Second Kind 
January 26 Prof J. Evans,t University of Southampton 
Shining Light on Catalysts 
February 2 Dr. A. Masters,t University of Manchester 
Modelling Water Without Using Pair Potentials 
February 9 Prof D. Young,t University of Sussex 
*Chemical and Biological Studies on the Coenzyme Tetrahydrofolic Acid 
February 16 Prof K. H. Theopold, University of Delaware, USA 
Paramagnetic Chromium Alkyls : Synthesis and Reactivity 
February 23 Prof P. M . Maitlis,t University of Sheffield 
* Across the Border: From Homogeneous to Heterogeneous Catalysis 
March 2 Dr. C. Hunter,t University of Sheffield 
*Noncovalent Interactions between Aromatic Molecules 
March 9 Prof F. Wilkinson, Loughborough University of Technology 
Nanosecond and Picosecond Laser Flash Photolysis 
March 10 Prof S.V. Ley, University of Cambridge 
*New Methods for Organic Synthesis 
March 25 Dr. J. Dilworth, University of Essex 
Technetium and Rhenium Compounds with Applications as Imaging 
Agents 
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April 28 Prof R. J. Gillespie, McMaster University, Canada 
The Molecular Structure of some Metal Fluorides and Oxofluorides: 
Apparent Exceptions to the VSEPR Model. 
May 12 Prof D. A. Humphreys, McMaster University, Canada 
* Bringing Knowledge to Life 
May 27 Prof. J.-M. Lehn, (Musgrave Lecture), University of Strasbourg, France. 
* Perspectives in Supramolecular Chemistry from molecular recognition 
towards self-organisation. 
1994-1995 (August 1-July 31) 
October 5 Prof N . L. Owen, Brigham Young University, Utah, USA 
* Determining Molecular Structure—the INADEQUATE NMR way 
October 19 Prof N . Bartlett, University of California 
*Some Aspects of Ag" and Ag'" Chemistry 
November 2 Dr. P. G. Edwards, University of Wales, Cardiff 
The Manipulation of Electronic and Structural Diversity in Metal 
Complexes—New Ligands 
November 3 Prof B. F. G. Johnson, Edinburgh University 
Arene-metal Clusters 
November 9 Dr. G. Hogarth, University College, London 
New Vistas in Metal-imido Chemistry 
November 10 Dr. M. Block, Zeneca Pharmaceuticals, Macclesfield 
Large-scale Manufacture of ZD 1542, a Thromboxane Antagonist 
Synthase Inhibitor 
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November 16 Prof. M. Page, University of Huddersfield 
*Four-membered Rings and /3-Lactamase 
November 23 Dr. J. M. J. Williams, University of Loughborough 
*New Approaches to Asymmetric Catalysis 
December 7 Prof D. Briggs, ICI and University of Durham 
Surface Mass Spectrometry 
January 11 Prof P. Parsons, University of Reading 
* Applications of Tandem Reactions in Organic Synthesis 
January 18 Dr. G. Rumbles, Imperial College, London 
Real or Imaginary Third Order Non-linear Optical Materials 
January 25 Dr. D. A. Roberts, Zeneca Pharmaceuticals 
* The Design and Synthesis of Inhibitors of the Renin-angiotensin System 
February 1 Dr. T. Cosgrove, Bristol University 
* Polymers do it at Interfaces 
February 8 Dr. D. O'Hare, Oxford University 
Synthesis and Solid-state Properties of Poly-, Oligo- and Multi-decker 
Metallocenes 
February 22 Prof E. Schaumann, University of Clausthal 
* Silicon- and Sulfur-mediated Ring-opening Reactions of Epoxide 
March 1 Dr. M. Rosseinsky, Oxford University 
Fullerene Intercalation Chemistry 
March 22 Dr. M. Taylor, University of Auckland, New Zealand 
Structural Methods in Main-group Chemistry 
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April 26 Dr. M. Schroder, University of Edinburgh 
Redox-active Macrocyclic Complexes : Rings, Stacks and Liquid Crystals 
May 4 Prof. A. J. Kresge, University of Toronto 
The Ingold Lecture: Reactive Lntermediates: Carboxylic acid Enols and 
Other Unstable Species 
1995-1996 (August 1-July 31) 
October 11 Prof. P. Lugar, Frei Univ Berlin, FRG 
Low Temperature Crystallography 
October 13 Prof. R. Schmutzler, Univ Braunschweig, FRG. 
Calixarene-Phosphorus Chemistry: A New Dimension in Phosphorus 
Chemistry 
October 18 Prof. A. Alexakis, Univ. Pierre et Marie Curie, Paris, 
*Synthetic and Analytical Uses of Chiral Diamines 
October 25 Dr. D. Martin Davies, University of Northumbria 
Chemical Reactions in Organised Systems. 
November 1 Prof W. Motherwell, University College, London 
*New Reactions for Organic Synthesis 
November 3 Dr B. Langlois, University Claude Bernard-Lyon 
* Radical Anionic and Pseudo-Cationic Trifluoromethylation 
November 8 Dr. D. Craig, Imperial College, London 
*New Strategies for the Assembly of Heterocyclic Systems 
November 15 Dr. Andrea Sella, UCL, London 
Chemistry of Lanthanides with Polypyrazoylborate Ligands 
November 17 Prof. David Bergbreiter, Texas A & M , USA 
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Design of Smart Catalysts, Substrates and Surfaces from Simple 
Polymers 
November 22 Prof L Soutar, Lancaster University 
*A Water of Glass? Luminescence Studies of Water-Soluble Polymers. 
November 29 Prof Dermis Tuck, University of Windsor, Ontario, Canada 
New Indium Coordination Chemistry 
December 8 Prof M. T. Reetz, Max Planck Institut, Mulheim 
*Perkin Regional Meeting 
January 10 Dr. Bill Henderson, Waikato University, NZ 
Electrospray Mass Spectrometry - a new sporting technique 
January 17 Prof J. W. Emsley , Southampton University 
Liquid Crystals: More than Meets the Eye 
January 24 Dr. Alan Armstrong, Nottingham Univesity 
*Alkene Oxidation and Natural Product Synthesis 
January 31 Dr. J. Penfold, Rutherford Appleton Laboratory, 
Soft Soap and Surfaces 
February 7 Dr. R. B. Moody, Exeter University 
Nitrosations, Nitrations and Oxidations with Nitrous Acid 
February 12 Dr. Paul Pringle, University of Bristol 
Catalytic Self-Replication of Phosphines on Platinum(O) 
February 14 Dr. J. Rohr, University of Gottingen, FRG 
Goals and Aspects of Biosynthetic Studies on Low Molecular Weight 
Natural Products 
February 21 Dr C. R. Pulham , University of Edinburgh 
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Heavy Metal Hydrides—An Exploration of the Chemistry ofStannanes 
and Plumbanes 
February 28 Prof. E. W. Randall, Queen Mary & Westfield College 
New Perspectives in NMR Imaging 
March 6 Dr. Richard Whitby, University of Southampton 
New Approaches to Chiral Catalysts: Induction of Planar and Metal 
Centred Asymmetry 
March 7 Dr. D. S. Wright, University of Cambridge 
Synthetic Applications of Me2N-p-Block Metal Reagents 
March 12 Prof. V. Balzani, University of Bologna 
RSC Endowed Lecture: *Supramolecular Photochemistry 
March 13 Prof. Dave Gamer, Manchester University 
Mushrooming in Chemistry 
April 30 Dr. L. D. Pettit, Chairman, lUPAC Commission of Equilibrium Data 
pH-Metric Studies using Very Small Quantities of Uncertain Purity 
t Invited specially for the graduate training programme. 
* Attended by the author. 
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7.2.5 First year induction courses 
This course consisted of a series of one hour lectures on the services available in the 
department. 
Departmental Organisation 
Safety Matters 
Electrical Appliances 
Chromatography and Microanalysis 
Absorptiometry and Inorganic Analysis 
Library Facilities 
Mass Spectroscopy 
Nuclear Magnetic Resonance Spectrocopy 
Glass Blowing Techniques 
Dr. E. J. F. Ross 
Dr. G. M. Brooke 
Mr. B. T. Barker 
Mr. T. F. Holmes 
Mr. R. Coult 
Mr. R. B. Woodward 
Dr. M. Jones 
Dr. R. S. Matthews 
Mr. R. Hart and Mr. G. Haswell 
7.2.4 Research conferences attended 
December 1993 
December 1994 
December 1994 
September 1995 
December 1995 
RSC Postgraduate Symposium on Bio-organic Chemistry, 
Exeter University. 
RSC Postgraduate Symposium on Bio-organic Chemistry, 
Durham University. 
Modem Aspects of Stereochemistry, Sheffield University. 
The 11th European Symposium on Fluorine Chemistry, Bled, 
Slovenia. 
RSC Postgraduate Symposium on Bioorganic Chemistry, 
Southampton University. 
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7.2.5 Seminars, colloquia and poster presentations 
September 1995 ¥ The 11th European Symposium on Fluorine Chemistry, 
Bled, Slovenia. 
December 1995 n RSC Postgraduate Symposium on Bioorganic Chemistry, 
Southampton University. 
December 1995 ¥ ICI Poster Competition, University of Durham. 
June 1995 ^ University of Durham Graduate Colloquia. 
n Oral presentation by the author. 
¥ Poster presentation by the author. 
7.2.6 Papers published 
Kinetic and Stereoelectronic Effects of a Fluorine Substituent on the Reaction Catalysed 
by an NADPH-Dependent Cyclohex-I -enylcarbonyl-CoA Reductase 
C. F. Bridge, D. O'Hagan, K. A. Reynolds and K. K. Wallace, J. Chem. Soc, Chem. 
Commun.. 1995,2329. 
The Synthesis of a-Fluoroketones by 1,4-Additions of Mono-Fluorinated enamines to 
Michael Acceptors 
C. F. Bridge and D. O'Hagan, J. Fluorine Chem., 1997, 82, 21. 
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